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Chapter 1 
 
General Introduction 
 
 
 
 
 
 
 
 
The roots of education are bitter, but the fruit is sweet. 
 
Aristotle 
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Psychiatry 
At the start of a treatment in a psychiatric clinic, some patients expect to lie on a couch. 
Everyday practice in psychiatry in the 21st century, however, has little to do with the former 
concept that started with the work of Sigmund Freud, in which patients used to lie on the 
therapist’s couch several times a week. In a psychiatric clinic nowadays, patients are treated 
by a multidisciplinary team with medication and psychotherapy of some kind. As to the 
effectiveness of treatment, Jensen (1990) found that patients were not very content with 
their treatment, and various reasons have been given to explain that (Astin, 1998); for 
example, conventional treatment has been ineffective (Jensen, 1990), has produced adverse 
effects (Jensen, 1990), or is seen as being too impersonal, too technologically oriented, 
and/or too costly (Astin, 1998). Studies show that patients tend to look for add-on 
complementary treatments (Samuels, Gropp, Singer, & Oberbaum, 2008). Particularly 
chronic patients, who suffer from an illness for a long time, often try complementary and 
alternative medicine (CAM) treatments in addition to allopathic medicine (Bhalerao et al., 
2013; Metcalfe, Williams, McChesney, Patten, & Jetté, 2010; Rosenberg et al., 2008). From a 
Traditional Chinese Medicine point of view (Dey, 1999), patients with schizophrenia are like 
any other patients in that they have some disharmony in their bodies that need to be 
treated. Acupuncture can be used for such a treatment. An integrative form of treatment 
that includes acupuncture can be found in regular psychiatric practice in Asia. From personal 
clinical experience, most patients instantly report a better sleep after acupuncture; 
therefore, sleep might be a mediating factor in acupuncture treatment, which is the reason 
for the focus on sleep in the current Ph.D. research. Therefore, along with the treatment for 
patients with schizophrenia, came the treatment for patients with depression, who are also 
treated with acupuncture in China and Korea and who are often characterized by comorbid 
sleep disorders. Before describing the research questions in this Ph.D. thesis in more depth, I 
will first describe the population on which this research was conducted, and I will provide 
some important factors that played some roles in the lives of those patients. Finally, I will 
give a short overview of the theories behind acupuncture. 
 
Schizophrenia 
The worldwide prevalence of schizophrenia is estimated to be between 0.5% and 1%. The 
age of onset among men is usually earlier (about 21 years of age) than it is among women 
(27 years of age). When patients who have previously been diagnosed with schizophrenia 
turn 30, about 90% of the men, but only 20% of the women, will present with a chronic stage 
of the disease (Andreasen & Black, 2006). 
 
For the clinical diagnosis of the disorder both the ICD-10 (10th revision of the International 
Classification of Diseases and Related Health Problems) (World Health Organization, 1992) 
and the DSM-5 (The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) 
(American Psychiatric Association, 2013) can be used. Both systems are revised from time to 
time, and the next edition of the ICD is expected in 2015. Some large changes in the 
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diagnostic criteria of schizophrenia occurred in the transition from DSM-IV to DSM-V. 
Moreover, differences between the ICD and the DSM systems are apparent. An overview of 
the ICD and the DSM classifications of schizophrenia and of depression and sleep disorders 
are presented below in order to best describe the population at risk. 
 
The characteristics for schizophrenia (F20), as described by the ICD-10, are presented in 
Table 1a). In addition schizophrenia can be divided into the following subtypes: paranoid 
schizophrenia, disorganized schizophrenia, catatonic schizophrenia, undifferentiated 
schizophrenia, residual schizophrenia, other schizophrenia, and schizophrenia unspecified 
(World Health Organization, 1992). 
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Table 1a.  
According to the ICD-10 (World Health Organization, 1992), the following symptoms are 
characteristic for schizophrenia. 
1. At least one of the following must be present: 
 thought echo, thought insertion or withdrawal, or thought broadcasting; 
 delusions of control, influence, or passivity, clearly referred to body or limb 
movements or specific thoughts, actions, or sensations; delusional perception; 
 hallucinatory voices giving a running commentary on the patient’s behavior, 
or discussing the patient among themselves, or other types of hallucinatory 
voices coming from some part of the body; 
 persistent delusions of other kinds that are culturally inappropriate and 
completely impossible (e.g., being able to control the weather, or being in 
communication with aliens from another world). 
2. Or at least two of the following: 
 persistent hallucinations in any modality, when occurring every day for at 
least 1 month, when accompanied by delusions (which may be fleeting or half-
formed) without clear affective content, or when accompanied by persistent 
overvalued ideas; 
 neologisms, breaks, or interpolations in the train of thought, resulting in 
incoherence or irrelevant speech; 
 catatonic behavior, such as excitement, posturing or waxy flexibility, 
negativism, mutism, and stupor; 
 negative symptoms, such as marked apathy, paucity of speech, and blunting 
or incongruity of emotional responses (it must be clear that these are not due 
to depression or to neuroleptic medication). 
 
G2. Most commonly used exclusion clauses: 
1. If the patient also meets criteria for manic episode or depressive episode, the 
criteria listed under G1(1) and G1(2) above must have been met before the 
disturbance of mood developed. 
2. The disorder is not attributable to organic brain disease or to alcohol- or drug-
related intoxication, dependence, or withdrawal. 
 
Note. G means General criteria that must be fulfilled by all members of a group of disorders. 
 
According to the DSM-5 (American Psychiatric Association, 2013), schizophrenia may be 
diagnosed when a patient has at least two of the following symptoms at the same time (see 
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Table 1b) for at least a month (Tandon et al., 2013). Note that although the DSM-V 
eliminates the use of subtypes, the clinical studies of the present Ph.D. thesis were 
conducted in Germany, where the ICD-10 is used. 
 
Table 1b.  
According to the DSM-5 (American Psychiatric Association, 2013), the following symptoms 
are characteristic of schizophrenia. 
 Delusions 
 Hallucinations 
 Disorganized speech 
 Disorganized or catatonic behavior 
 Negative symptoms 
 
 
Patients with schizophrenia often differ in their signs and symptoms, but the following 
classification, according to the National Institute of Mental Health (2009), can be made: 
1) Positive symptoms  these are symptoms that patients with schizophrenia have, but 
individuals without schizophrenia do not (Rosen et al., 1984). Here, one can think of 
delusions (Van Oosterhout et al., 2014). 
2) Negative symptoms  these are elements that patients with schizophrenia no longer 
have, but individuals without schizophrenia do (Rosen et al., 1984). An example of a negative 
symptom in a patient with schizophrenia is, for instance, the blunted affect (Lee, Chun, Yoon, 
Park, & Kim, 2014). 
3) Cognitive symptoms  like negative symptoms, cognitive symptoms (Buchanan et al., 
2007) are subtle and are often not easy to recognize as part of the disorder. Here, one can 
think of working memory problems in individuals with schizophrenia (Mayer, Fukuda, Vogel, 
& Park, 2012). 
 
The group of patients with schizophrenia is prone to suicide attempts. About one-third will 
conduct a suicide attempt; eventually about one in ten will succeed (Andreasen & Black, 
2006). The global costs of schizophrenia for society are high (Knapp, Mangalore, & Simon, 
2004; Goeree et al., 2005). Recently, a large German study by Frey (2014) was conducted on 
8224 matched (schizophrenia patient versus healthy control) pairs. The costs per year as a 
result of schizophrenia were found to be 11.304 Euros per patient from the payers’ 
perspective and 20.609 Euros from the German societal perspective. In addition, large 
variations among age groups were found. On the one hand, the highest direct medical costs 
were for the patients above 65 years of age whereas, on the other hand, the largest non-
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medical costs were incurred by patients with schizophrenia who were under 25 years of age. 
The total cost due to schizophrenia as seen from the German societal perspective ranges 
between 9.63 billion Euros and 13.52 billion Euros. In the first year after the onset of the 
disease, costs are particularly great, and they stay relatively high up until the third year after 
onset (Nicholl, Akhras, Diels, & Schadrack, 2010). 
 
Depression 
In 2004, unipolar depression was listed by the World Health Organization (World Health 
Organization, 2008) as the third most important cause of disease burden worldwide, and a 
difference existed between low-income countries, for which unipolar depression was in 
eighth place, and middle- and high-income countries, for which it was in the first place. As 
can be seen in Table 2a, the ICD-10 (World Health Organization, 1992) uses a list of ten 
depressive symptoms to identify if someone suffers from depression and to determine the 
degree of depression. Depression is listed under F32 (depressive episode) and F33 (recurrent 
depressive disorder). 
 
Table 2a.  
According to the ICD-10 (World Health Organization, 1992), the following symptoms are 
characteristic of a major depressive disorder. 
At least one of these, most days, most of the time for at least 2 weeks: 
 Persistent sadness or low mood; and/or 
 Loss of interest or pleasure 
 Fatigue or low energy 
If any of above present, ask about associated symptoms: 
 Disturbed sleep 
 Poor concentration or indecisiveness 
 Low self-confidence 
 Poor or increased appetite 
 Suicidal thoughts or acts 
 Agitation or slowing of movements 
 Guilt or self-blame 
 
A differentiation in the severity of depression can be made by using the following four 
subcategories: not depressed (< four symptoms), mild depression (four symptoms), 
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moderate depression (five to six symptoms), and severe depression (seven or more 
symptoms, with or without psychotic symptoms). According to the ICD-10, the depressive 
symptoms should exist for a duration of one month or longer, and every symptom should be 
present for most of every day (World Health Organization, 1992). According to the DSM-5 
(American Psychiatric Association, 2013), depression occurs when the individual has at least 
five of the symptoms shown in Table 2b at the same time. 
 
Table 2b. 
According to the DSM-5 (American Psychiatric Association, 2013), the following symptoms 
are characteristic for major depressive disorder. 
 A depressed mood during most of the day, particularly in the morning 
 Fatigue or loss of energy almost every day 
 Feelings of worthlessness or guilt almost every day 
 Impaired concentration, indecisiveness 
 Insomnia (an inability to sleep) or hypersomnia (excessive sleeping) almost every day 
 Markedly diminished interest or pleasure in almost all activities nearly every day 
 Recurring thoughts of death or suicide (not just fearing death) 
 A sense of restlessness or being slowed down 
 Significant weight loss or weight gain 
 
Kessler, Chiu, Demler, Merikangas, and Walters (2005) conducted a survey on 9282 
participants 18 years of age and older, and found that in 2004, 6.7% of U.S. adults 
experienced a major depressive episode. As for gender differences, women were found to 
have a higher prevalence (11.7%) than men (5.7%) (Ford & Erlinger, 2004). 
 
Differences in the major depression and the suicide attempt rates across ethnic groups have 
been reported (Oquendo, Ellis, Greenwald, Malone, Weissman, & Mann, 2001). For instance, 
Oquendo, Lizardi, Greenwald, Weissman, and Mann (2004) found ethnic differences in the 
percentages of the American population that suffer from a major depression: 6.52% among 
whites, 4.57% among blacks, and 5.17% among Hispanics. However, one must keep in mind 
that factors such as the impact of the migration process and the socioeconomic status may 
account for, or at least have some impact on, these ethnic differences (Oquendo et al., 
2004). 
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Psychiatric Population 
Several diagnostic tools are used to describe patients and patient groups. For patients with 
schizophrenia, different outcomes where found in several studies (e.g., Ketter, Wang, 
Becker, Nowakowska, & Yang, 2004; Tsuang, Lyons, & Faraone, 1990). Those different 
outcomes can be explained by the extreme heterogeneity of the patient group studied 
(Buchanan & Carpenter, 1994). Not only might the different subtypes of schizophrenia be 
part of the explanation (Tsuang et al., 1990), but factors of chronicity might also be 
responsible for the different outcomes between studies (Liddle, Barnes, Morris, & Haque, 
1989). Patients might function and feel differently in the first five years after having been 
diagnosed with a psychiatric disorder than in the years that follow. The same problem of 
clinical heterogeneity was found for depression (Goldberg, 2011; Ostergaard, Jensen, & 
Bech, 2011). This results in possible maltreatment of part of the group because patients with 
one and the same diagnosis might need different treatments depending on factors like 
severity or chronicity. Nevertheless, these varying outcomes in studies on treatment effects, 
depending on the composition of the groups (Paris, 2014), might mislead researchers and 
clinicians when those outcomes are generalized to the whole group. When focusing on 
patients with chronic psychiatric disorders, one often needs to give special attention to an 
accompanying group of disorders such as sleep disorders. Sleep structure disturbances in 
these patients are associated with, among other things, memory deficits; thus, an effective 
treatment of their sleep should improve not only sleep but also the associated memory 
impairments (Göder, Nissen, & Rasch, 2014). 
 
Chronic Illness 
Chronic (or long-term) psychiatric illness is described as a situation in which the patient has 
suffered from a disorder for at least five years without having had a symptom-free period 
that lasted longer than six months (Robins, 1978). One important aspect in these patients 
that needs consideration is demoralization (O’Keeffe & Ranjith, 2007). Demoralization can 
be described as a response that may follow chronification of the disease, which has been, for 
instance, found in patients with schizophrenia (Restifo, Harkavy-Friedman, & Shrout, 2009) 
and depression (Koekkoek, van Meijel, Schene, & Hutschemaekers, 2008). Depression and 
demoralization have been described as separate states since the 1970s. Demoralization may 
be described as a lost sense of one’s own capability whereas patients suffering from 
depression are not capable of using their capacity (Jacobsen, Maytal, & Stern, 2007). 
 
Sleep Disorders and Psychiatric Disorders 
Ample evidence exists for an association between psychiatric disorders and various sleep 
disorders (Buysse et al., 1994; Sateia, 2009); moreover, previous research has shown that 
when sleep disorders are untreated, the risk of developing psychiatric disorders, such as 
major depression, increases (Ford & Kamerow, 1989). In their study, Hsu, Liu, and Chen 
(2006) found that 65.8% of patients referred to sleep-disorder centers were suffering from a 
psychiatric disorder. Depression (Urilla et al., 2012), anxiety (Staner, 2003), and substance 
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abuse (e.g., drugs, alcohol, etc.) (Conroy & Arnedt, 2014) are among the most common 
psychiatric disorders associated with sleep problems. Sleep disorder treatment was found to 
improve the co-existing psychiatric condition and the overall health-related quality of life of 
psychiatric patients (Matteson-Rusby, Pigeon, Gehrman, & Perlis, 2010). Before discussing 
sleep disorders and coexisting schizophrenia or depression, I will first describe the diagnostic 
criteria for sleep disorders. 
 
Sleep Disorders 
A sleep disorder, also called somnipathy, is a medical disorder in which the usual sleep 
pattern is disturbed. In a condition like this, an unsatisfactory quantity and/or quality of 
sleep is present over a significant period of time. Thereby, the person has difficulties falling 
and/or staying asleep, and the final wakening may be early. As can be seen in Table 3a, 
according to the ICD-10 (World Health Organization, 1992), sleep disorders are classified 
under F51.0-F51.9 nonorganic sleep disorders or under G47.0-G47.9 organic disorders. Non-
organic sleep disorders are diagnosed when the sleep disorder is perceived as a condition in 
itself. Organic sleep disorders have an identifiable physical cause. 
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Table 3a. 
According to the ICD-10 (World Health Organization, 1992), the following characteristics are 
used in the classification of non-organic sleep disorders. 
  
Classification sleep disorder: 
 A complaint of excessive daytime sleepiness or sleep attacks or prolonged transition 
to the fully aroused state upon awakening (sleep drunkenness) (not accounted for 
by an inadequate amount of sleep). 
 Occurrence nearly every day for at least one month or recurrently for shorter 
periods of time, causing either marked distress or interference with personal 
functioning in daily living. 
 Absence of auxiliary symptoms of narcolepsy (cataplexy, sleep paralysis, hypnagogic 
hallucinations) or of clinical evidence for sleep apnea (nocturnal breath cessation, 
typical intermittent snorting sounds, etc.). 
 Absence of any known causative organic factor, such as a neurological or other 
medical condition, psychoactive substance use disorder or a medication. 
Subtype classification: 
 F51.0 Nonorganic insomnia 
 F51.1 Nonorganic hypersomnia 
 F51.2 Nonorganic disorder of the sleep-wake schedule 
 F51.3 Sleepwalking [somnambulism] 
 F51.4 Sleep terrors [night terrors] 
 F51.5 Nightmares 
 F51.8 Other nonorganic sleep disorders 
 F51.9 Nonorganic sleep disorder, unspecified 
 G47 Sleep disorders 
 G47.0 Disorders of initiating and maintaining sleep (insomnias) 
 G47.1 Disorders of excessive somnolence (hypersomnias) 
 G47.2 Disorders of the sleep-wake schedule 
 G47.3 Sleep apnoea 
 G47.4 Narcolepsy and cataplexy 
 G47.8 Other sleep disorders 
 G47.9 Sleep disorder, unspecified 
 
 
 
As can be seen in Table 3b, according to the DSM-5 (American Psychiatric Association, 2013), 
sleep-wake disorders encompass 10 disorders or disorder groups. The key features of each 
disorder is related to the patient's dissatisfaction with respect to the timing, quality, and 
total sleep quantity, thus leading to daytime distress and impairment. 
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Table 3b. 
The 10 disorders or disorder groups that encompass the classification sleep-wake disorder 
according to the DSM-5 (American Psychiatric Association, 2013). 
 Insomnia disorder 
 Hypersomnolence disorder 
 Narcolepsy 
 Breathing-related sleep disorders 
 Circadian rhythm sleep disorders 
 Non-REM (NREM) sleep arousal disorders 
 Nightmare disorder 
 REM sleep behavior disorder 
 Restless legs syndrome 
 Substance- or medication-induced sleep disorder 
 
The International Classification of Sleep Disorders Version 2 (ICSD-2) (American Academy of 
Sleep Medicine, 2005) can be used for diagnostic procedures. Accordingly, parasomnias can 
be divided into three categories, i.e., ‘partial arousals during non-REM sleep,’ ‘REM-sleep 
parasomnias,’ and ‘other parasomnias.’ The first category consists of sleep walking, 
confusional arousals and pavor nocturnus (sleep terror), usually occurring during sudden 
awakenings out of ‘slow-wave sleep’ (SWS) (Broughton, 2000). The second category mostly 
occurs during the shift from REM sleep to wakefulness and consists of ‘REM-sleep behavior 
disorder’ (RSBD), nightmares and sleep paralyses. The remaining category consists of 
parasomnias that do not specifically present themselves during a certain stage: nocturnal 
enuresis or bedwetting, sleep-related dissociative disorder, ‘exploding head syndrome,’ 
sleep-related eating disorder (SRED), catathrenia or nocturnal expiratory groaning, and 
hypnagogic hallucinations (Mason & Pack, 2007). 
 
Sleep Disorders and Coexisting Schizophrenia 
From daily clinical practice, patients with schizophrenia are known to suffer from problems 
with sleep (Wilson & Argyropoulos, 2012). Disturbed sleep can be found in 30-80% of 
patients with schizophrenia; this large difference in percentages can be explained by the 
severity of the psychotic symptomatology (Cohrs, 2008). 
 
Studies that used polysomnography have found that patients with schizophrenia show 
decreased total sleep time, increased sleep latency, and decreased sleep efficiency 
(Chouinard, Poulin, Stip, & Godbout, 2004; Monti & Monti, 2004, 2005). In addition, 
alterations of slow-wave sleep (Göder et al., 2004) and REM sleep variables, such as reduced 
REM latency (Monti et al., 2013; Poulin, Daoust, Forest, Stip, & Godbout, 2003) and REM 
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density (Cohrs, 2008), have been found. Therefore, although sleep disorders are not among 
the first symptoms that come to mind when thinking of schizophrenia, they seem to be a 
part of its pathophysiology and should not be underestimated (Cohrs, 2008). 
 
Sleep Disorders and Coexisting Depression 
The majority of patients with depression suffer from sleep disorders (Nutt, Wilson, & 
Paterson, 2008), varying from problems with falling asleep to early morning awakening, 
difficulties in staying asleep, or non-refreshing sleep. Excessive daytime sleepiness is also 
reported in these patients (Fava, 2004); however, this is peculiar to a subtype of depression 
that is found in patients suffering from seasonal affective disorder (Øyane, Ursin, Pallesen, 
Holsten, & Bjørvatn, 2008). 
 
Research in patients with depression has revealed prolonged sleep latency (time to fall 
asleep) and reduced rapid-eye-movement (REM) sleep latency (time to REM sleep from 
sleep onset) compared to healthy control participants (Dahl et al., 1996). In addition, a 
decrease in the amount of slow-wave sleep and an increased amount of REM sleep and REM 
density have been found in patients with depression (e.g., Palagini, Baglioni, Ciapparelli, 
Gemignani, & Riemann, 2013). 
 
Failure to treat insomnia increases the risk of a depression relapse (Franzen & Buysse, 2008). 
Several cross-sectional studies (e.g., Breslau, Roth, Rosenthal, & Andreski, 1996; Eaton, 
Badawi, & Melton, 1995; Chang, Ford, Mead, Cooper-Patrick, & Klag, 1997; Livingston, 
Blizard, & Mann, 1993) revealed that symptoms of depression and insomnia are strongly 
associated; moreover in cases where insomnia is present, the chances of developing 
depressive episodes and showing poor treatment results are increased (Franzen & Buysse, 
2008). 
 
Pharmacological Treatment 
Pharmacological interventions have been developed for the treatment of patients suffering 
from schizophrenia, depression and/or (coexisting) sleep disorders. Patients with 
schizophrenia have been treated with several antipsychotics, starting with the so-called first 
generation drugs such as chlorpromazine, followed by antipsychotics of the second 
generation. Nevertheless, the list of adverse effects of these medications is long, and 
compliance has always been, and still is, an issue for patients with schizophrenia (Haller, 
Padmanabhan, Lizano, Torous, & Keshavan, 2014). Several pharmacological treatments can 
be used for patients with depression, and discussions on their efficacies are ongoing (Paris, 
2014). As to medications for sleep disorders with or without comorbid psychiatric disorders, 
10 to 17% of the American population has recently been found to use sleep medications 
regularly (Vaidya, Hufstader-Gabriel, Gangan, & Borse, 2014). Because all of these 
treatments have their own side effects and none actually cures the disorder for which it is 
given, different treatment methods should be sought. 
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In addition to these pharmacological treatments for schizophrenia, depression, and sleep 
disorders, other cultures have different approaches that they have already implemented in 
allopathic medicine. In Asia, for instance, several branches of Traditional Oriental Medicine 
(TOM) have been integrated into psychiatric care. One part of TOM is acupuncture, a 
technique involving the insertion of needles that originated in China within the so-called 
Traditional Chinese Medicine (TCM). Acupuncture is now used alongside allopathic medicine 
as a non-pharmacological add-on treatment. Besides China, it is used in Korea (where it is 
called Traditional Korean Medicine or Hangul), Japan (where it is called Kampō), Tibet 
(where it is called Traditional Tibetan Medicine), etc. First, I will first briefly summarize part 
of the philosophical background of this ancient technique and its key critical methodological 
issues, before discussing the results that have been found in research on acupuncture 
treatment for schizophrenia, depression, and sleep disorders. 
 
Acupuncture and Its Traditional Chinese Medicine Background 
TCM contains a broad range of medical practices besides acupuncture: for instance herbal 
medicine, Feng Shui, dietary advice, Qi Gong (exercises) and Tuina (massage). In TCM, Qi 
(life’s vital energy) is believed to be transported through “highways” or meridians that flow 
through the body. These meridians might get blocked (like a traffic jam on the highway), in 
which case the police (needles; for an example, see Figure 1) might be used to get the traffic 
going again at the end of the line or to stop more cars from arriving at the beginning of the 
road. This metaphor might explain why symptoms like, for instance, a headache might be 
treated by inserting needles into the head, but also by inserting needles into the feet or 
somewhere in between. TCM theory is philosophical and it is based on principles like Qi, Yin 
and Yang, the Zang-Fu organs, and the Five Elements (Cheng, 1987). 
 
 
Figure 1. Examples of common acupuncture needles used in the current Ph.D. project 
(with permission of the CMC Tasly Centre, Amsterdam). 
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When these concepts of TCM are compared to Western medicine, some similarities can be 
found. About 2000 years ago, Hippocrates started personality studies with the four humors, 
(see page 45 in Wittendorff, 1994). This ancient medical concept of humorism suggests that 
four bodily fluids affect human personality traits and behaviors. This theory hypothesizes 
that our bodies are filled with four basic substances that are called “humors”. These 
substances are thought to be in balance when a person is healthy. Excesses or deficits of one 
or more of these four humors inevitably result in diseases and disabilities. The fluids are 
described as phlegm and blood, and yellow and black bile. An excess of yellow bile results in 
a choleric person and makes that person quick-tempered. Too much black bile indicates a 
melancholic and pessimistic person. A phlegmatic person has an excess of phlegm, which 
results in a sluggish and calm temper. A high level of blood makes a person sanguine and is 
characterized by a cheerful, passionate tendency (see page 45 in Wittendorff, 1994). These 
four humors are closely related to the elements and/or seasons, that form the pillars of TCM 
(Han, 2008). They can be seen as a basis for an explanation of the mind-body connection 
from both a Western and an Eastern point of view. In TCM, the relation between body and 
mind is often described as the integration of essence (Jing), energy (Qi) and mind or spirit 
(Shen) (Yang, 2008). In this philosophical description, Jing can be seen as the biological basis 
of body and mind. It is formed by the so called pre-heaven essence that is inherited from 
one’s parents (this might be seen as the ancient equivalent of DNA), and by the post-heaven 
essence, which is consumed from that which is taken in by our bodies: food, fluids, and 
breath. Jing forms the organs and the bodily structure, including the brain, the nervous 
system, and the endocrine system (Yang, 2008). 
 
The classical assumption in TCM is that, in the process of development, Jing generates 
marrow which rises up to form the Sea of marrow (the brain). Jing is the material basis of all 
physiological functions of all organs. When Jing is weak or blocked, mental problems arise 
(Yang, 2008). In addition, Qi is translated as energy (Cheng, 1987). It is formed from the 
inherited life power (also called pre-heaven Qi), the essence that arises from the 
transformation of food, fluids, and the air we breathe. Qi is the force that fluently moves 
through the body and that promotes a normal functioning of the body (Cheng, 1987). Qi 
leaves the body at death. Pathological conditions can be described with help of the Qi 
concept: Qi can stagnate or move in the wrong direction and this might be the cause of 
physical or mental disorders. Moreover, as everything is connected, so are Jing and Qi (Yang, 
2008). One more important aspect in explaining mental disorders, according to TCM theory, 
is Shen. Shen is the manifestation of Qi and Jing in relation to knowledge, emotions and 
behavior (Yang, 2008). Enough Jing and Qi flowing fluently are the basis for stabile mental 
activity. A disturbance of either can lead to mental emotional problems. 
 
In TCM, different “patterns of disharmony” that somehow obstruct the free flow of Qi and 
thereby influence emotions, behavior and mental activity overall are described (Gao, 1982). 
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Disharmony may occur because of problems with or due to Qi, Essence, Blood (a vital 
nutrient substance in the body according to TCM; Cheng, 1987), Body Fluids (a collective 
term for all the normal fluids of the body; Cheng, 1987), the meridians, or the Zang-Fu 
organs. Some explanation is needed here when it comes to these latter concepts. Twelve 
main meridians, 8 extra meridians, 12 divergent meridians, 12 muscle regions, and 12 
cutaneous regions exist (He & Tan, 1998). All of these are responsible for the circulation of 
Qi and Blood. The meridians and collaterals are distributed both interiorly and exteriorly 
across the body (Cheng, 1987). The Zang and Fu organs are functional entities situated 
interiorly and manifested exteriorly. Each organ is considered to be Yin (the Zang organs) or 
Yang (the Fu organs), and all organs are thought to belong to one of the five elements. The 
Zang-Fu organs are the center of the philosophical explanation of how the body works 
according to TCM (Zhang, Ming 1563-1640). All so-called “organs” have their own functions. 
When a disharmony occurs, the theory on the Zang-Fu organs can be used in order to find 
the origin of the disharmony and, accordingly, to create a treatment plan that uses 
acupuncture needles to influence the meridians and thereby the Zang-Fu organs in order to 
re-establish harmony. One more important concept that needs to be mentioned is the Five 
Element Theory. Everything in the natural world can be classified according to their nature, 
function and form into the Five Elements (Wood, Fire, Earth, Metal, Water). The Five 
Elements are in a state of constant motion and change; if harmony exists, they depend on 
each other and are inseparable (Cheng, 1987). In clinical practice, a pattern is sought that 
best describes the situation of the patient, with all his or her symptoms and signs. In order to 
decide where needles should be inserted, a TCM practitioner will conduct diagnostics before 
each treatment, investigating all of the above-mentioned ideas and will arrive at a diagnosis 
by using the five diagnostic methods that are used in TCM: inspection, auscultation, 
olfaction, inquiry, and palpation, including tongue and pulse diagnosis. After information has 
been gathered by using all these methods, a pattern of disharmony is diagnosed, and 
treatment is planned accordingly. In the TCM tradition, this pattern is called a diagnostic 
pattern. 
 
Working Mechanisms Behind Acupuncture 
Although TCM has a philosophical background and its working mechanisms have been 
explained by the above-mentioned theories, its physical mechanisms have not been 
measured and “proven” from a Western point of view. In fact, although many ideas on the 
working mechanisms behind acupuncture have been published, its exact effects on the body 
and mind are unknown. At the moment, research into the neurobiological mechanisms by 
using neuroimaging techniques is flourishing (Bai et al., 2014). However, although many 
hypotheses have been formed, no clear mechanism has arisen from the growing number of 
studies. In veterinary studies, a search for the involved neurotransmitters is ongoing (Fry, 
Neary, Sharrock, & Rychel, 2014). In response to needle irritation of a local area, certain 
neurotransmitter levels are influenced; among these are met-enkephalin and substance P 
along the nociceptive pathway, the luteinizing hormone via the hypothalamus pituitary axis, 
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and the level of serotonin and dopamine in the limbic system (Cheng, 2014). All in all, many 
questions remain unanswered regarding the mechanism behind acupuncture, and research 
is ongoing. 
 
Acupuncture and Guidelines for Research 
The Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) were 
first formulated in 2001 (MacPherson et al., 2010a, 2010b) and are aimed to improve the 
completeness and transparency of acupuncture research by providing sufficient details in 
order to facilitate replication and interpretation. In addition to the style of acupuncture 
(manual acupuncture, laser acupuncture, electro acupuncture, etc.), the reasoning for the 
treatment (meaning the choice of treatment, which might differ slightly between the schools 
of TCM that all use the same philosophical background, but differ when it comes to the 
choice and the order of treatment principles), the extent to which treatment varies, the 
details of needling (number of needle insertions, needling locations and depths, responses 
sought, needle stimulation, needle retention times, needle types), the treatment regimen 
(number of sessions, frequencies and durations of the treatment sessions), other 
components of treatment (details of other interventions, as well as the setting and the 
context of treatment), the practitioner’s background, and controls or comparator 
interventions need to be addressed and discussed in research reporting on the effects of 
acupuncture (MacPherson et al., 2010a, 2010b). 
 
Critical Methodological Issues in Acupuncture Research 
Several important methodological issues in acupuncture need to be taken into account. 
Some of these are typical for acupuncture and some concern research in general. One issue 
is the presence of a control group. TCM studies on the clinical effect of acupuncture often 
have not used a control group, reasoning that not treating a patient would be unethical 
(Bosch, Ausfeld, & Van den Noort, 2008). As a result, older TCM studies investigating the 
clinical effect of acupuncture in a psychiatric population frequently consisted of one or more 
case studies (Shi & Tan, 1986; Shi, 1988, 1989). 
 
In recent years, acupuncture researchers have tried to develop a successful control 
intervention. For the development of good acupuncture placebo interventions, both the 
physiological activity of the control intervention as well as the way in which the control 
intervention may activate the “placebo” response must be taken into account (Bosch et al., 
2008). If, for instance, “non-acupuncture point needling” is used in the control group, 
physiological acupuncture effects are implied, resulting in effects that are often close to 
those found in the real acupuncture group (Streitberger & Kleinhenz, 1998). Following these 
results, three different conclusions are possible: (1) Acupuncture is not point specific, 
meaning that where the needles are inserted does not matter; an effect will always be 
observed. (2) Acupuncture is based on a placebo effect. (3) Acupuncture is point specific, but 
acupuncture needles in meridian zones result in an effect that is larger than no acupuncture, 
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but smaller than acupuncture at a “true” acupuncture point. In other acupuncture studies, 
very different treatments, such as transcutaneous electrical nerve stimulation (TENS) (Dias, 
Vellarde, Olej, Teófilo Salgado, & de Barros Rezende, 2014) or low-intensity high-frequency 
electro-stimulation treatment (Johansson et al., 2001) have been used in the control group; 
thus, whether or not the effects that are found when the effects of the control group are 
deducted from the effects of the treatment group are due to acupuncture is unclear. In the 
above-mentioned studies, a design was chosen that should compare a treatment to a 
placebo, thereby eliminating a possible psychological placebo effect and creating the 
opportunity to conclude something about the actual treatment effects. In the above-
mentioned studies, however, whether the effects that were found in the control group were 
only the result of a psychological effect or were actually the result of the control group’s 
treatment was not clear (Streitberger & Kleinhenz, 1998). Despite considerable intellectual 
and practical efforts on designing and testing placebo controls in acupuncture research 
(Vickers, 2002), researchers have not found and have not reached agreement with respect to 
a convincing and proven “placebo” for acupuncture (Moroz et al., 2013). Nevertheless, 
several controls such as the placebo-needle, sham acupuncture, and double-blind 
experiments, have been tried and found to be useful to a certain degree (White, Golianu, 
Zaslawski, & Seung-Hoon, 2007). I will discuss them in more detail below. 
 
One attempt by the acupuncture researchers to find a suitable control was the development 
of an instrument that gave the participant the sensation of an acupuncture needle. That 
instrument is the so-called “placebo-needle”, and in recent years, different kinds of placebo-
needles have been developed (e.g., Park, White, Stevinson, Ernst, & James, 2002; 
Streitberger & Kleinhenz, 1998; Takakura & Yajima, 2008). However, placebo-needles have 
their limitations. First, they cannot be applied to all acupuncture point locations, for 
instance, the acupuncture points on the toes, fingers, and scalp (Kaptchuk, 1998). Secondly, 
the placebo-needle method does not allow significant variations in manual stimulation 
methods or diversity in needle-insertion directions (Kaptchuk, 1998), and nearly 40% of the 
participants did not find that the placebo-needle and the acupuncture interventions felt the 
same, raising concerns with respect to the use of the placebo-needle as a standard 
acupuncture placebo (White, Lewith, Hopwood, & Prescott, 2003). Thirdly, sham needles are 
expensive (in comparison with standard acupuncture needles). Finally, the largest limitation, 
however, is the fact that the placebo-needle method does not solve the problem of double 
blinding, meaning the masking of the practitioner (if a practitioner is to insert a needle, he or 
she feels the difference between a placebo needle and a real one) (Kaptchuk, 1998). 
 
Another attempt is nowadays known as “sham acupuncture”, in which needling is conducted 
on places on the body that are away from the classical acupuncture points, but the depth of 
insertion and the stimulation are the same as in real acupuncture (Vincent & Lewith, 1995; 
for examples, see Deng et al., 2013; Foroughipour et al., 2014). Moreover, in sham 
acupuncture, acupuncture points may be stimulated without inserting a needle or with 
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needles that are only superficially inserted. However, a serious limitation of sham 
acupuncture is that stimulation of a point without inserting a needle may also lead to a 
therapeutic effect (Lund & Lundeberg, 2006). Furthermore, Traditional Japanese Medicine 
works with superficial needling only; thereby, some sham treatments might have been 
nothing more than a different acupuncture technique instead of a control treatment. 
 
One more methodological problem is whether acupuncture treatment should be 
standardized or individualized in clinical studies on the efficacy of acupuncture (Pach et al., 
2013). In individualized treatment, one keeps as close as possible to daily clinical TCM 
practice that any (psychiatric) patient would receive if he or she were being treated by an 
Oriental medical practitioner (Bosch et al., 2013). From a pure scientific point of view, one 
would prefer as much standardization as possible; however, one must keep in mind that 
studies that test acupuncture within its own medical traditions seem to give a more 
appropriate and more clinically meaningful assessment of acupuncture’s efficacy 
(Hammerschlag, 1998). The choice of a research design using individualized treatment or a 
standardized treatment protocol, in comparison with another control group (some sort of 
sham acupuncture or a different kind of control group), inevitably raises a basic question: 
What is the research question being asked? Are we asking the question whether 
acupuncture is better than a sham acupuncture which was found to be highly different from 
a placebo treatment (Vincent and Lewith, 1995)? Real (standardized or individualized) 
acupuncture, in comparison with sham acupuncture (in which sham points are used), would 
in that case only provide information on the role of the point’s location. If acupuncture is not 
point specific, the results for all groups should be the same. The same goes for superficial 
needling versus deeper needling, or even just touching of the skin, in which case one would 
be comparing two or three kinds of treatment, instead of one treatment to a placebo, as was 
intended in the first place. Thus, questioning whether acupuncture should be compared to a 
placebo seems reasonable, or to describe it in line with MacPherson’s (2000) words: the 
question should be whether acupuncture is of better value than what is currently on offer, 
instead of asking whether acupuncture is better than placebo. 
 
Clinical acupuncture studies are designed to be either pragmatic or explanatory 
(MacPherson, 2004). A pragmatic clinical study is designed in a way that allows the 
effectiveness of a treatment (in this case acupuncture) in real clinical practice to be 
determined (Godwin et al., 2003). On the other hand, explanatory clinical studies are 
designed in order to determine whether acupuncture treatment has an efficacy, as 
compared to a placebo, under ideal experimental conditions (MacPherson, 2004). In 
pragmatic clinical studies, the researcher tries to find a balance between the external validity 
(in other words the generalizability of the results) of the study on the one hand and the 
internal validity (the reliability or accuracy of the results) of the study (Godwin et al., 2003) 
on the other. In contrast, the explanatory clinical study tries to maximize the internal validity 
of the study by having rigorous control of all variables other than the clinical (acupuncture) 
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intervention. Examples of these are the double-blind, randomized, placebo-controlled trials 
of acupuncture (Ng et al., 2004; Rebhorn et al., 2012). In pragmatic clinical acupuncture 
studies (MacPherson, Thorpe, & Thomas, 2006; Martins, Kaster, Schützler, & Witt, 2014), the 
researcher tries to maximize external validity, making generalizability of the results possible; 
however, the risk of pragmatic clinical acupuncture studies is that the internal validity may 
be severely compromised in order to ensure the generalizability (Godwin et al., 2003). 
 
In sum, to date, acupuncture research has no such thing as a “golden” methodological study 
design, which presumably will remain a hot and highly-discussed topic in the years to come. 
All designs that have been developed and proposed by researchers within the acupuncture 
field have their own strengths and limitations, varying from high external validity to high 
internal validity. Depending on the research question and the aim of the study, the 
researcher needs to select the best design. In the present Ph.D. project, different kinds of 
study designs were used, depending on the research questions and aims of the study, as well 
as on the research possibilities in daily clinical practice with psychiatric patients. 
 
Acupuncture in Depression 
The overall results on the use of acupuncture to treat patients with depression seem 
promising. Acupuncture was found to be an effective, safe, and cost-effective therapy in 
treating major depressive disorders (e.g., Spackman et al., 2014; Qu et al., 2013; Wang et al., 
2008; Wang, Wang, Tao, & Chen, 2014; Zhang et al., 2010). Yeung, Ameral, Chuzi, Fava, and 
Mischoulon (2011), for instance, conducted a study on 30 patients with depression in order 
to investigate the efficacy of acupuncture in treating patients who had responded partially 
or not at all to antidepressants. They found that the use of acupuncture once or twice a 
week was safe and that patients tolerated it well. More importantly, they found acupuncture 
to be an effective treatment intervention in patients with depression, who were responding 
either partially or not at all to antidepressants therapy. Yeung et al. (2011) concluded that 
their results suggested the feasibility of using acupuncture for the treatment of patients with 
depression in outpatient settings, but that replication in controlled trials was needed before 
firm conclusions could be drawn. Acupuncture was found to be a safe and well-tolerated 
monotherapy (Mischoulon, Brill, Ameral, Fava, & Yeung, 2012), as well as a safe and well-
tolerated add-on treatment in addition to antidepressants (Wu, Yeung, Schnyer, Wang, & 
Mischoulon, 2012). Even though patients with depression have shown improvements in 
depressive symptoms after acupuncture treatment (Andreescu, Glick, Emeremni, Houck, & 
Mulsant, 2011), caution is required regarding these positive clinical treatment effects (Smith, 
Hay, & MacPherson, 2010) because, for instance, Ernst, Lee, and Choi (2011) and Leo and 
Ligot (2007) drew the conclusion that the effectiveness of acupuncture as a treatment for 
patients with depression remained unproven and was too premature and that more, larger, 
methodologically-better-designed Western studies on acupuncture and depression were 
needed (Ernst, Lee, & Choi, 2011; Wu et al., 2012). 
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Acupuncture in Schizophrenia 
 
 
Figure 2. Example of the acupuncture treatment of a patient suffering 
from schizophrenia (Bosch, Staudte, & Van den Noort, 2014). 
 
The number of acupuncture studies on schizophrenia is much smaller than the number of 
acupuncture studies on depression (for an example of the acupuncture treatment of a 
patient suffering from schizophrenia, see Figure 2). So far, only a few clinical studies have 
been conducted on acupuncture and schizophrenia, most of which originated from China 
(Lee, Shin, Ronan, & Ernst, 2009). In the study by Bloch and colleagues (2010), sleep was 
found to be improved after acupuncture treatment; moreover, the patients with 
schizophrenia showed less anxiety and an improved mood after acupuncture therapy. The 
overall results of the clinical trials and the case studies on patients with schizophrenia 
provided limited evidence for the effectiveness of acupuncture in treating the ‘symptoms’ of 
schizophrenia (e.g., Bouhlel et al., 2011; Lee et al., 2009; Rathbone & Xia, 2005). 
Nevertheless, in some research, positive results in the treatment of hallucinations by using 
acupuncture were reported (Shi, 1988, 1989). In several studies, the hallucinations entirely 
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disappeared (Wu & Bi, 2004; Zhang, 1988) or their number decreased (Wu & Bi, 2004; 
Zhang, 1988); furthermore, in a single case study, the severity of the hallucinations 
decreased (Bosch, Staudte, van den Noort, & Lim, 2014), and the patient felt less disturbed. 
In other studies, not only sleep quality but also the quality of life seemed to be improved in 
patients with schizophrenia as a result of acupuncture treatment (e.g., Bosch et al., 2013; 
Bosch et al., 2014; Reshef et al., 2013). Tani, Suzuki, Takada, Yagyu, and Kinoshita (2005), for 
instance, found a positive effect of acupuncture therapy in treating the side-effects of long-
time drug use in a patient with chronic schizophrenia. Acupuncture treatment was reported 
to have a positive effect on tardive dystonia, including axial dystonia; the posture of the neck 
and body improved, and the involuntary movement disappeared completely. Moreover, Xu, 
Su, and Wang (2010) found that the combined therapy of acupuncture and a small dose of 
antipsychotics showed an efficacy equal to that of a full dose of antipsychotics and that the 
combined therapy had several important advantages: a shorter initiation time and fewer 
side effects compared to treatment with a full dose of antipsychotics. However, the results 
of systematic reviews, as well as comparative and case studies, need to be interpreted with 
caution because more, larger and methodologically-sound studies on acupuncture and 
schizophrenia are needed (Lee et al., 2009; Rathbone & Xia, 2005) before any firm 
conclusions on the possible effects of acupuncture treatment on the symptoms of patients 
with schizophrenia can be drawn. 
 
Acupuncture in Sleep Disorders 
The overall results of clinical studies, most of which were randomized, controlled, clinical 
trials, on the use of acupuncture to treat insomnia have shown positive effects (Cao, Pan, Li, 
& Liu, 2009; Zhao, 2013). Several studies showed acupuncture treatment to be effective in 
the treatment of insomnia (e.g., Da Silva, Nakamura, Cordeiro, & Kulay, 2005; Guo et al., 
2013; Kim et al., 2004). Moreover, acupuncture can be as, or even more, effective than 
conventional pharmacological treatment with drugs, such as trazodone, zolpidem, or 
estazolam, in the treatment of insomnia (Luo, Zhang, & Lai, 2010; Tu, Chung, Yang, & Tzeng, 
2012; Xuan, Guo, Wang, & Wu, 2007). Although acupuncture was found to be a safe clinical 
intervention (Huang, Kutner, & Bliwise, 2009) and showed great potential to be an effective 
treatment for insomnia (Huang et al., 2009), its positive results are less than certain because 
of methodological limitations (Zhao, 2013) such as a high risk of bias (Cheuk, Yeung, Chung, 
& Wong, 2012). In addition, the majority of clinical acupuncture studies on insomnia are 
heterogeneous in the way insomnia, the participants’ characteristics, the acupuncture 
points, and the treatment regimen have been defined (Cheuk et al., 2012). Therefore, high-
quality clinical studies with randomized, controlled trials on larger samples (Cao et al., 2009) 
and with longer follow-up measurements in order to measure the sustained effects of 
acupuncture (Carlsson, 2002) are required in future research on the its efficacy for the 
treatment of patients with insomnia (Cheuk, Yeung, Chung, & Wong, 2007). 
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Outline 
 
Aim of the thesis 
This thesis investigates a possible add-on treatment for patients with schizophrenia and 
depression. Acupuncture effects on sleep and psychopathology are studied. The research 
questions areas follows: (1) What possible problems in sleep, psychopathology and working 
memory performance can be found in a population of long-term patients with schizophrenia 
and patients with depression? (2) Does acupuncture improve the patients’ sleep? (3) Does 
acupuncture decrease the patients’ psychopathology? (4) Does acupuncture improve the 
patients’ working memory performance? 
 
First, in Chapter 2, a study is presented that characterizes our patient population. More 
specifically, whether the long-term illness (chronicity) of the patients with depression or 
schizophrenia itself might influence the score on a personality inventory; the Minnesota 
Multiphasic Personality Inventory-2, was investigated. Whether chronicity itself might have a 
differential effect on the profiles of these patients and whether demoralization 'associated 
with long-term illness' might affect the scales of the personality inventory was also studied. 
Thirty patients with long-term schizophrenia, 30 long-term patients with depression, and 30 
healthy participants completed the personality inventory. Groups were compared on Clinical 
Scales and on the Restructured Clinical (RC) Scales. 
 
Chapter 3 is an inventory of the parasomnias and other nocturnal behaviors in our 
population with depression and schizophrenia. These behaviors were determined by using a 
parasomnia screening test. In this chapter, 21 parasomnias and other nocturnal behaviors 
were assessed. 
 
Chapter 4 describes a pilot study, in which the effects of three months of acupuncture 
treatment on sleep were evaluated and compared between a group of 16 patients with 
schizophrenia and a group of 16 patients with depression. In addition, eight healthy controls 
were included in order to establish reference values. Patients with schizophrenia and 
depression were randomly placed on a waiting list or assigned a treatment. A sleep quality 
inventory was completed by the patients who received acupuncture both before and after 
the treatment (individualized and according to Traditional Chinese Medicine principles) and 
by the patients who had been placed on the waiting list both at the beginning and at the end 
of the three month period. 
 
Chapter 5 describes a preliminary clinical trial, in which the existence or not of a positive 
influence of acupuncture on sleep in patients with schizophrenia or depression was 
investigated. In total, 100 participants entered the study: 40 outpatients with schizophrenia, 
40 outpatients with depression, and 20 healthy controls. They all completed a depression 
inventory, and the positive and the negative symptoms of the patients with schizophrenia 
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were evaluated by their psychiatrists. All participants were asked to complete a sleep log for 
two weeks. For the psychiatric patients, a randomized design with experimental (three 
months of acupuncture treatment) and control (waiting list) conditions was used, after 
which all measurements were conducted once more. 
 
In Chapter 6, the question of whether acupuncture may be able to improve mood and 
working memory in patients suffering from depression or schizophrenia is addressed. In 
total, 50 patients with depression and 50 patients with schizophrenia were randomly divided 
into an experimental group and a waiting-list group. In addition, 25 healthy control 
participants entered the study. The patients in the experimental groups received twelve 
weeks of individualized acupuncture treatment, and a pragmatic clinical trial design was 
used. All patients in the experimental group were tested twice on a mood scale, a simple 
working memory task, and a complex working memory task both before (T1) and after (T2) 
acupuncture treatment; the waiting-list group was also tested twice, but without treatment 
other than their normal regimen. The healthy control participants were only tested at T1. 
 
Chapter 7 contains a single case study. It describes the effect of acupuncture on the number 
and kind of hallucinations suffered by a patient with long-term schizophrenia. In addition, 
sleep quality, depressive feelings, and positive and negative symptoms were assessed. In one 
case, a 63-year-old woman suffered from persistent hallucinations and even physical pain as 
a result of the hallucination of a black bird that kept pecking her back. The patient received 
12 weekly acupuncture treatments as an add-on treatment. A clinical diagnostic interview 
and psychological testing (on sleep quality, depression, and positive and negative symptoms) 
were conducted before, immediately after and three months after the acupuncture 
treatment. 
 
In Chapter 8, the different TOM diagnostic patterns in patients with a Western diagnosis of 
schizophrenia, depression, or sleep disorders are described from a literature and a clinical 
perspective. Psychiatric disorders can be described and treated from both a Western 
(allopathic) and an Eastern perspective, which is important when research on acupuncture in 
psychiatry is conducted. Patients with schizophrenia or depression are likely to be 
undergoing Western treatment when they are referred to an acupuncturist for (add-on) 
treatment, and knowledge of both types of treatments is necessary to integrate them 
successfully. In this chapter, the diagnostic patterns that are found within our groups of 30 
patients with depression and 30 patients with schizophrenia are presented and illustrate the 
problem encountered in research when comparing results from different studies containing 
different numbers of patients with different diagnostic patterns within the samples 
 
In Chapter 9, the clinical evidence for the use of acupuncture as an add-on treatment for 
patients with depression and schizophrenia and the evidence on its working mechanisms are 
assessed. Four databases (Medline, Scopus, ERIC, and the Cochrane Library) were searched 
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until March 31, 2014. Systematic reviews of and meta-analyses on acupuncture treatment 
for patients with depression or schizophrenia were considered for inclusion. As a result of 
the scarce acupuncture research on schizophrenia, randomized controlled trials (RCTs) and 
case studies on acupuncture and schizophrenia were also included. 
 
The main findings and implications of this research are summarized and discussed in Chapter 
10. 
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Abstract 
While previous studies on the MMPI-2 in patients with schizophrenia and depression have 
used mixed samples of both early stage and chronic psychiatric patients, here, it is 
investigated whether chronicity itself might have a differential effect on the MMPI-2 profiles 
of these patients and whether demoralization 'associated with long-term illness' affects the 
scales of the MMPI-2. Thirty long-term patients with schizophrenia, 30 long-term patients 
with depression, and 30 healthy participants completed the MMPI-2. Groups were 
compared on Clinical Scales and on the Restructured Clinical (RC) Scales. Patients with 
schizophrenia differed from patients with depression on 14 MMPI-2 scales and from healthy 
controls on 10 scales, generally showing mean UT-scores < 65, indicating a subjective 
experience of (near) normal functioning. Patients with depression differed from healthy 
controls on 17 scales mostly with UT-scores > 65, indicating impaired functioning. 
Demoralization was higher in patients with depression than in patients with schizophrenia 
and both psychiatric groups differed from the healthy control group. It is concluded that 
long-term patients with depression show impaired functioning and high demoralization, 
while long-term patients with schizophrenia surprisingly show near normal functioning and 
less demoralization. 
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Introduction 
The severity of psychopathology may differ over the years in patients with long-term 
(defined as a duration of at least five years after being diagnosed) schizophrenia (Bromet, 
Naz, Fochtmann, Carlson, & Tanenberg-Karant, 2005) and in patients with depression 
(Kennedy, Abbott, & Paykel, 2004). 
An instrument that explores the self report of psychopathology and personality is the 
Minnesota Multiphasic Personality Inventory-2 (MMPI-2; Butcher et al., 2001), which 
comprises 567 self-report items. Most studies with the MMPI-2 on patients with 
schizophrenia as well as on patients with depression found significant differences from 
healthy controls on scales in the anxious-neurotic domain (e.g., 2-D, 7-Pt, 0-Si) and on scales 
that measure dysfunctions of interpersonal affect and emotion regulation (e.g., 4-Pd and 9-
Ma scales; Ben-Porath, Butcher, & Graham, 1991; Munley, Busby, & Jaynes, 1997). In 
general, these studies have been performed in patients with various lengths of illness (both 
first-episode and chronic patients), which might have had an influence on the results 
(Nuechterlein & Dawson, 1984). 
The first aim of this study was to investigate whether there are differences in MMPI-2 
scales and profiles between patients with long-term schizophrenia and patients with long-
term depression in comparison with each other and each with healthy controls. High levels 
of overall distress are expected for patients with depression due to their acute depressive 
symptoms (Wiersma et al., 2011), even in a long-term and chronic stage (see page 44, 
Wiersma et al., 2011), resulting in high scores (uniform T (UT)-score > 65) on their MMPI-2 
profiles. On the other hand, clinically stable outpatients with schizophrenia report “normal” 
emotional responses to emotional stimuli (Hempel et al., 2005; Herbener, Song, Khine, & 
Sweeney, 2008; Schlenker, Cohen, & Hopmann, 1995), perhaps due to the character of the 
illness. Note that deficits in emotional functioning associated with schizophrenia seem to 
occur further downstream, and involve the successful integration of emotion and cognition 
required for adaptive functioning (e.g., goal-setting, motivation, memory, etc.) (Herbener et 
al., 2008). 
Based on the literature findings, it is proposed that patients with schizophrenia will 
show lower scores than patients with depression on the 2-D, 7-Pt, 0-Si, 4-Pd, and 9-Ma (Ben-
Porath et al., 1991; Munley et al., 1997) scales, although nevertheless higher than healthy 
controls, due to their long-term illness. 
When it comes to explaining scores on questionnaires and tests performed by chronic 
patients, the concept of demoralization plays an important role (O’Keeffe & Ranjith, 2007). 
Demoralization may be seen as a somewhat normal response to a long and debilitating 
disease and has been found in patients with long-term schizophrenia (Restifo, Harkavy-
Friedman, & Shrout, 2009) as well as in patients with long-term depression (Koekkoek, Van 
Meijel, Schene, & Hutschemaekers, 2008). Demoralization has been discussed as a state 
distinct from depression since the 1970s. Patients with depression cannot take a direction, 
whereas patients suffering from demoralization do not know what direction to take and 
experience a lost sense of efficacy (Jacobsen, Maytal, & Stern, 2007). Because patients with 
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long-term schizophrenia generally suffer more from stigmatization and less favorable long-
term outcome expectancies than patients with long-term depression (Angermeyer & 
Matschinger, 2003), one might expect a larger demoralization effect in patients with long-
term schizophrenia than in patients with depression. On the other hand, patients with 
depression often suffer from feelings of hopelessness and a persistent inability to cope, 
which might result in a larger demoralization effect. In sum, the question arises whether 
MMPI-2 profiles may be influenced by demoralization after a long period of a mental illness, 
and in which illness demoralization plays a larger role. 
The MMPI-2 Restructured Clinical (RC) Scales were developed by Tellegen and 
colleagues (2003), partly to address MMPI-2 interpretation issues that may be related to 
demoralization (Van der Heijden, Egger, & Derksen, 2008). Another reason for developing 
the RC Scales was to eliminate the item overlap found among the MMPI-2 Clinical Scales 
(Tellegen et al., 2003). The RC Scales are not intended to replace the Clinical Scales. 
Differences between the Clinical Scales and the RC Scales are a result of removing the non-
specific variance associated with demoralization, the K correction, and subtle items (Tellegen 
et al., 2003). With respect to demoralization, distinct from O'Keeffe & Ranjith (2007) who 
defined the concept as transient or understandable reactions to severe or life-threatening 
illness, Tellegen and colleagues (2003) used the Watson and Tellegen (1985) two-
dimensional model of affect to explain the construct of demoralization. This mood model 
consists of two orthogonal bipolar dimensions, “Positive Affect or Arousal” and “Negative 
Affect or Arousal”, and a third dimension called “Pleasantness versus Unpleasantness”, 
positioned midway between the previously described two dimensions (Tellegen, Watson, & 
Clark, 1999a, 1999b). Unpleasantness is one pole of the dimension of general hedonic 
valence and according to Tellegen et al. (2003) this pole taps the essence of demoralization. 
After empirical study, the RCd scale was developed considering that demoralization lies in 
the middle between high negative emotion (anxiety) and low positive emotion (depression) 
(Ben-Porath & Tellegen, 2008). 
Therefore, the second aim of our study is to investigate whether demoralization affects 
the MMPI-2 profiles in both patient groups. It is expected that both patient groups are 
demoralized (Koekkoek et al., 2008; Restifo et al., 2009) and this should lead to higher scores 
on the RCd scale, a scale that was specifically developed to embody the demoralization 
construct (Tellegen et al., 2003, p. 12). Moreover, since the other RC Scales were developed 
to exclude demoralization, it is hypothesized that patients will have lower scores on the RC 
Scales than on the Clinical Scales of the MMPI-2. 
 
Methods 
 
Participants 
All participants entered the study on a voluntary basis and were not paid. The healthy 
controls were recruited by advertisements, whereas all patients were outpatients recruited 
at a psychiatric hospital in Germany. Diagnoses were based on clinical examination by 
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experienced psychiatrists of the clinic, using the International Classification of Diseases-10 
(World Health Organisation, 1992). The Mehrfach-Wortschatz-Intelligenz-Test-B (MWT-B; 
Lehrl, 2005) was used as an inclusion criterion since an IQ of at least 80 is needed to 
complete the MMPI-2 correctly (Derksen, de Mey, Sloore, & Hellenbosch, 2006). Beck’s 
Depression Inventory-II (BDI-II; Beck et al., 1996) was used as an inclusion criterion for 
patients with depression; at a cut-off score of 19, indicating (at least) a moderate depression 
(Beck, Steer, & Brown, 1996). The Positive And Negative Syndrome Scale (PANSS) (Kay, 
Fiszbein, & Opler, 1987) was used as an inclusion criterion for the schizophrenia group, at a 
cut-off score of 58 (e.g., Leucht et al., 2005). MMPI-2 profiles met the following inclusion 
criteria: Cannot Say < 30, VRIN and TRIN ≤ 80, Fp < 100, and L ≤ 80 (Butcher et al., 2001). A 
duration of illness of at least five years was used as a final inclusion criterion. Application of 
the MMPI-2 profile inclusion criteria resulted in the deletion of four participants (three out 
of the group with schizophrenia and one out of the control group). The exclusion criteria 
were: epilepsy, addiction or other neurological dysfunctions. 
In total, 86 participants fulfilled all inclusion criteria. There were 27 males and 59 
females and all participants were between 19 and 70 (M = 41.79, SD = 12.33) years old (see 
Table 1 for an overview of the average length of illness, number and length of 
hospitalizations, the MWT-B score, and the level of education specified for the 
schizophrenia, depression, and healthy control group). Seven participants, aged 19-64 (M = 
41.70, SD = 10.83) of which 12 were males and 15 females, carried the diagnosis 
schizophrenia. Thirty participants aged 23-70 (M = 48.87, SD = 9.33) years of which six were 
males and 24 females, carried the diagnosis depression. The patients with schizophrenia had 
a significantly higher length of illness (p = .002, partial η2 = .160), number of hospitalizations 
(p = .000, partial η2 = .269) and length of hospitalization in days (p = .000, partial η2 = .223) 
compared to the patients with depression, but the average intelligence (p = .560, partial η2 = 
.006) and level of education (p = .976, partial η2 = .000) did not differ between the two 
psychiatric groups. Finally, the control group consisted of 29 healthy participants aged 22-56 
(M = 34.55, SD = 12.45) years of which nine were males and 20 females. 
 
Table 1. 
Descriptives of the schizophrenia, depression, and healthy control group. 
 Schizophrenia Depression Healthy Controls 
Scale M SD M SD M SD 
Length of illness1 17.91a 9.59 10.29 8.15 0 0 
Average number of hospitalizations 4.52a 3.18 1.53 1.74 0 0 
Length of hospitalization2 310.00a 287.39 87.40 103.58 0 0 
MWT-B 102.89 16.18 99.93 10.88 104.19 9.53 
Level of education3 3.07b 1.00 3.10b .85 3.86 .35 
 
Notes. 1 Length of illness in number of years, 2 Average length of hospitalizations in number of days, 3 The 
following scores were used according to the German education system (from low to high education): 1 = no 
education finished, 2 = Hauptschule, 3 = Realschule, and 4 = Gymnasium. a Mean score is significantly different 
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(p < .05) from the mean score of the patient group with depression; b Mean score is significantly different (p < 
.05) from the mean score of the healthy control group. 
 
Although there was a significant age difference between the groups, age was not found 
(analyses of covariance) to have a significant influence on the results on the Clinical (p = 
.509, partial η2 = .138) or RC Scales (p = .472, partial η2 = .105). The depression group 
contained three times more women; therefore, gender was used as covariate as well. No 
significant influence was found for gender on the Clinical Scales (p = .223, partial η2 = .183) 
nor the RC Scales (p = .050, partial η2 = .196). Moreover, no significant difference in 
intelligence (p = .618, partial η2 = .013) was found between the three groups and the 
analyses of covariance showed that intelligence did not have a significant influence on the 
results on the Clinical (p = .724, partial η2 = .121) or RC Scales (p = .503, partial η2 = .113). 
Finally, a significant difference in level of education was found between the three groups (p 
= .000, partial η2 = .197). As can be seen in Table 1, the healthy control participants on 
average had a significantly higher level of education as compared to the schizophrenia (p = 
.001) and depression groups (p = .000). The level of education was therefore examined as 
covariate as well. No significant influence was found for level of education on the Clinical (p 
= .381, partial η2 = .156) or RC Scales (p = .780, partial η2 = .070). 
 
Clinical measures 
MMPI-2 
The MMPI-2 (Butcher & Rouse, 1996) is a psychopathology and personality inventory. Its 
psychometric qualities showed test-retest coefficients ranging from rtt =.62 to rtt = .92 (M = 
.83) for the Clinical Scales. Internal consistency coefficients range between α = .60 and α = 
.88 for the Clinical Scales (Engel, 2000). 
The MMPI-2 has been used to distinguish patients with a depression from patients with 
schizophrenia (Ben-Porath et al., 1991), this despite some psychometric drawbacks, like a 
high inter-correlation among the Clinical Scales attributed to the First Factor (Rouse, Greene, 
Butcher, Nichols, & Williams, 2008). This prompted the construction of the RC Scales 
(Tellegen et al., 2003). It was subsequently established that the RC Scales show satisfying 
reliability and internal validity (Van der Heijden et al., 2008). 
Specific Clinical Scales of the MMPI-2 have been found to show differences between 
schizophrenia and depression: 2-D, 9-Ma, 7-Pt (Ben-Porath et al., 1991; Munley et al., 1997), 
4-Pd, 0-Si (Munley et al., 1997). 
The RC Scale corresponding to Clinical Scale 2-D is RC2 (Low Positive Emotions); 
endorsement of the RC2 items indicates a lack of positive engagement in life. The RC version 
of scale 9-Ma is RC9 (Hypomanic Activation) which describes emotions, cognitions, attitudes 
and behaviors that are consistent with hypomanic activity. The RC version of the 7-Pt scale is 
RC7 (Dysfunctional Negative Emotions); elevated scores on this scale indicate a large number 
of negative emotional experiences; these patients tend to experience a high level of anxiety. 
The restructured version for 4-Pd is RC4 (Antisocial Behavior); it measures the tendency 
toward antisocial behavior. There is no RC equivalent for 0-Si. 
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MWT-B 
The MWT-B (Lehrl, 2005) is a verbal intelligence test and consists of 37 lines with each five 
words. Four of them are non-words, and one is a true word that has to be found by the 
patient. Previous research found that the MWT-B correlates significantly r = .81 with the 
total IQ score from the HAWIE (Wiessner & Felber, 1981), indicating its reliability as an 
inclusion criterion in order to ensure sufficient capabilities to fill out the MMPI-2. 
 
Procedure 
Participants voluntarily entered the study, after receiving general information and signing for 
informed consent. Participants individually completed the MWT-B, BDI-II, and MMPI-2 
during approximately two hours in a quiet room with a member of staff available for 
questions. The instruments were administered in accordance with the procedures described 
in the manuals. After the study, all participants were debriefed. The present study was 
approved by the local ethics committee (Ärztekammer Nordrhein) and followed the 
Declaration of Helsinki (World Medical Organization, 2008). 
 
Statistical analyses 
First, raw-scores for the Clinical Scales were used in a one-way multivariate analysis of 
variance (MANOVA) using SPSS version 19 (IBM Corp., 2010) to indicate whether the three 
groups differ significantly across the Clinical Scales. The dependent variables were the 
Clinical Scale-scores and the between-subjects factor was group (depression, schizophrenia, 
or healthy control). After a significant result on the one-way MANOVA, univariate ANOVAs 
were then conducted for each scale separately to determine which scales contribute to the 
multivariate difference between the groups. If appropriate, this was followed by post-hoc 
tests. A Sidak adjustment of the alpha level (.05) was used to correct for multiple tests. 
These analyses were repeated for the RC Scales. 
 
Results 
 
Clinical Scales 
Mean UT-scores and SDs for the groups of patients with depression, schizophrenia, and the 
healthy controls were computed on the Clinical Scales. Patients with depression tended to 
have UT-scores > 65 on nine of the Clinical Scales, patients with schizophrenia reached this 
score on only Clinical Scale 2-D. 
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Table 2. 
Mean UT-Scores, SDs, number of patients (and in percentages) that scored above 65, F, and η2 on Clinical Scales of the schizophrenia, depression, and healthy control 
group. 
 Schizophrenia  Depression  Healthy Controls    
Scale M SD >65 M SD >65 M SD >65 F (2,83) η2 
L 51.04b 9.79 4 (15%) 46.73 10.40 0 (0%) 40.90 8.05 0 (0%) 7.94 .16 
            
F 62.33a,b 14.82 10 (37%) 73.87
b 
16.20 22 (73%) 50.69 10.48 2 (7%) 19.81 .32 
K 48.04a 10.48 1 (4%) 38.10
b 
10.71 1 (3%) 50.03 9.89 1 (3%) 11.39 .22 
1-Hs 55.07a 10.93 4 (15%) 69.77
b 
11.50 20 (67%) 48.86 8.88 1 (3%) 34.81 .46 
2-D 65.48a,b 13.24 14 (52%) 79.67
b 
9.80 28 (93%) 50.17 11.27 4 (14%) 49.12 .54 
3-Hy 60.89a,b 17.96 9 (33%) 69.03
b 
9.55 21 (70%) 47.97 8.39 1 (3%) 23.94 .37 
4-Pd 64.85a,b 12.68 15 (56%) 74.33
b 
11.06 24 (80%) 53.59 11.52 3 (10%) 23.69 .36 
5-Mf 52.04 11.31 3 (11%) 50.07 10.63 2 (7%) 45.97 13.73 0 (0%) 1.95/1.63 .05/.04 
 
6-Pa 64.78b 14.86 13 (48%) 69.13
b 
12.87 15 (50%) 54.86 12.81 4 (14%) 8.70 .17 
7-Pt 62.67a,b 12.68 12 (44%) 79.07
b 
11.05 27 (90%) 50.72 10.56 2 (7%) 47.06 .53 
8-Sc 63.37a,b 11.39 14 (52%) 73.23
b 
10.82 22 (73%) 50.17 9.89 1 (3%) 33.79 .45 
9-Ma 48.93 8.38 2 (7%) 53.60 8.88 3 (10%) 50.21 9.42 1 (3%) 1.61 .04 
 
0-Si 55.96a 15.98 8 (30%) 71.03
b 
11.89 23 (77%) 48.79 11.52 3 (10%) 23.12 .36 
________________________________________________________________________________________________________________________________ 
Notes. MF consists of the UT-score of the MF scale, in the F and η2 this consists of raw data MFM/MFV; aMean UT-score is significantly different (p < .05) from the mean UT-
score of the patient group with depression; bMean UT-score is significantly different (p < .05) from the mean UT-score of the healthy control group. 
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The multivariate ANOVA showed significant group differences (F(2,83) = 5.845, p = .00, η2 
= .69). ANOVAs were therefore conducted separately for each of the Clinical Scales to 
indicate which of these significantly differentiated between the groups. As can be seen in 
Table 2, the depression group generally scored higher than the schizophrenia group; the 
control group generally scored lowest. Scores for the depressed group exceeded those of the 
schizophrenia group on the F, 1-Hs, 2-D, 3-Hy, 4-Pd, 7-Pt, 8-Sc, 0-Si scales, and scored lower 
on K (defensiveness). Moreover, the schizophrenia patients scored higher than the healthy 
controls on scales L, F, 2-D, 3-Hy, 4-Pd, 6-Pa, 7-Pt, and 8-Sc, while the depression patients 
scored higher on F, 1-Hs, 2-D, 3-Hy, 4-Pd, 6-Pa, 7-Pt, 8-Sc, 0-Si, and lower on the K-scale than 
the healthy controls. 
 
RC Scales 
While the depression group obtained UT-scores > 65 on four of the RC Scales, scores for the 
schizophrenia group failed to reach this level on any of these scales. 
The MANOVA found significant group differences (F(2,86) = 7.358, p = .000, η2 = .469), see 
also Table 3. ANOVAs and Posthoc analysis, the outcomes are presented in Table 3 as well, 
showed that the following scales were responsible for this result: The depression group 
scored higher than the schizophrenia group on RCd, RC1, RC2, RC3, and RC7. Additionally, 
the schizophrenia group scored higher than the controls on RCd, RC2, and RC8, while the 
depression group exceeded the controls on RCd, RC1, RC2, RC3, RC6, RC7, and RC8. The 
control group scored lowest on all scales that showed a significant group effect. 
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Table 3. 
Mean UT-Scores, SDs, number of patients (and in percentages) that scored above 65, F, and η2 on RC Scales of the schizophrenia, depression, and healthy control 
group. 
 Schizophrenia  Depression  Healthy Controls    
Scale M SD >65 M SD >65 M SD >65 F (2,83) η2 
RCd 60.85a,b 12.06 9 (33%) 75.90
b 
8.21 27 (90%) 52.24 9.92 3 (10%) 46.38 .53 
RC1 52.96a 11.34 5 (19%) 67.97
b 
13.57 15 (50%) 46.72 8.66 1 (3%) 30.38 .42 
RC2 59.74a,b 13.54 8 (30%) 74.10
b 
12.07 21 (70%) 50.55 12.21 6 (21%) 26.80 .39 
RC3 49.48a 14.01 3 (11%) 63.70
b 
12.96 16 (53%) 52.03 12.48 6 (21%) 8.04 .16 
RC4 57.07 12.46 8 (30%) 61.53 10.31 12 (40%) 54.69 8.86 3 (10%) 2.76 .06 
RC6 48.93 16.97 3 (11%) 54.43
b 
20.52 8 (27%) 40.79 16.05 2 (7%) 4.70 .10 
RC7 55.44a 14.26 5 (19%) 68.47
b 
12.91 18 (60%) 51.38 9.51 3 (10%) 17.49 .30 
RC8 57.89b 11.27 5 (19%) 60.60
b 
9.08 8 (27%) 46.69 8.18 0 (0%) 13.93 .25 
RC9 45.33 9.10 1 (4%) 48.77 9.92 3 (10%) 52.03 10.28 5 (17%) 2.52 .06 
________________________________________________________________________________________________________________________________ 
Notes. MF consists of the UT-score of the MF scale, in the F and η2 this consists of raw data MFM/MFV; RC = Restructured Clinical; RCd = Demoralization; RC1 = Somatic 
Complaints; RC2 = Low Positive Emotions; RC3 = Cynicism; RC4 = Antisocial Behavior; RC6 = Ideas of Persecution; RC7 = Dysfunctional Negative Emotions; RC8 = Aberrant 
Experiences; RC9 = Hypomanic Activation; aMean UT-score is significantly different (p < .05) from the mean UT-score of the patient group with depression; bMean UT-score 
is significantly different (p < .05) from the mean UT-score of the healthy control group. 
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Additional scales 
Although our focus has been on the comparison of the Clinical and RC Scales among the 
depression, schizophrenia, and healthy control groups, for the sake of completeness MMPI-2 
scores for the Harris-Lingoes subscales, the Content and Content Component scales, the 
Personality Psychopathology-Five (PSY-5), Superlative Self-Presentation subscales, and the 
Supplementary scales can be found in Table 4 (see supplementary material). 
 
Discussion 
The present study examined the MMPI-2 differences between long-term outpatients with 
schizophrenia or depression and healthy controls. The main outcomes were that 
unexpectedly, it was much harder to differentiate long-term patients with schizophrenia 
from healthy controls than to distinguish long-term patients with depression from healthy 
controls. This was especially the case from a single-case perspective because UT-scores 
higher than 65 were rarely encountered in the patients with schizophrenia. Although the 
patients with schizophrenia differed significantly from the healthy controls, most patients 
scored 60 or lower, indicating near normal scores. Finally, the presence of demoralization 
could be demonstrated in both patient groups and this should be considered as an 
important and underestimated issue in chronic psychiatric illness, especially in depression. 
Significant differences between the three groups were found on both the Clinical and RC 
Scales, as expected. Our analysis demonstrated that among the 22 scales that were the 
primary focus of the study, nine Clinical (F, K, 1-Hs, 2-D, 3-Hy, 4-Pd, 7-Pt, 8-Sc, and 0-Si), and 
five RC Scales (RCd, RC1, RC2, RC3, and RC7) were able to differentiate the depression and 
schizophrenia patient groups. The differences found were generally consistent with those 
found in previous literature: 2-D, 7-Pt, 9-Ma (Ben-Porath et al., 1991; Munley et al., 1997), 4-
Pd, and 0-Si (Munley et al., 1997), with the exception of 9-Ma. Eleven scales differentiated 
patients with schizophrenia from healthy controls, with L, F, 2-D, 3-Hy, 4-Pd, 6-Pa, 7-Pt, 8-Sc, 
RCd, RC2, and RC8 were higher in the schizophrenia group. Seventeen scales differentiated 
patients with a depression from healthy controls, with the depression group scoring higher 
on F, 1-Hs, 2-D, 3-Hy, 4-Pd, 6-Pa, 7-Pt, 8-Sc, 0-Si, and lower on K. Moreover, the patients with 
depression scored higher than the healthy control group on RCd, RC1, RC2, RC3, RC6, RC7, 
and RC8. 
All in all, the MMPI-2 was found to differentiate between the three groups, but was 
better able to differentiate patients with long-term depression from healthy controls than to 
differentiate patients with long-term schizophrenia from the controls. The generally higher 
scale scores in the depression group are in line with our hypothesis, and the scores of the 
schizophrenia group were mostly lower than for the depression group, also as expected. The 
finding that the MMPI-2 scores for the schizophrenia group were mostly within the normal 
range (UT-scores < 65) was unexpected. More precisely, percentages of individuals scoring 
below the threshold of 65 on the various Clinical and RC Scales, range between 44% up to 
96% in the patients with schizophrenia (see also Table 2 and Table 3 for the percentages of 
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patients that scored > 65). Note that it is generally accepted that if the highest UT-scores of a 
MMPI-2 profile are < 65, patients seem to function reasonably well. Mean scores falling < 65 
are considered within the normal range, whereas a meaningful clinical interpretation may 
begin with scores > 60 (Butcher et al., 2001). Bearing in mind that the MMPI-2 is a measure 
of the individual’s level of emotional adjustment (Groth-Marnat, 2009), the results of the 
present study are in agreement with earlier findings that patients with schizophrenia only 
slightly differ from healthy controls in their emotional reactions and evaluations (e.g., 
Hempel et al., 2005; Herbener et al., 2008; Schlenker et al., 1995). It is important to note, 
however, that the MMPI-2 is not a diagnostic tool like, for instance, the PANSS (Kay et al., 
1987) that has the sole goal to tap positive and negative symptoms. On the MMPI-2, patients 
with schizophrenia seem to display a broad variety of symptoms (Bagby et al., 1997); 
therefore, elevations on several scales are associated with the possible presence of 
schizophrenia. The MMPI-2 does not provide the same profile for each patient with 
schizophrenia and therefore, some individual variance is possible (Bagby et al., 1997). 
It appears that patients with long-term schizophrenia report less dysfunction than might 
be assumed in patients considered to have such a disabling illness. Considering that the 
MMPI-2 is based on self-report, the results indicate that our schizophrenia patients consider 
or experience themselves to be roughly within the normal range. Scant research has focused 
on the relatively “normal” scores on clinical tests that often arise in patients in whom 
schizophrenia has been manifest for many years. Profiles and scores on different 
psychological tests and questionnaires that fall within the normal range are a phenomenon 
that (a) may simply point towards adequate functioning (Harding, Brooks, Ashikaga, Strauss, 
& Breier, 1987), (b) hint at poor suitability of the test used for the group under research 
(Bromet et al., 2005); with respect to the MMPI-2, for instance, one could think of the 
possible underreporting of the negative symptoms on the test, (c) suggest that the disorder 
might be emotionally distressing but not sufficiently so to lead to grossly elevated scores 
(Graham, 2012), or (d) indicate that the effects of chronic disease itself influence test results, 
such as in patients with Korsakoff syndrome (e.g., Egger, Wester, de Mey, & Derksen, 2002). 
A profound difference between patients’ self-reported and their actual level of functioning 
may occur (Sabbag et al., 2012), whereby self-reported functioning is influenced by the 
chronic psychiatric illness, causing patients to view their functioning as relatively normal or 
to overestimate their actual functioning. Reasons for this may be that schizophrenia is 
characterized by a prodromal phase, in which symptoms develop slowly and cumulatively 
until the point at which the disorder becomes apparent (Bäuml et al., 2005). Patients may 
have adapted to their symptoms, evaluate them as normal and therefore do not feel 
disturbed by them. It has been shown that patients with schizophrenia and good insight feel 
more depressed because they have a good understanding and are more aware of the 
limitations due to their disorder (Karow & Pajonk, 2006). Patients with schizophrenia in our 
sample might not properly evaluate the seriousness of their disorder. 
A second reason (in addition to chronicity) for the flat profiles characterizing our 
schizophrenia sample may be the type of medication. Antipsychotic drugs may cause 
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patients to be less bothered by their symptoms or experience fewer of them (Rossell, 
Coakes, Shapleske, Woodruff, & David, 2003), yielding lower scores. A larger sample of 
patients that were more comparable when it comes to medication might have been able to 
shed some light on the putative role of the type of medication in relation to the flat profiles. 
It is therefore suggested that future research will use a larger group with systematic 
variation in the type of medication. 
The RC Demoralization scale (RCd) was significantly higher in the depression group than 
in the other two groups. The patients with schizophrenia also scored significantly higher than 
the healthy control group. Taken together, these results show that the effect of 
demoralization is larger for both patient groups as compared to the healthy controls. On the 
other hand, our results might be partly explained by the fact that the RCd measure of 
demoralization is essentially a congener of the Depression content scale. In previous studies, 
high correlations between RCd and Depression as high as .95 have been found (Nichols, 
2006; Tellegen & Ben-Porath, 2008/2011), thereby sharing virtually all of their reliable 
variance. 
Patients with a depression scored higher than their healthy counterparts on all Clinical 
and RC Scales, confirming our hypothesis that patients with depression will score high on 
both sets of scales. The scores of the healthy controls were in the lower normal range. The 
differences between patients with depression and healthy controls were smaller on the RC- 
than on the Clinical Scales (one scale: RC4, was not significant, but Clinical Scale 4-Pd was 
significant). While this would suggest that demoralization has a large effect on many aspects 
of psychopathology and personality in this group, it needs further study as well as 
comparison with the effect of the aforementioned general psychopathology or 'first' factor. 
Demoralization did not influence the tendency towards antisocial behavior in these patients. 
One limitation of our data is the relatively small sample size (Streiner, 1990), which was 
due to recruiting difficulties (Patel, Doku, & Tennakoon, 2003). In future research, a larger 
sample size may enhance generalizability of the results (Mudano et al., 2013). 
To conclude, the main finding of our study is that, with regard to psychopathology and 
personality self report, it is hard to differentiate long-term patients with schizophrenia from 
healthy controls, considering their flat profiles and low individual UT-scores. The current 
study suggests clinical alertness in cases with relatively low clinical scale scores in 
combination with slightly elevated RCd scores. These findings are rather unexpected, and in 
sharp contrast to what the MMPI-2 can do with respect to differentiating patients with long-
term depression from healthy controls. Secondly, demoralization may play an important role 
in both patient groups. This might be due to the patients’ perception of their own symptoms 
and their long-term illness. We conclude that long-term patients with depression show 
impaired functioning and high demoralization, while long-term patients with schizophrenia 
surprisingly show near normal functioning and less demoralization. Since the self report of 
patients with chronic psychiatric illness may markedly contrast with their daily functioning, 
the clinician is prone to incorrect judgments on health status, possibly resulting from 
underestimation of actual psychopathology. A special awareness for this phenomenon 
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should be developed among clinicians and, where possible, be incorporated in the relevant 
residency programs. 
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Abstract 
Background The aim was to investigate the subjective experience of parasomnias and other 
nocturnal behaviors in depression and schizophrenia. 
Materials and Methods Using the Munich Parasomnia Screening (MUPS), 21 parasomnias 
and other nocturnal behaviors were assessed in 85 participants; 27 were patients with 
depression, 29 were patients with schizophrenia and 29 were healthy control participants. 
Results A significant group-difference was found for: hypnagogic hallucinations, sleep-
related bruxism, sleep talking, sleep-related abnormal swallowing, leg cramps, nightmares, 
pavor nocturnus, confusional arousals, and sleep paralysis. Highest scores in depression 
point towards a correlation between depression and the prevalence of parasomnias. 
Parasomnias did not cluster according to their occurrence. 
Conclusion Although all patients with depression had experienced nocturnal behaviors, none 
had a previous parasomnia diagnosis or was treated accordingly. 97.6% of all participants 
had experienced nocturnal behaviors. Prevalence in depression was highest, asking for more 
clinical awareness and thereby better future treatments and outcomes. A screening 
instrument like the MUPS is essential in filtering out patients who seem to experience 
parasomnias. 
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Introduction 
 
Although there is ample evidence for a correlation between psychiatric disorders and various 
sleep disorders (Buysse et al., 1994; Sateia, 2009), much is still unclear about parasomnias 
and their prevalence in depression and schizophrenia (e.g., Kerkhof, 2006). 
According to the International Classification of Sleep Disorders Version 2 (ICSD-2) 
(American Academy of Sleep Medicine, 2005), parasomnias can be divided into three 
categories, i.e., ‘partial arousals during non-REM sleep’, ‘REM-sleep parasomnias’ and ‘other 
parasomnias’. The first category consists of: sleep walking, confusional arousals and pavor 
nocturnus (sleep terror), usually occurring during sudden awakenings out of ‘slow wave 
sleep’ (SWS) (Broughton, 2000). The second category consists of ‘REM-sleep behavior 
disorder’ (RSBD), nightmares and sleep paralyses; RSBD occurs during REM sleep, while 
nightmares and sleep paralyses mostly occur during the shift from REM sleep to 
wakefulness. The third category consists of parasomnias that do not specifically present 
themselves during a certain stage: nocturnal enuresis or bedwetting, sleep related 
dissociative disorder, ‘exploding head syndrome’, sleep related eating disorder (SRED), 
cathathrenia or nocturnal expiratory groaning, and hypnagogic hallucinations (Mason & 
Pack, 2007). 
The subjective experience of parasomnias in depression, schizophrenia and healthy 
controls, is the focus of the present study. Both psychiatric disorders are characterized by 
marked disturbances of sleep (Costa e Silva, 2006; Kerkhof, 2006; Lam, Fong, Ho, Yu, & Wing, 
2008; Sateia, 2009). Because parasomnias and other sleep disorders often co-occur (e.g., 
Kerkhof, 2006; Lam et al., 2008), a co-morbidity of different types of sleep disorders and 
psychopathology is expected. However, most studies on the correlation between nocturnal 
behavior and psychopathology describe few parasomnias only. From those studies, 
especially sleepwalking (Lam et al., 2008; Ohayon, Guilleminault, & Priest, 1999), sleep 
paralysis (Rotenberg et al., 2002; Van Os & Kapur, 2009), RSBD, and SRED (Lam et al., 2008) 
seem to be associated with depression. In schizophrenia spectrum disorders, nightmares are 
frequently reported (Hublin, Kaprio, Partinen, & Koskenvuo, 1999; Levin & Fireman, 2002). In 
order to detect and quantify parasomnias, the Munich Parasomnia Screening (MUPS) (Fulda 
et al., 2008) was used. Since sleep walking and pavor nocturnus have been found to appear 
together (Oudiette et al., 2009), it is hypothesized that parasomnias out of the same group 
co-occur. Patients with a depression spend more time in REM sleep (Rotenberg et al., 2002), 
and because REM sleep parasomnias therefore have more opportunities to occur, it is 
expected that they will occur more in this group. Moreover, depression is a risk factor for the 
occurrence of parasomnias. This view is based on previous research (Lam et al., 2008), 
describing that sleep walking, SRED and RSBD occur more often in patients with depression 
than in those with schizophrenia. Partial arousals to non-REM sleep are known to occur 
more in childhood and in some families hat have a (genetic) history of partial arousals. 
Moreover, they may be facilitated by factors that deepen sleep (Markov, Jaffe, & Doghramji, 
2006) Schizophrenia is characterized by continuing larger percentages of deep non-REM 
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sleep (Keshavan et al., 1998). Because parasomnias belonging to this sleep stage have more 
opportunities to occur and since more deeper sleep may facilitate the occurrence of partial 
arousals to non-REM sleep, this group may show more partial arousals of non-REM sleep 
than the other groups (Broughton, 2000) and more partial arousals of non-REM sleep than 
REM sleep parasomnias. 
 
Method 
 
Participants 
Eighty-five participants (36 men and 49 women, age M = 42.95, SD = 10.66) took part in the 
study, of which 27 were outpatients with depression (6 men and 21 women, age M = 48.00, 
SD = 9.56), 29 were outpatients with schizophrenia (15 men and 14 women, age M = 41.48, 
SD = 9.82), and the control group consisted of 29 healthy participants (15 men and 14 
women, age M =39.72, SD = 11.06). Recruiting limitations resulted in a higher mean age 
(schizophrenia (p < .05) and control (p < .01)) and more women (schizophrenia (p < .05) and 
control (p < .05)) in the group with depression. 
All patients (age 18-64, diagnosed according to the ICD-10 (World Health 
Organization, 1992)) participated voluntarily and signed an informed consent after being 
asked by their therapist in the LVR-Klinik Bedburg-Hau in Germany. The study was approved 
by the ethical committee, and performed in accordance with the Declaration of Helsinki 
(World Medical Organization, 2008). 
Exclusion criteria were substance abuse and/or epilepsy and other neurological 
conditions. For the control group, the exclusion criteria were the presence of neurological- 
or psychiatric disorders. 
 
Material 
The MUPS (Fulda et al., 2008) is a self-evaluation questionnaire that assesses 21 
parasomnias and other nocturnal behaviors (see Table 1). With seven possible answering 
categories, the lifelong frequency of appearance is assessed for every item. The main 
question is ‘How often do you experience the following behaviors?’. The answering 
categories are ‘never’, ‘was observed _ years ago, but not anymore’, ‘very seldom – less than 
once a year’, ‘seldom – once or several times a year’, ‘sometimes – once or several times a 
month’, ‘frequently – once or several times a week’ and ‘very frequently – every or almost 
every night’. For reasons of analyses, the qualitative MUPS was scored quantitatively using a 
seven point scale (0 = never, 1 = years ago, 2 = very rarely, 3 = rarely, 4 = sometimes, 5 = 
often, 6 = very often). Every score was calculated per item and per group. 
All but two of the 21 questions were shown (Fulda et al., 2008) to have a sensitivity 
of equal to or above 90%, and all items have a specificity of more than 80%, 19 of 21 items 
even above 90%. It was found to be a valid and easy to use instrument in the recognition of 
nocturnal behaviors (Wetter & Schenck, 2008). 
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Procedure 
Due to the fact that the dataset is not normally distributed, the Kruskal Wallis Test 
was conducted with α = .05 in order to evaluate possible group differences. The group 
(depression, schizophrenia, control) was used as grouping variable, with the 21 items of the 
MUPS as dependent variable. The Mann-Whitney-U Test was used as follow-up. Moreover, 
factor analyses on the MUPS items were conducted using promax rotation. 
 
Results 
 
Comparison of Nocturnal Behavior 
It was found that 97.6% of the participants had experienced parasomnias and other 
nocturnal behaviors (see Table 1.) 
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Table 1. 
Overview of the scores on the different parasomnias per experimental group 
 Parasomniasa 
Groupb Scorec  1  2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 
C 0 10 21 28 27 27 25 8 22 11 28 20 26 8 26 20 29 27 28 24 21 25 
C 1 4 0 0 0 0 0 3 3 1 0 0 2 3 0 0 0 0 0 2 1 1 
C 2 3 1 0 0 1 1 6 0 5 0 2 1 6 2 4 0 1 1 3 5 2 
C 3 5 5 0 2 1 2 11 1 6 0 2 0 8 0 4 0 1 0 0 0 1 
C 4 4 2 0 0 0 0 1 2 5 1 3 0 3 1 0 0 0 0 0 2 0 
C 5 3 0 0 0 0 0 0 0 1 0 2 0 1 0 1 0 0 0 0 0 0 
C 6 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
D 0 8 14 21 20 17 20 4 12 8 18 17 26 2 13 15 27 17 20 21 18 8 
D 1 2 2 1 0 2 0 5 3 1 2 1 0 2 2 1 0 0 1 2 1 2 
D 2 1 2 1 3 4 0 3 3 7 1 1 0 5 3 5 0 3 2 2 4 1 
D 
Table 
Continues 
3 7 1 2 1 1 3 8 2 5 1 4 0 5 5 1 0 2 2 1 0 7 
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 Parasomniasa 
D 4 6 5 1 2 1 3 5 3 2 1 2 1 5 1 1 0 3 1 1 1 6 
D 5 2 2 0 1 1 0 2 2 0 3 1 0 4 3 1 0 2 1 0 1 2 
D 6 1 1 1 0 1 1 0 2 4 1 1 0 3 0 3 0 0 0 0 2 1 
S 0 13 23 22 25 22 21 10 22 18 21 24 22 4 22 14 27 19 27 24 24 24 
S 1 3 2 2 0 2 2 8 2 5 0 0 4 2 0 1 0 1 0 3 3 3 
S 2 4 1 1 2 2 3 7 1 1 1 3 2 6 4 2 2 5 2 0 0 2 
S 3 2 0 1 1 2 1 2 1 1 2 2 0 7 2 3 0 1 0 2 1 0 
S 4 5 0 0 0 1 1 1 0 2 5 0 0 5 1 6 0 3 0 0 1 0 
S 5 1 1 2 1 0 1 1 2 1 0 0 0 4 0 2 0 0 0 0 0 0 
S 6 1 2 1 0 0 0 0 1 1 0 0 1 1 0 1 0 0 0 0 0 0 
 
a: 1 = Hypnic jerks, 2 = Rhythmic feet movements, 3 = Rhythmic movement disorder, 4 = Exploding head syndrome, 5 = Hypnagogic hallucinations, 6 = Periodic leg 
movements, 7 = Nocturnal leg cramps, 8 = Sleep-related bruxism, 9 = Sleep talking, 10 = Sleep-related abnormal swallowing, 11 = Nocturnal groaning, 12 = Nocturnal 
enuresis, 13 = Nightmares, 14 = Pavor nocturnus, 15 = Nocturnal eating, 16 = Sleep related eating disorder, 17 = Confusional arousals, 18 = Sleep paralysis, 19 = Sleep 
walking, 20 = Violent behavior, 21 = RSBD. 
b: C = control group, D = group with depression, S = group with schizophrenia. 
c: 0 = never, 1 = years ago, 2 = very rarely, 3 = rarely, 4 = sometimes, 5 = often, 6 = very often. 
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A descriptive analysis was made for all variables (see Table 2). Kruskal-Wallis tests 
were conducted to evaluate differences among the three groups on the 21 items of the 
MUPS. For the following items, tests were corrected for tied ranks and found to be 
significant. A strong effect was found for pavor nocturnus χ2(2, N = 85)= 12.64, p = .00, η2 = 
.15 and a medium effect for: hypnagogic hallucinations χ2(2, N = 85) = 7.24, p = .02, η2 = .09; 
nocturnal leg cramps χ2(2, N = 85) = 9.55, p = .01, η2 = .09; sleep-related bruxism χ2(2, N = 85) 
= 8.08, p = .02, η2 =.10; sleep talking χ2(2, N = 85) = 7.52, p = .02, η2 = .09; sleep-related 
abnormal swallowing χ2(2, N = 85) = 8.29, p = .02, η2 = .10; nightmares χ2(2, N = 85) = 8.83, p 
= .01, η2 = .11; confusional arousals χ2(2, N = 85) = 8.53, p = .01,η2 =.10 and sleep paralysis 
χ2(2, N = 85) = 8.10, p = .02, η2 = .10. 
Subsequently, post hoc Mann-Whitney-U tests with Bonferroni correction (p < .016), 
were conducted for all significant items. The results show that the group with depression 
scored highest on all nocturnal behaviors that differed significantly between the groups. The 
results show a significant difference between the group with depression and the control 
group for the items: hypnagogic hallucinations z = -2.68, p = .007, sleep-related bruxism z = -
2.44, p = .015, sleep-related abnormal swallowing z = -2.87, p = .004, nightmares z = -2.87, p 
= .004, pavor nocturnus z = -3.35, p = .00, confusional arousals z = -2.80, p < .01, sleep 
paralyses z = -2.41, p = .001. 
On sleep talking z = -2.67, p = .008, sleep paralyses z = -2.41, p = .016 nocturnal leg 
cramps z = -2.92, p = .004, sleep-related bruxism z = -2.29, p = .015, and pavor nocturnus z = -
2.23, p = .001, the group with schizophrenia achieved the lowest scores, that were 
significantly different from the group with depression, but not from the control group. 
On sleep-related abnormal swallowing z = -2.47, p = .013, and confusional arousals z 
= -2.55, p = .011 the group with schizophrenia scored significantly higher than the control 
group only. 
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Table 2.  
Mean Ranks on the Items per Nocturnal Behavior 
Item Occurrence Parasomnia/Nocturnal 
behavior 
Depression Schizophrenia Control 
13. REM sleep parasomnias Nightmares 51.91a 44.83 32.88 
18. REM sleep parasomnias Sleep paralysis 49.19a,b 40.83 39.41 
21. REM sleep parasomnias RSBD 46.59 41.79 40.86 
14. Partial arousals during non-REM 
sleep 
Pavor nocturnus 53.52a,b 40.93 35.28 
17. Partial arousals during non-REM 
sleep 
Confusional arousals 48.61a 46.00a 34.78 
19. Partial arousals during non-REM 
sleep 
Sleep walking 44.70 42.24 42.17 
4. Other parasomnias Exploding head syndrome 47.56 42.29 39.47 
5. Other parasomnias Hypnagogic hallucinations 49.39a 43.57 36.48 
11. Other parasomnias Nocturnal groaning 46.72 38.09 44.45 
12. Other parasomnias Nocturnal enuresis 39.22 47.72 41.79 
15. Other parasomnias Nocturnal eating 43.74 48.29 37.02 
16. Other parasomnias Sleep related eating disorder 42.00 44.93 42.00 
1. Other sleep related nocturnal 
behaviors 
Hypnic jerks 48.09 38.62 42.64 
2. Other sleep related nocturnal 
behaviors 
Rhythmic feet movements 50.31 38.38 40.81 
3. Other sleep related nocturnal 
behaviors 
Rhythmic movement disorder 45.35 46.16 37.66 
6. Other sleep related nocturnal 
behaviors 
Periodic leg movements 45.28 44.45 39.43 
7. Other sleep related nocturnal 
behaviors 
Nocturnal leg cramps 52.94b 33.07 43.67 
8. Other sleep related nocturnal 
behaviors 
Sleep-related bruxism 52.41a,b 38.88 38.36 
9. Other sleep related nocturnal 
behaviors 
Sleep talking 49.91b 33.52 46.05 
10. Other sleep related nocturnal 
behaviors 
Sleep-related abnormal 
swallowing 
48.31a 45.53a 35.52 
20. Other sleep related nocturnal 
behaviors 
Violent behavior 46.91 38.78 43.59 
According to the Mann Whithney U tests: a Mean rank is significantly different (p < .05) from control. b Mean 
rank is significantly different (p < .05) from schizophrenia. 
 
Parasomnia Categories 
In order to establish whether the parasomnias within one category (the three 
categories being: ‘partial arousals during non-REM sleep’, ‘REM-sleep parasomnias’ and 
‘other parasomnias’) are indeed associated, a Spearman’s Rank Order correlation was run to 
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determine the relationship between parasomnias in one category. If parasomnias would 
cluster according to their appearance, that would justify categorization according to these 
three categories. Only pavor nocturnus and confusional arousals were correlated (rs(83) = 
.305, p < .01) in the partial arousal from non-REM sleep category, while sleepwalking was 
not significantly correlated to the other two. 
In the REM sleep parasomnia category, both nightmares and sleep paralysis (rs(83) = 
.272, p < .05) as well as nightmares and RSBD (rs(83) = .222, p < .05) were correlated, 
whereas the correlation between sleep paralysis and RSBD was not significant. 
Moreover, most parasomnias from one category also correlated with parasomnias 
from other categories. Significant correlations were found between pavor nocturnus and all 
three REM sleep parasomnias: nightmares (rs(83) = .379, p < .01), sleep paralysis (rs(83) = 
.336, p < .01) and RSBD (rs(83) = .256, p < .05), and moreover, between confusional arousals 
and nightmares (rs(83) = .305, p < .05) and between sleep walking and RSBD (rs(83) = .292, p 
< .01). 
The factor analysis extracted eight factors and its structure was not compatible with 
the categories suggested by the ICSD-2 (American Academy of Sleep Medicine, 2005), 
because two of the three partial arousals during non-REM sleep (pavor nocturnus and 
confusional arousals) load high on the same factor, but the third one (sleep walking) does 
not. The three REM sleep parasomnias (nightmares, sleep paralysis and RSBD) all loaded high 
on three different factors (see Table 3). Moreover, it was difficult to interpret the eight 
factors, because the items that load high on the same factor did not seem to have anything 
in common. 
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Table 3. 
Factorloads of the Items after Factor Analysis with Maximum Likelihood and Promax Rotation 
 Factor 
1 
Factor 
2 
Factor 
3 
Factor 
4 
Factor 
5 
Factor 
6 
Factor 
7 
Factor 
8 
Violent behavior .987        
RSBD .664        
Sleep related groaning .474        
Sleep talking .305        
Pavor nocturnes  .770       
Confusional arousals  .685       
Sleep-related abnormal 
swallowing 
 .488       
Rhythmic movement disorder  .301       
Exploding head syndrome   1.039      
Hypnagogic hallucinations   .447 .371     
Hypnic jerks    .908     
Rhythmic feet movements    .508     
Sleepwalking     .995    
Sleep-related eating disorder         
Nightmares      .943   
Sleep paralysis         
Nocturnal leg cramps       -.906  
Nocturnal enuresis       .372  
Nocturnal eating         
Periodic leg movements        .588 
Sleep-related bruxism        .564 
 
Continuing factor analyses until every item loads higher than .30 on one factor and 
thereby excluding the items that load high on no factor or that load high on more factors at 
the same time, resulted in 12 items that were distributed along five factors. But even then 
parasomnia from one category load high on different factors and parasomnia from different 
categories load high on the same factor. 
 
Category Differences in Schizophrenia 
A number of REM sleep parasomnias appear more often than partial arousals during 
non-REM sleep in the group with schizophrenia χ2(3) = 43.93, p = 0.000. A post-hoc Mann 
Whitney U Test with Bonferroni correction was applied, resulting in a significance level set at 
p < 0.008. It was found that the REM sleep parasomnia nightmares appeared more than the 
three arousals during non-REM sleep: pavor nocturnus (Z = -4.033, p = .000), confusional 
arousals (Z = -3.758, p = .000), and sleepwalking (Z = -4.393, p = .000). On the other hand, 
one of the other REM sleep parasomnias; sleep paralysis was found significantly less than 
the non-REM sleep parasomnia; confusional arousals (Z = -2.176, p = .007). 
 
Differences between the Groups 
The distribution of men and women was not equal. Analysis of covariance showed 
that gender influenced only sleep related bruxism (which was significantly higher in the 
depression group, and therefore in the group with more women). A second difference 
between the groups was that age was also higher in the group with depression. Analyses of 
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covariance, however, showed that age was only a contributing factor in explaining sleep 
related abnormal swallowing (which occurred more in the older group), it did not contribute 
to any of the other results. 
 
Discussion 
Of the total sample, 97.6% had experienced nocturnal behaviors; the parasomnias 
that occurred the most by far were nightmares, followed by hypnic jerks, nocturnal leg 
cramps, sleep talking, and finally nocturnal eating. Patients with a depression suffered the 
most. 
The assumption that parasomnias would correlate within their category and that 
there would be specific differences in prevalence between the groups with depression and 
schizophrenia, was partially confirmed. Among the three partial arousals during non-REM 
sleep, pavor nocturnus and confusional arousals were correlated, while sleepwalking and 
pavor nocturnus merely showed a marginally significant correlation. These findings are not 
in line with Oudiette et al. (2009), who found that sleepwalking and pavor nocturnus co-
occurred. Among the three REM sleep parasomnias significant correlations were found 
between nightmares and sleep paralyses and between nightmares and RSBD, but not 
between sleep paralyses and RSBD. These findings partly confirm the theory that 
parasomnias from one category correlate and co-occur more often. Moreover, significant 
correlations were found with parasomnias that belong to another category. Pavor nocturnus 
was found to be significantly correlated to nightmares and RSBD, confusional arousals was 
correlated to nightmares and sleepwalking was related to RSBD. Also by means of a factor 
analysis only few correlations between parasomnias belonging to the same category were 
found. 
Factor analysis resulted in eight factors that do not have anything in common with 
the ICSD-2 (American Academy of Sleep Medicine, 2005). Moreover, they do not seem 
relevant for clinical practice, and therefore it would not be helpful to restructure the MUPS, 
creating a score system for the different factors. It seems more practical to keep the MUPS 
the way it is now, providing a clear overview of the subjective presence of parasomnias 
within two A4 pages. 
The expectation that having a depression is a risk factor for developing parasomnias 
is strongly affirmed in accordance with Lam et al. (2008). From the 21 items, nine showed a 
significant difference between the depression, schizophrenia and the healthy control group. 
Two of the items belong to the arousals during non-REM sleep, two belong to the REM sleep 
parasomnias, one to other parasomnias, and four to other nocturnal behaviors. All occur 
most in the group with depression, which discriminates significantly from the control group 
on 7 and from that with schizophrenia on 5 nocturnal behaviors. On the other hand, the 
group with schizophrenia scores significantly higher than the control group on two items 
only. 
Parasomnias appeared more often in people with psychiatric problems than in 
healthy people, confirming earlier findings (e.g., Vgontzas & Kales, 1999). This has clinical 
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relevance because sleep problems in general (Shneerson, 2000) and particularly parasomnia 
(Lam et al., 2008), are often deficiently diagnosed or treated. Remarkably, none of the 27 
patients with a depression was previously diagnosed with parasomnias or nocturnal 
behaviors, illustrating the extreme under-diagnoses. This finding illustrates that the MUPS is 
able to function as a screening instrument, because it illustrates patient’s subjective opinion 
of possible parasomnias that they have experienced. They may not mention these 
parasomnias when they visit their psychiatrist and therefore, these symptoms remain 
unnoticed. To optimize treatment, in sharp contrast to current practice, these patients 
should be screened with an instrument like the MUPS. 
Perhaps patients with schizophrenia are less aware of the appearance of parasomnias 
than the other groups due to the use of antipsychotic medication (Van Os & Kapur, 2009). In 
future research proxy ratings/observations might be used to shed more light on this subject. 
Moreover, in this study, the subjective patient’s experience of parasomnias was 
investigated; however, in future research it would be interesting to investigate not only the 
subjective experience, but also the actual clinical confirmation of parasomnias and their 
diagnosis. 
A shortcoming of this study is that the medication used by the different patients 
groups was not comparable in doses or sort of medication. Most patients with schizophrenia 
used two or more types of medication, including antipsychotics and antidepressants, 
whereas most patients in the group with depression used at least one antidepressant and 
some used additional medication. In future research more strict inclusion criteria might be 
used in order to have a more comparable sample and to exclude influence by the 
medication. 
A second shortcoming of our study is the size of the experimental groups. Owing to 
recruitment difficulties and strict ethical limitations, it was not possible to include more 
patients in the study. 
To conclude, the development and standardized use of tests like the MUPS that focus 
on sleep disorders seems to be a simple, cheap, and timesaving method to avoid further 
under-diagnoses of parasomnias and other nocturnal behaviors. More awareness might lead 
to better treatments and thereby better treatment outcomes. 
 
Conclusion for clinical practice 
Parasomnias and other nocturnal behaviors occur often, and patients with depression in 
particular are at risk. Tests like the MUPS are a great method with which to increase 
awareness of parasomnia, thereby helping to develop better treatments and treatment 
outcomes. 
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Chapter 4 
 
Sleep ameliorating effects of acupuncture in a psychiatric population 
 
Based on: 
Bosch, P., van Luijtelaar, G., van den Noort, M., Lim, S., Egger, J., & Coenen, A. (2013). Sleep 
ameliorating effects of acupuncture in a psychiatric population. Evidence-Based 
Complementary and Alternative Medicine, 969032. doi:10.1155/2013/969032 
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Abstract 
 
The interest of psychiatric patients for complementary medicine, such as acupuncture, is 
stable, but effect studies in psychiatry remain scarce. In this pilot study, the effects of 3 
months of acupuncture treatment on sleep were evaluated and compared between a group 
of patients with schizophrenia (n = 16) and a group with depression (n = 16). Healthy 
controls were included in order to establish reference values (n = 8). Patients with 
schizophrenia and depression were randomly assigned to either a waiting list or a treatment 
condition. The Pittsburgh Sleep Quality Inventory was completed before and after the 
acupuncture treatment (individualized and according to Traditional Chinese Medicine 
principles) or the waiting list condition. Both acupuncture groups showed significant lower 
scores on the sleep inventory, which was not the case for the waiting list condition. 
Moreover, it was found that the effectiveness of the acupuncture treatment was higher in 
the patients with schizophrenia than in the patients with depression. Acupuncture seems 
able to improve sleep in this convenient sample of patients with long lasting psychiatric 
problems and may be a suitable and cost-effective add-on treatment for this group, 
particularly if conducted group-wise. 
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1. Introduction 
Interest in complementary and alternative medicine (CAM), such as acupuncture, has 
increased in popularity in Western societies in the last part of the twentieth century and 
there has been a continued interest ever since (Harris, Cooper, Relton, & Thomas, 2012). The 
use of CAM includes its application in psychiatric patients (Elkins, Rajab, & Marcus, 2005). 
Two large groups that need long-term treatment are patients with depression and patients 
with schizophrenia. Besides the typical depressive or positive and negative symptoms, their 
disorders are characterized by marked disturbances of sleep (Buysse et al., 2008; Chouinard, 
Poulin, Stip, & Godbout, 2004; Cukrowicz et al., 2006; Monti & Monti, 2004; Monti & Monti, 
2005; Taylor, Lichstein, Durrence, Reidel, & Bush, 2005). Patients with schizophrenia show 
increased sleep latency, decreased total sleep time, and decreased sleep efficiency 
(Chouinard et al., 2004; Monti & Monti, 2004; Monti & Monti, 2005). A bidirectional 
relationship between insomnia and depressive symptoms in patients with depression is 
described (Buysse et al., 2008; Cukrowicz et al., 2006; Taylor et al., 2005). Sleep problems 
such as increased sleep latency, awakenings in the night or early in the morning with an 
incapability to go back to sleep, and decreased sleep efficiency are typical symptoms of 
depression; whereas hypersomnia and dream-disturbances are also often reported. The 
sleep disorders appear to maintain or even deteriorate the mood disorder (Stein, Kupfer, & 
Schatzberg, 2006). 
In Western psychiatry, a growing consumption of antipsychotic (Lertxundi, Echaburu, & 
Palacios, 2012) and antidepressant drugs (Pratt, Brody, & Gu, 2011) can be seen. 
Antipsychotic application is seen as the cornerstone in therapy for patients with 
schizophrenia (Tandon, Nasrallah, & Keshavan, 2010); whereas due to their positive effects, 
antidepressants have found their place in the clinical guidelines for the treatment of, for 
instance, patients with depression (NICE Depression, 2010). Despite these clinical successes, 
a problem with pharmaceutical therapies (Ascher-Svanum, Peng, Faries, Montgomery, & 
Haddad, 2009), like any other therapy, is that they are subject to patient non-adherence and 
declining patient compliance (Bodén, Brandt, Kieler, Andersen, & Reutfors, 2011; Goff, Hill, 
& Freudenreich, 2010). 
Previous research has shown that adherence to treatment correlates negatively with 
sleep disturbance and depression (Phillips et al., 2005). It seems that a lack of contact with 
this patient group makes it difficult to engage in a therapeutic relationship or to prescribe 
and monitor medication effectively. The medicines used to treat these conditions often 
cause drowsiness (Seeman, 2012). Patients are therefore often advised to take them at night 
which cause problems with sleep (e.g. excessive dreaming and increase in total sleep time in 
patients with schizophrenia (Monti & Monti, 2004)) even though taking them at night 
minimizes daytime drowsiness. Moreover, tiredness, drowsiness and poor sleep interferes 
with the patient’s ability to engage with therapeutic services because they are too tired, 
unmotivated and they do not see the point or do not want to take medicines that cause such 
adverse effects. Presumably, these are not the only factors that are of importance, but they 
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seem highly relevant in patient groups that suffer from depression, as well as those that 
suffer from schizophrenia, since both diseases are prone to sleep disorders. 
Acupuncture is part of Traditional Chinese Medicine (TCM), which in itself is a form of 
CAM that is based on thousands of years of practice (Kavoussi, 2007). One of the features of 
the TCM approach is the individualization of treatment, which relies on a symptom-based 
diagnostic process (Zhang et al., 2005). TCM diagnoses are based on clinical symptoms and 
signs that are completely discerned by the oriental medical practitioner (Zhang et al., 2005). 
Recent years have seen an increase in trials on particularly depression and acupuncture 
(Yeung, Ameral, Chuzi, Fava, & Mischoulon, 2011; Lyons, van der Watt, Shen, & Janca, 2012; 
Zhang, Yang, & Zhong, 2009). Various reviews, however, have concluded that evidence for 
the effects of acupuncture on depression still remains preliminary (Leo & Ligot, 2007; 
Schroer & Adamson, 2011; Wang et al., 2008). In particular methodological problems, such 
as different techniques (electro-, manual-, or laser acupuncture), various control groups and 
study designs, limit the generalization of the results (Bosch, Ausfeld, & van den Noort, 2008; 
Yeung et al., 2011). Although efforts have been made to standardize and optimize research 
and the way it is reported, further research is warranted (Leo & Ligot, 2007; MacPherson et 
al., 2010). 
Even less research with acupuncture has been conducted on schizophrenia. Some 
literature research (Bosch & van den Noort, 2008; Rathbone & Xia, 2005) indicates that more 
research is necessary to draw firm conclusions on acupuncture’s effectiveness in the 
treatment of schizophrenia. Moreover, even though some research was reported (Lee, Shin, 
Ronan, & Ernst, 2009; Ronan, Harbinson, MacInnes, Lewis, & Robinson, 2010), hinting in the 
direction of effectiveness and thereby providing the basis for future research, the existing 
research remains preliminary. 
Acupuncture may be beneficial in the treatment of sleep disorders (Peterson, 2002). It 
can be used alone or combined with other interventions, since no interactions were found to 
date and adverse events related to treatment seem sufficiently controllable by providing 
thorough training (Vincent, 2001). Although some research has been conducted on 
acupuncture and sleep disorders (Bosco Guerreiro da Silva, Uchiyama Nakamura, Cordeiro, 
& Kulay, 2005; Freire et al., 2007; Montakab, 1999; Spence et al., 2004), results are still 
tentative, particularly in patients with psychiatric disorders. Results call for research in a 
group, in which symptoms are prominent, since acupuncture’s effectiveness is thought to 
rely on its homeostatic actions, striving to return the body to its normal physiological state. 
Therefore, it is thought that acupuncture has more effects on patients that experience 
serious problems than on healthy participants or patients with only mild symptoms (Bosch & 
van den Noort, 2008). 
This pilot study evaluates and compares the effects of acupuncture on the subjective 
quality of sleep in long-term patients with schizophrenia and patients with depression. It is a 
pragmatic trial, and a first start to conduct research in an integrative treatment setting in 
which psychiatric treatment and TCM are combined. 
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2. Materials and Methods 
 
2.1. Participants. In total the convenient sample consisted of 40 participants (13 men, 27 
women). 16 of them (10 women, 6 men, mean age was 44.25 years, SD = 2.44) diagnosed 
with schizophrenia, 16 of them (12 women, 4 men, mean age was 50.94 years, SD = 1.33) 
diagnosed with depression. The healthy control group consisted of 5 women and 3 men 
(mean age was 36.75 years, SD = 12.43). Mean length of illness was 13.56 years (SD = 1.59) 
for the group with schizophrenia and 5.94 years (SD = 1.05) for the group with depression. 
The randomization function in Excel was used to randomly divide the patients into a 
treatment and a waiting list condition. For an overview of the descriptive statistics see Table 
1 and for an overview of the medication used, see Table 2. 
 
Table 1. 
Overview of the descriptive statistics of the convenient sample. 
 Schizophrenia (SD) Depression (SD) Healthy 
Control (SD) 
 Total Waiting 
list 
Acupuncture Total Waiting 
list 
Acupuncture Total 
Men 6 3 3 4 2 2 3 
Women 10 5 5 12 6 6 5 
Length 
of 
illness 
13.56 
(1.59) 
12.63 
(5.90)a 
14.50 
(7.07)a 
5.94 
(1.05) 
4.38 
(3.54) 
7.50 
(4.41) 
0 
Age 44.25 
(2.44) 
42.25 
(10.99) 
46.25 
(8.57) 
50.94 
(1.33) 
52.88 
(5.59)b 
49.00 
(4.54) 
36.75 
(12.43) 
According to the one-way ANOVA (groups as between subjects factor) at baseline: a Mean is 
significantly different (p < 0.05) from the depression waiting list group. b Mean is significantly 
different (p < 0.05) from the healthy control group. 
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Table 2. 
Overview of the medication used by the different groups at the start of the study. 
Group CPZ Atypical Typical SSRI Tricyclic 
anti-
depressives 
SNRI 
and 
SSNRI 
Others 
Depression 
and 
acupuncture 
group 
Chlorprothixe
ne in 1 patient 
Promethazine 
in 1 patient 
Pipamperone 
in 1 patient 
0,33 in 1 
patient 
In 2 
patients 
In 2 
patients 
In 4 
patients 
In 3 patients In 3 
patients 
In 2 
patients 
Depression 
and waitlist 
group 
Pipamperone 
in 1 patient 
0,33 in 1 
patient 
In 1 
patient 
In 1 
patient 
In 4 
patients 
In 2 patients In 3 
patients 
In 2 
patients 
Schizophrenia 
and 
acupuncture 
group 
Amisulpride + 
1 in 1 patient 
Zotepine + 1 in 
1 patient 
Prothipendyl + 
2 in 1 patient 
Flupenazine + 
3 in 1 patient 
6 in 1 patient 
4 in 1 patient 
3,5 in 1 
patient 
1,83 in 1 
patient 
In 8 
patients 
In 3 
patients 
In 0 
patients 
In 1 patient In 1 
patient 
In 4 
patients 
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Group CPZ Atypical Typical SSRI Tricyclic anti-
depressives 
SNRI 
and 
SSNRI 
Others 
Schizophrenia 
and waitlist 
group 
Fluphenazine + 
3 in 1 patient 
6 in 1 patient 
Pipamperone + 
3,17 in 1 
patient 
1,83 in 1 
patient 
1 in 1 patient 
Zotepine and 
Chlorprothixene 
and Melperone 
+ 4 in 1 patient 
10 in 1 patient 
3,5 in 1 patient 
In 8 
patients 
In 3 
patients 
In 0 
patients 
In 2 patients In 0 
patients 
In 4 
patients 
CPZ (Chlorpromazine Equivalents) were calculated using published equivalencies for oral 
conventional (American Psychiatric Association, 1997) and atypical (Woods, 2003) antipsychotics. 
SSRI = Selective Serotonin Reuptake Inhibitor, SNRI = Serotonin Norepinephrine Reuptake Inhibitor, 
SSNRI = Selective Serotonin Norepinephrine Reuptake Inhibitor 
 
Recruiting limitations resulted in a higher mean age in the depression waiting list condition 
than in the healthy control group (p < 0.05). There was a poster in the entrance section and 
in the waiting room that gave information on the study. Moreover, potential participants 
(diagnosed with schizophrenia F 20.0 (paranoid schizophrenia), F20.5 (schizophrenic 
residuum), or depression F33.2 according to the ICD-10) (World Health Organization, 1992) 
were identified and approached by their therapist at the LVR-Klinik Bedburg-Hau. Patients 
that agreed to participate did so voluntarily and signed an informed consent form; 
moreover, their therapist signed for their mental ability to understand the form. The Becks 
Depression Inventory-II (Beck, Steer, & Brown, 1996) and Positive And Negative Symptom 
Scale (PANSS) (Kay, Fiszbein, & Opler, 1987) were used as inclusion criteria. The study was 
carried out in accordance with the Declaration of Helsinki (World Medical Organization, 
2008) and was approved by the ethical committee of the Ärztekammer Nordrhein. 
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Participants continued with their normal psychiatric treatment, including medication, 
alongside acupuncture. After the project, the medical files were checked for possible 
changes in medication during the time of the project. Moreover, possible use of sleep 
medication was mentioned by the patients on the Pittsburgh Sleep Quality Inventory (PSQI). 
Five of the patients with schizophrenia (all in the acupuncture condition) used sleep 
medication beforehand. Six of the patients with depression (two in the acupuncture and four 
in the waiting list condition) and none of the healthy control group used sleep medication. 
Of the five patients in the schizophrenia and acupuncture group, one of them used 
Prothipendyl (80 mg daily), one used Prothipendyl (40 mg daily), one used Sifrol (0.36 mg 
daily) one used Amitriptyline (50 mg daily), and one used Melperone (75 mg daily). In the 
depression and acupuncture group one patient used Chlorprothixene (30 mg daily) and one 
patient Pipamperone (40 mg daily). Finally in the depression and waiting list condition group 
one patient used Pipamperone (40 mg daily) and three patients Zopiclone (7.5 mg 
daily/when needed). Probably due to the natural course of the diseases and recruitment 
limitations, the group of participants diagnosed with schizophrenia had been in treatment 
significantly longer than those with depression. There were no gender differences within and 
between the groups. Exclusion criteria for the patients were substance abuse and/or 
epilepsy and other neurological conditions. For the control group, the exclusion criteria were 
the presence of neurological- or psychiatric disorders. 
 
2.2. Instruments 
 
2.2.1. Pittsburgh Sleep Quality Inventory. The German version of the PSQI (Buysse, Reynolds, 
Monk, Berman, & Kupfer, 1989) was used in order to gain information on the subjective 
quality and quantity of sleep in the participants. With this retrospective list, conducting 
questions about sleep during the last four weeks, information on the number of sleep 
disturbances, estimation on sleep quality, sleep duration, sleep latency and sleep times, use 
of medication, and sleepiness during the day is being gathered. The questionnaire consists of 
18 items, divided into 7 components that can be scored from 0-3. The PSQI Total Score 
results in the sum of the component scores and can be any score from zero to 21. A high 
score means sleep quality is bad. Five was originally seen as the cutoff score. Participants 
that score below five have a good sleep quality. However, there is a tendency to use 6 as a 
cutoff score (Hametner et al., 2012) to be more selective. The internal consistency for the 
American and Japanese version was found to be good. Cronbach’s alpha for the total score 
was .77 (Doi et al., 2000). The validity of the PSQI in patients with primary insomnia was 
good, since a high correlation between PSQI scores and a sleep diary was obtained by 
Backhaus and colleagues (Backhaus, Junghanns, Broocks, Riemann, & Hohagen, 2002). 
Moreover, they found a significant correlation between the PSQI and polysomnografic 
measurements. These results were confirmed in research on the Chinese version of the PSQI 
(Tsai et al., 2005). In all, the PSQI has a high sensitivity and specificity for patients with 
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insomnia (Backhaus et al., 2002) and also for patients with depression and schizophrenia 
(Doi et al., 2000). 
 
2.3. Experiment 
 
2.3.1. Needles. The needles (AcuPro C, Wujiang City Cloud & Dragon Medical Device Co., Ltd., 
China) that were used were 0.25 x 25 mm or 0.20 x 15 mm stainless steel (depending on the 
place of needling) single use needles. The needles were placed according to TCM principles. 
 
2.3.2. Intervention. The participants in the acupuncture groups were given acupuncture 
treatment once a week, twelve weeks in a row. Individualized acupuncture according to TCM 
principles was applied after careful individual diagnosis by a licensed oriental medical 
practitioner with more than five years of clinical experience (MacPherson et al., 2010). 
Acupuncture treatment took place in a light room with (very) soft background music (Enya) 
playing. According to the demand of the ethics committee to decrease anxiety (Yu, Liu, Li, & 
Ma, 2009) as much as possible in patients with schizophrenia and to make them feel 
comfortable, music along with acupuncture was used. The music was kept constant over all 
participants and all sessions. There were 12 “relax” chairs in which it was possible to adjust 
the back and put the feet up, resulting in a near-lying position. It was, however, also possible 
to remain upright, this was left to the patients to decide for themselves. Due to the fact that 
acupuncture was applied with patients in a sitting or near lying position, access to 
acupuncture points on the back was limited. Patients came into the room in intervals, in 
order to reduce waiting time. Treatment (after needles were inserted) lasted for one hour. 
After this hour, needles were removed. This group treatment setting made sure practitioners 
were directly at hand in case anxiety would arise and it was one of the important points that 
were made in the dialogue with the ethics committee. In case individuals had personal 
questions or sensitive matters that needed to be discussed prior to treatment, there was an 
empty room next to the treatment room where confidentiality could be assured. As there 
were two acupuncturists present, the other patients would not be left alone in the mean 
time. 
All participants continued with regular treatment including appointments with their 
psychiatrists, this was not influenced by the project since acupuncture was used as an add-
on treatment. 
 
2.3.3. Procedure. All participants were tested in an experimental testing room in the clinic, 
by apprentices who were blind to group or time of testing. The healthy control group was 
tested at T1 (pre-test) only, the participants with schizophrenia and depression were tested 
at T1 and T2 (post-test). After the tests at T1, participants were randomly divided into a 
treatment and a waiting list condition. The duration of the whole experiment was 13 weeks, 
which included 12 weekly acupuncture sessions and pre- and post-testing. At the end of the 
experiment, all participants received a debriefing and were individually informed about their 
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own test results. Patients on the waiting list were given the opportunity to attend 
acupuncture treatment after T2 if they wanted to. The current study stopped at T2, although 
acupuncture treatment was given after T2 in order to provide equal treatment 
opportunities. The patients, however, were not tested afterwards and therefore these data 
were not included in the study. Moreover, any acupuncture that was provided after the 
study was part of their normal treatment, not of any study. 
 
2.4. Statistics. Differences between the five groups on the subtests of the PSQI before the 
start of the treatment were analyzed with a one-way analysis of variance (one-way ANOVA) 
with groups as between subjects factor, followed by post-hoc (Bonferroni) tests. Repeated 
measures analyses of variance were used to analyze possible differences on the PSQI Total 
Score and on the subtests of the PSQI pre- and post-treatment (in the four experimental 
groups), followed by post-hoc (Bonferroni) t-tests if appropriate, that is t(7) in our pilot-
study. A value of p < 0.05 was considered to be statistically significant. 
 
3. Results 
 
3.1. Acupuncture Points that were used 
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Table 3. 
Acupuncture points that were used. 
Points/Patients D1 D2 D3 D4 D5 D6 D7 D8 S1 S2 S3 S4 S5 S6 S7 S8 
EX-HN-1 12 12 12 12 12 12 11 12 12 11 12 12 11 12 12 12 
DU-24         2 5 5 2    8 
DU-14          1       
DU-17         1        
DU-18         1       1 
DU-19         1        
EX-HN-3 5  1   2           
EX-HN-5 5  1   2         1  
LI-20      1           
ST-8 10 3 3 9 8  7 2  7 5  10 1 2 1 
ST-7         1        
ST-6     2            
TB-21       1      1    
KI-23      2           
KI-24     1 2   1        
KI-25     1    1        
(Table continues) 
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Points/Patients D1 D2 D3 D4 D5 D6 D7 D8 S1 S2 S3 S4 S5 S6 S7 S8 
KI-26         1        
GB-6 1                
GB-7         1        
GB-8         1 1       
GB-13         2 1 2  1   9 
GB-20 2    1            
SI-3 5  11       2 2  1    
SI-4            1     
SI-5               2  
HT-2     1            
HT-3 1 4 3  3 1 4 2         
LI-4 12 12 12 12 12 12 12 12 7 3 5 9 10 8 12 4 
PC-6 3 2  1 4 2   1 1  2 1 1 1  
PC-7  1   4   2 5 4 2 1 2  1 7 
HT-7 12 12 11 12 12 12 12 12 9 1 7 3 3 8 3  
HT-8     1            
(Table continues) 
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Points/Patients D1 D2 D3 D4 D5 D6 D7 D8 S1 S2 S3 S4 S5 S6 S7 S8 
LU-5            1   1  
LU-6             8    
LU-7 1 11 8  5 3 3 12 8  1  3 5 1  
TB-5 5  10 3   2      2    
TB-6            1     
LI-7 1 2 1   2 10  2 1  1 1    
LI-11 6 6 3 12 10 1 12 6 5 10 8 8 8 11 12 11 
CV-12                2 
CV-14         1        
CV-15        1         
CV-16     1        1    
CV-17 7 2 3 7 10 1 7 9  12 3 6 9 9 8 11 
CV-18     2         3 1  
ST-21          3      4 
ST-25 4        2 1  3 5  1 3 
CV-5           1      
(Table continues) 
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Points/Patients D1 D2 D3 D4 D5 D6 D7 D8 S1 S2 S3 S4 S5 S6 S7 S8 
CV-4 3 8 9  2   9         
KI-10   1 2             
SP-10 7 6 9   2 3 1    1     
BL-39             1    
BL-40             1 3   
SP-9 12 12 12 12 11 12 12 12 7 6 10 9 12 12 12 3 
GB-34 8 7 5 7 8 6 5 6 1   1    4 
ST-36 12 12 12 8 12 12 2 12 7 1 3 8 9 8 9 2 
ST-40 1 1  12   11  1 10 9 3 2 4 2 9 
SP-6 12 12 12 12 12 12 12 11 11 4 12 8 12 11 12 10 
KI-3 11 12 12 12 12 12 12 12 1 2 4 7 11  12  
KI-5              2   
KI-6 9 8 9   5 8 12 2       2 
LR-3 10 12 11 12 10 4 7 10 10 9 6 8 10 9 5 7 
LR-1 2   2 4            
SP-4 4 4 1 11 4 7 9 7 1   2     
(Table continues) 
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Points/Patients D1 D2 D3 D4 D5 D6 D7 D8 S1 S2 S3 S4 S5 S6 S7 S8 
BL-60   2     2     1 3   
BL-62             2    
ST-44         2 7   1 3  7 
ST-45    6   2    1   1   
GB-41            1    1 
GB-44 3   9 6  2  1 5    4  2 
GB-45              1   
BL-67 1 1   6 5  3 2  1 1 11 1   
Eye of the 
Knee 
     8  3  5    6   
BAXIE      3           
Note. D = Patient with depression, S = Patient with schizophrenia. 
 
3.2.Pre-Test Results. Descriptive characteristics of the five different groups are shown in 
Table 4, as well as the outcomes of the post-hoc tests following the one-way ANOVA. On 
some of the subtests differences were found between the healthy control and the 
psychiatric groups. 
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Table 4. 
Corrected means and SDs of the PSQI subtest scores at baseline (T1) for all groups. 
PSQI Subtest Schizophrenia 
Waiting list 
(SD) 
Schizophrenia 
Acupuncture 
(SD) 
Depression 
Waiting list 
(SD) 
Depression 
Acupuncture 
(SD) 
Healthy 
(SD) 
Total Score 5.75 
(1.91) 
8.50 b 
(4.21) 
9.63 b 
(4.57) 
8.50 b 
(3.02) 
3.50 
(2.07) 
Subjective 
Sleepquality 
1.00 
(.76) 
1.00 
(.76) 
1.63 
(.52) 
1.38 
(.52) 
.75 
(.46) 
Latency .87 
(1.36) 
1.88 
(1.13) 
1.50 
(1.07) 
1.50 
(.93) 
.50 
(.54) 
Duration .25 
(.46) 
.38 
(1.06) 
1.00 
(1.41) 
.50 
(.93) 
.63 
(.74) 
Efficiency 1.38 
(1.51) 
1.00 
(1.07) 
1.13 
(1.55) 
1.00 
(1.31) 
.25 
(.71) 
Disorders .88 
(.35) 
1.38 
(.52) 
1.63 
(.74) 
1.50 
(.54) 
.88 
(.35) 
Medication .00 a 
(.00) 
1.88 b 
(1.55) 
1.25 
(1.49) 
.75 
(1.39) 
.00 
(.00) 
Daytime 
Sleepiness 
1.38 
(.52) 
1.00 b 
(.76) 
1.50 
(.93) 
1.88 
(.84) 
.50 
(.54) 
According to the one-way ANOVA (groups as between subjects factor) and post-hoc tests at baseline: 
a Mean is significantly different (p < 0.05) from the schizophrenia acupuncture group. b Mean is 
significantly different (p < 0.05) from the healthy control group. 
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3.3. Evaluation of Sleep Quality between the Groups 
 
Table 5.  
Corrected pre-test (T1) means of the PSQI for all five groups and post-test (T2) means of the 
PSQI for the four groups with patients. 
 Schizophrenia 
Waiting list 
Schizophrenia 
Acupuncture  
Depression 
Waiting list 
Depression 
Acupuncture 
Healthy 
Control 
PSQI 
Subtest 
T1 T2 P T1 T2 P T1 T2 P T1 T2 P T1 
Total Score 5.75 4.88 .576 8.50 5.50 .048* 9.63 9.00 .493 8.50 6.88 .003** 3.50 
Subjective 
Quality 
1.00 .75 .170 1.00 .50 .170 1.63 1.50 .685 1.38 1.00 .080 .75 
Latency .87 .75 .732 1.88 .75 .038* 1.50 1.63 .685 1.50 1.12 .197 .50 
Duration .25 .13 .598 .38 .63 .351 1.00 .75 .451 .50 .63 .351 .63 
Efficiency 1.38 .63 .365 1.00 1.50 .407 1.13 1.38 .563 1.00 .75 .170 .25 
Disorders .88 .88 1.00 1.38 .88 .033* 1.63 1.63 1.00 1.50 1.13 .080 .88 
Medication .00 .38 .351 1.88 .38 .033* 1.25 .13 .094 .75 .75 1.00 .00 
Daytime 
Sleepiness 
1.38 1.38 1.00 1.00 .88 .685 1.50 2.00 .104 1.88 1.50 .080 .50 
Note. Difference T1-T2 within the groups: *p < 0.05, **p < 0.005. 
 
All patients randomized and treated over 12 weeks in the depression and schizophrenia 
group were analyzed (each N = 8). 
As can be seen in Table 5, post hoc t-tests for each subtest and group separately resulted in 
the following significant differences: The depression acupuncture group showed a significant 
reduction for PSQI Total Score t(7) = 4.333, p = 0.003. For the depression waiting list 
condition, no significant differences were found between the pre- and post-test 
measurements. A significant reduction for the schizophrenia acupuncture group was found 
for PSQI Total Score t(7) = 2.393, p = 0.048, for PSQI Latency t(7) = 2.553, p = 0.038, for PSQI 
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Disorders t(7) = 2.646, p = 0.033, and for PSQI Medicine t(7) = 2.646, p = 0.033. No 
differences were found for the schizophrenia waiting list condition. 
 
3.4. Side Effects. Two patients reported bruising as a side effect after one of the acupuncture 
treatment sessions. Moreover, one patient reported having been extremely tired after the 
first session. Otherwise, no side effects were reported. 
 
4. Discussion 
 
In this pilot study, the effects of three months of acupuncture treatment on subjective sleep 
quality were investigated in a group of patients with schizophrenia and a group of patients 
with depression that were diagnosed by their therapists according to the ICD-10 (World 
Health Organization, 1992). All patients were chronically ill. Significant improvements were 
found on the PSQI Total Score for both treatment groups, indicating that patients slept 
better after 12 acupuncture treatments. The waiting list condition groups showed no 
significant improvements. As was suggested by Hametner and colleagues (Hametner et al., 
2012), a cutoff score of six can be used in order to clinically divide patients with sleep 
problems from patients with good sleep. The patient group with schizophrenia falls below 
this clinically relevant score after treatment. The patient group with depression has 
improved and although the differences might not seem large, they seem borderline clinically 
relevant. 
Three subscales (PSQI Latency, PSQI Medication, and PSQI Disorders) showed significant 
improvements in the schizophrenia group, but not in the depression group. This indicates 
that the patients with schizophrenia took more benefit from acupuncture than the patients 
with depression. Of note, these patients fell asleep faster and even approached normal 
levels on the subtest (PSQI Latency), meaning that patients with schizophrenia lay awake less 
long before falling asleep after acupuncture treatment and that they reached levels that are 
commonly found in healthy controls. They also used less medication in order to sleep and 
reached normative levels also on the subtest for sleep disorders. Five of the patients with 
schizophrenia (from the acupuncture condition) used sleep medication of different kinds 
beforehand, whereas four of them answered that they had stopped using this medication 
during the time of the acupuncture treatment. Moreover, one of the patients in the waiting 
list condition of this group, who had not used sleep medication beforehand, started using 
sleep medication. On the other hand, six of the patients with depression (two in the 
acupuncture group and four in the waiting list condition) used sleep medication beforehand 
of which four (in the waiting list condition) stopped using this medication and one of the 
other patients in the waiting list group started to use sleep medication. There were no 
differences between or within the depression groups on medication use as reported by the 
patient. 
The intervention phase lasted three months (12 treatments) only. Future studies might 
consider whether the novelty factor of this intervention or the short term availability implies 
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that patients are more likely to attend. It is not known whether patients would be so keen to 
attend acupuncture were it available as part of their normal treatment package. There were 
no withdrawals from the acupuncture or waiting list groups in this study. In this clinic, as part 
of the normal treatment package, patients can choose to visit treatment groups like for 
instance: a psychosis education group, sleep training, depression group, social competency 
training group or a memory training. All of these groups last 10 to 12 times and have a 
dropout rate between 30 to 40%. These differences between the regular groups and this 
study might be caused by the small amount of appointments in the waiting list condition as 
well as a positive experience in the acupuncture groups. This impression is supported by the 
absent dropout and the comments made by participants (that reported for instance: feeling 
less tired, more relaxed and better able to sleep), that they were satisfied with the 
treatment and keen to have it. On the other hand, it is important to note that the 
participants were largely self-selecting (as they are in every group they attend in this clinic) 
and therefore more likely to come to the treatments anyway. However, in order to draw 
more firm conclusions, it would have been better to implement a measure of treatment 
satisfaction in the study. 
Some participants reduced their medication, in consultation with their psychiatrist, as a 
result of the acupuncture treatment. These participants saw this as a benefit of the 
acupuncture. Medication reduction is usually seen as positive by patients. It is felt to be a 
sense of improvement or achievement. It may be that the promise of a reduction in 
medication through acupuncture may be a motivational factor for attendance at 
acupuncture treatments. On the other hand, it is important to note that there are possible 
pitfalls in reducing medication as well. It has been described that patients with schizophrenia 
who improve through the use of acupuncture and as a result reduce or even stop taking 
medication may become more vulnerable to breakdown (Ronan, Robinson, Harbinson, & 
MacInnes, 2011). Further research is needed to confirm these subjective comments that 
were reported by the patients in this study and to investigate the possibility that 
acupuncture may be misused as an excuse for non-adherence with conventional medication. 
Limitations: Since the study involves acupuncture, it is obvious that the problem of the 
absence of a suitable control group or placebo needs to be mentioned (MacPherson et al., 
2010). In this study, it was chosen to investigate the “normal” or “real world” manual 
individualized acupuncture treatment that any patient would receive if they should go to an 
oriental medical practitioner. The use of a standardized protocol for acupuncture is, besides 
the National Acupuncture Detoxification Association (NADA) protocol that is used for 
addiction and trauma (Cui, Wu, & Luo, 2008), unheard of in clinical TCM practice. The use of 
such a standardization would therefore not shed any light on the possible effect that an 
acupuncture add-on treatment (that patients seek outside our psychiatric clinics) would 
have on patients and would not be generalisable to routine clinical practice (Schroer & 
Adamson, 2011). In this study, a pragmatic randomized controlled trial (RCT) was used; this 
approach attempts to answer a “real world” question whether acupuncture as add-on 
treatment improves sleep more than without this treatment. Our overall goal was to deliver 
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better treatment to patients and this implies that we have to evaluate what can be done in 
daily practice. MacPherson (MacPherson, 2000) paraphrased this issue by stating that “the 
question in acupuncture research should be rather whether acupuncture is of better value 
than what is currently on offer instead of asking whether acupuncture is better than 
placebo?” 
Due to the ethical problems related to discontinuing treatment with antipsychotic and 
antidepressant drugs, patients continued their medication during the study. We have listed 
the doses in Chlorpromazine equivalents and information on medication that was used in 
Table 2. Due to the fact that psychiatric patients use a wide variety of medication, it was not 
possible, within the convenient sample in our mono-center pilot study, to include only those 
that use the same medication and medication doses. 
One more limitation of the study is the fact that a second baseline might have been used, 
it is recommended for future research. 
Since the ethics committee required group treatments due to the fact that a practitioner 
needed to be present at all times, a limitation was that some participants talked to each 
other before, during or after treatment sessions. It was not possible to control for the 
content of these conversations. 
Finally, the number of patients in the present study is relatively small. Therefore, in 
further research it is necessary to increase the sample size, though, despite the small 
numbers, significant improvements in sleep quality were found. 
There is anxiety about giving acupuncture to people with schizophrenia in Europe, since it 
is not normally practiced and people in psychiatric hospitals are not normally left alone with 
needles or other dangerous objects. Moreover, anxiety exists about the needles becoming 
part of hallucinations or psychotic thoughts. For instance, patients might think that they are 
being radiographic controlled through the needles. The present study further proves that 
people with schizophrenia can be safely treated with acupuncture and that the use of 
needles did not evoke negative emotional reactions. 
It is important to realize that in this pilot study, positive results were obtained in a group of 
patients with schizophrenia that have been ill for more than 10 years. Length of illness was 
analyzed more specifically and it was found that, although there was a difference between 
the schizophrenia and depression experimental and waiting list groups when it comes to this 
factor, it did not account for the more significant results in the group with schizophrenia. 
It is obvious that the positive outcomes of this pilot study warrant further and larger scale 
research, but the tentative conclusion is that the present study shows that acupuncture 
seems to influence sleep in a positive way in sleep disturbed patients and seems a suitable 
add-on treatment in psychiatry, even in patients with long-term depression or schizophrenia. 
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Chapter 5 
 
Sleep disorders in patients with depression or schizophrenia: A randomized 
controlled trial using acupuncture treatment 
 
Based on: 
Bosch, P., Van den Noort, M., Staudte, H., Lim, S., Yeo, S., Coenen, A., & van Luijtelaar, G., 
(under review/2015c). Sleep disorders in patients with depression or schizophrenia: A 
randomized controlled trial using acupuncture treatment. Explore: The Journal of 
Science and Healing. 
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Abstract 
 
Objective: The purpose of this preliminary clinical trial was to investigate whether 
acupuncture has a positive influence on sleep and symptomatology in patients with 
schizophrenia or depression. 
Design: A randomized controlled trial. 
Patients and Methods: One hundred participants were recruited: 40 outpatients with 
schizophrenia, 40 outpatients with depression, and 20 healthy controls. They all filled in a 
depression inventory, and the positive and negative symptoms of the patients with 
schizophrenia were evaluated by their psychiatrists. All participants were asked to complete 
a sleep log for two weeks. For the psychiatric patients, a randomized design with 
experimental (three months of acupuncture treatment) and control (waitlist) conditions was 
used, after which all measurements were conducted once more. 
Results: Before treatment, patients with depression were awake longer during the night, 
needed more time to fall asleep, evaluated their sleep as less relaxed, felt more exhausted, 
and reported a lower average performance level than healthy controls did. Moreover, 
patients with depression slept shorter and felt more exhausted than patients with 
schizophrenia. Patients with schizophrenia solely reported a lower average performance 
level compared to healthy controls. Acupuncture slightly improved sleep and depressive 
symptoms in patients with depression, but did not affect sleep nor influence positive and 
negative symptoms in patients with schizophrenia. 
Conclusions: These preliminary data suggest that acupuncture can be used in order to 
reduce symptoms and improve sleep to some extent in patients with depression, but does 
not seem to have beneficial effects for patients with schizophrenia. 
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INTRODUCTION 
 
Epidemiological studies show that approximately 40 million people in the USA suffer from 
sleep disorders (Luppi, 2005) and that 20% to 35% of the population show symptoms that 
are related to insomnia (Ford & Kamerow, 1989; Leger, Guilleminault, Dreyfus, Delahaye, & 
Paillard, 2000; Ohayon, Caulet, & Lemoine, 1998); moreover, 57% of the patients with 
insomnia have a psychiatric disorder or develop one in the next year (Ford & Kamerow, 
1989). Insomnia and nightmares are important predictors of depressive symptoms (Buysse 
et al., 2008; Cukrowicz et al., 2006), and depressive symptoms are risk factors for insomnia 
(Katz & McHorney, 1998); therefore, the relation between depression and sleep disorders 
seems to be bidirectional (Morawetz, 2003; Roberts, Shema, Kaplan, & Strawbridge, 2000; 
Taylor, Lichstein, Durrence, Reidel, & Bush, 2005). 
Sleep disorders are found in about 30 - 80% of the patients with schizophrenia (Cohrs, 
2008) and in more than 80% of the patients with depression (Reynolds & Kupfer, 1987). 
Moreover, problems with sleep are among the complaints that occur most often before a 
patient has a recurrent episode (Herz, 1985; Kerkhofs, 1997; Monti & Monti, 2004; Perlis et 
al., 1997; Reynolds et al., 1997). In their longitudinal study, Sands and Harrow (1999) found 
that about one-third of the patients with schizophrenia suffered from depression, and a 
depression that was neither recognized nor treated could cause sleep disorders (Costa e 
Silva, 2006). 
Compared to healthy controls, patients with schizophrenia were found to have a larger 
sleep latency in combination with a decreased total sleep time, decreased sleep efficiency, 
less time in phase-3 and -4 sleep (deep sleep), and longer REM sleep latency (Chouinard, 
Poulin, Stip, & Godbout, 2004). Indications exist that in patients with schizophrenia, 
decreased sleep efficiency may be caused by longer sleep latency and an increased number 
of awakenings during the night (Benson, Faull, & Zarcone, 1991). 
Sleep disorders, especially in vulnerable patients with depression as well as those with 
schizophrenia, should be treated due to the beneficial overall influence of good sleep 
(Benson, 2006). This is not only relevant for these patients, but also for society, because an 
improvement in sleep is estimated to lead to lower costs; yearly costs for insomnia for the 
USA alone are estimated to be $30 to $35 billion (Walsh & Engelhardt, 1999). 
Different methods exist for the treatment of sleep disorders (Pagel & Parnes, 2001). 
Traditionally, pharmacological interventions are used (Montgomery & Dennis, 2003). 
Previously, benzodiazepines were prescribed for the treatment of sleep disorders, but 
nowadays, non-benzodiazepine hypnotic medications, like zolpidem, zaleplon, and 
eszopiclone, are often prescribed because they have a lower risk of tolerance and abuse 
(Richey & Krystal, 2011). Also, psychological treatments, like stimulus control therapy, 
relaxation, paradoxical intention, sleep restriction, and cognitive-behavior therapy are 
frequently used (Morin et al., 2006). One relatively new method in non-Asian countries for 
the treatment of sleep disorders is the use of acupuncture as a non-pharmacological 
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intervention technique because evidence exists that it may have beneficial effects as a 
treatment for insomnia (Cao, Pan, Li, & Liu, 2009; Reshef et al., 2013; Zhao, 2013). 
The aim of this study was to investigate whether acupuncture has a positive influence 
on sleep in patients with schizophrenia and patients with depression. Before treatment (at 
baseline), we expected that patients with depression and patients with schizophrenia would 
sleep worse than the healthy controls and that, in line with the literature, the patients with 
depression would have the worst sleep of the three groups. Our hypothesis was that 
acupuncture would have a beneficial effect on sleep in patients with depression and in 
patients with schizophrenia and that typical symptoms would decrease. 
 
METHODS 
 
Design overview 
In this study, an experimental (three months of acupuncture treatment) and a control (on a 
waitlist for over three months) condition were used. All participants were asked to complete 
a sleep log for two weeks in order to establish a baseline (T1) measurement. The healthy 
control group was not treated with acupuncture; while no clinical effect of acupuncture 
could be expected in healthy participants (previous research has shown that acupuncture 
has a modulating and normalizing effect) (Bosch, Staudte, van den Noort, & Lim, 2014; Hui, 
Marina, Liu, Rosen, & Kwong, 2010), they were only included to establish reference values in 
the current cultural and geographical cohort and were only used in the tests at T1. In the 
patient groups, two measurements were taken: before (T1) and after acupuncture 
treatment or a waitlist period (T2). Note that the sleep log had to be filled in every morning 
and evening just after waking up and before going to sleep (Fischer, Mayer, Peter, Riemann, 
& Sitter, 2002), which took approximately 10 minutes a day. Previous research showed that 
the sleep log was a reliable instrument for registering sleep in patients; in a study by Rogers, 
Caruso, and Aldrich (1993), for instance, subjective data taken from sleep logs was found to 
be comparable to data from polysomnography (kappa = 0.87). Moreover, the sensitivity and 
the specificity of the sleep logs in this study (Rogers et al., 1993) were found to be 92.3% and 
95.6%, respectively. In addition to the sleep log, both the patients with depression and the 
patients with schizophrenia filled in a typical clinical instrument, namely, the Becks 
Depression Inventory-II (BDI-II) (Beck, Steer, & Brown, 1996), to assess depression before 
and after the treatment or the waitlist period. The severity of the schizophrenia symptoms 
was assessed using the Positive and Negative Symptom Scale (PANSS) (Kay, Fiszbein, & 
Opler, 1987), which was filled in by each patient’s psychiatrist before and after the 
treatment or the waitlist period of three months. The current study was approved by the 
local ethics committee (Ärztekammer Nordrhein, trial number: 2008331). 
 
Setting and participants 
In total, 100 participants were enrolled in this study: 40 patients with schizophrenia, 40 
patients with depression, and 20 healthy controls. Participants were recruited at the LVR-
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Klinik Bedburg-Hau. All patients were outpatients who had received regular care at a 
psychiatric department. There were 22 female and 18 male adult patients with 
schizophrenia (average age = 42.20, standard deviation (SD) = 10.11 years), there were 33 
female and 7 male adult patients with depression (average age = 48.37, SD = 8.88 years), and 
there were 11 female and 9 male adult healthy controls (average age = 33.05, SD = 11.27 
years). The inclusion criterion for all participants was that they be between 18 and 65 years 
of age. The exclusion criteria for the patients with depression and the patients with 
schizophrenia were epilepsy, substance abuse, and other neurological disorders. For the 
healthy control participants, the exclusion criteria were the presence of any neurological or 
psychiatric disorder or substance abuse. All participants of our study took part voluntarily 
without any inducement. 
 
Randomization and intervention 
Participants were randomly divided into an experimental or a control group. In the 
experimental group, acupuncture treatment was given as intervention to the participant 
once a week. In total twelve treatments were given, each lasting one hour after needle 
insertion. In the control group, the participants were on a waitlist and only received their 
regular care; no extra interventions were offered. 
 
Acupuncture as clinical intervention 
Individualized acupuncture was used after careful individual diagnosis by a licensed Oriental 
medical practitioner with more than five years of clinical experience (MacPherson et al., 
2010). The single-use needles (AcuPro C, Wujiang City Cloud & Dragon Medical Device Co., 
Ltd., China) for the acupuncture treatment were 0.25 x 25 mm or 0.20 x 15 mm stainless-
steel needles, depending on the location on the body. For both the individualized 
acupuncture, as well as for the individual clinical diagnosis, the principles of Traditional 
Chinese Medicine (TCM) were followed (Bosch et al., 2013). 
 
Outcome sleep logs 
The primary outcome measures in this study were the scores on the following six sleep 
variables of the sleep log at T1: 1. “Total sleep time”, 2. “How many minutes awake during 
the night?”, 3. “How many minutes awake before falling asleep?” 4. “How relaxing was your 
sleep?”, 5. “Did you feel exhausted?”, and 6. “How was your average performance level 
today?” (Note that the first three sleep variables are the more “objective” ones and that the 
last three sleep variables are the more “subjective” ones.) The secondary outcome measures 
in our study were the difference scores (between “before” (T1) and “after 
treatment/waitlist” (T2)) for the same six sleep variables. 
 
Outcome clinical tests 
Further outcome measures were the scores on the BDI-II at baseline and the differences on 
the BDI-II between T1 and T2 within the groups. Moreover, the scores on the PANSS 
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subscales (PANSSPOS, measuring the positive symptoms, PANSSNEG, measuring the 
negative symptoms, PANSSPSYCHO measuring general psychopathology and PANSSTOT 
measuring the total score on the PANSS) at T1, as well as the differences between the scores 
at T1 and T2, within the groups were further outcome measures. 
 
Data analyses 
As a result of the large drop-out of participants, mostly lost during the waitlist period for the 
schizophrenia group, differences between the two psychiatric groups for the six sleep 
variables before (baseline = T1) and after acupuncture treatment (T2) were analyzed 
separately. Moreover, at T1 a healthy control group was included. 
At T1, the scores for the six sleep variables of the sleep log were analyzed with a one-
way analysis of variance (ANOVA) by using SPSS version 22.0 (IBM Corp., 2013) to indicate 
whether the three groups differed significantly across the different sleep variables. The 
dependent variables were the scores for the sleep variables and the between-subjects factor 
was the group (depression, schizophrenia, or healthy control group). A significance level of P 
< .05 was used. 
The results on the sleep log data at T2 should have been analyzed together with their T1 
counterparts by using General Linear Model (GLM) repeated measures or difference scores 
in order to compare the results of the two psychiatric groups for the six sleep variables 
before (T1) and after acupuncture treatment (T2). Due to the large drop-out, especially in 
the schizophrenia waitlist group, however, the scores for the sleep variables were analyzed 
with a one way ANOVA for three groups: depression treatment, depression waitlist, 
schizophrenia treatment groups. 
The BDI-II data were more complete, and a sufficient number of participants were 
present at T1 and T2 for meaningful statistical analyses (although the number of subjects 
with schizophrenia on the waitlist was only seven). First, data at T1 were analyzed with an 
ANOVA with groups (depression waitlist, depression treatment, schizophrenia waitlist, 
schizophrenia treatment) as between-subjects factor, followed by post-hoc tests. Next 
differences between T1 and T2 were established for all groups by using paired sampled 
Student t-tests. The PANSS data were only collected for the patients with schizophrenia, and 
the differences between T1 and T2 were analyzed by using GLM repeated measures. Only 
significant group differences are reported. 
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RESULTS 
 
Sleep log results at baseline 
 
Table 1. 
Overview of the Sleep Log Results at Baseline (T1) for the Depression Group, the 
Schizophrenia Group, and the Control Group 
__________________________________________________________________________________ 
Sleep variable  Depression  Schizophrenia  Control 
    (N1 = 28)  (N = 20)  (N = 18) 
How long have you slept?2   7.17 (0.83)a     7.98 (1.25)    7.43 (0.64) 
How long (min.) were you  20.52 (21.05)b  11.88 (9.35)      3.16 (3.64) 
  awake during the night? 
How long did it take  30.29 (19.70)b  ) 26.17 (25.19)   14.31 (11.30) 
  before falling asleep?3 
How relaxing was    3.28 (1.84)a,b     2.37 (0.72)    2.23 (0.55) 
  your sleep?4 
Have you felt exhausted?5   1.39 (0.56)a,b      0.92 (0.75)     0.77 (0.44) 
How was your average    3.15 (0.55)a,b    2.67 (0.88)b     2.08 (0.56) 
  achievement today?6 
_________________________________________________________________________________________________________________________________ 
Note. 1 N = number of participants. 
2 In hours. 
3 In minutes. 
4 On a 5 point scale (1 = very relaxing; 5 = not at all relaxing). 
5 On a 4 point scale (0 = no; 3 = very). 
6 On a 6 point scale (1 = good; 6 = bad). 
a Average score is significantly different (p < .05) from the average score for the group with schizophrenia. 
b Average score is significantly different (p < .05) from the average score for the control group. 
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As can be seen in Table 1, the ANOVA showed a significant group effect (F(2,59) = 4.03, p < .05, 
eta2 = .120) on the “Total sleep time”: patients with depression slept less than patients with 
schizophrenia (p < .01). The analyses of the “How many minutes awake during the night?” 
(F(2,58) = 7.54, p = .001, eta2 = .206) and of “How many minutes awake before falling sleep?” 
(F(2,59) = 3.48, p < .05, eta2 = .105) showed a group effect. In both cases, the patients with 
depression were awake longer than the healthy controls (p’s < .05). The more subjective 
sleep results (see also Table 1), where the participants had to indicate how they evaluated 
their sleep, also showed differences between the three groups. Significant group effects 
(F(2,62) = 4.59, p < .05, eta2 = .129) were found for “How relaxing was your sleep?” and “Did 
you feel exhausted?” (F(2,62) = 6.60, p < .01, eta2 = .175) and for “How was your average 
performance level today?” (F(2,63) = 14.05, p < .000, eta2 = .308). The patients with depression 
evaluated their sleep as less relaxing and were more exhausted compared to the patients 
with schizophrenia and the healthy control participants (p’s < .05). Both patient groups 
indicated their average performance level as worse (p‘s < .01) compared to the healthy 
control participants. Moreover, the patients with depression evaluated their average 
performance level as being worse than that of the patients with schizophrenia (p < .01). 
 
Clinical tests at baseline 
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Table 2. 
Overview of the BDI-II at Baseline (T1) and after Treatment or after Waitlist (T2) for the 
Depression Waitlist Group, the Depression Treatment Group, the Schizophrenia Waitlist 
Group and the Schizophrenia Treatment Group. Overview of the PANSS POS, PANSS NEG, 
PANSS PSYCHO, and the PANSS TOT scores at Baseline (T1) and after Treatment or after 
Waitlist (T2) for the Schizophrenia Waitlist and the Schizophrenia Treatment Groups. 
Variable Depression Group Schizophrenia Group 
 WL1 T1 WL1 T2 TR2 T1 TR2 T2 WL1 T1 WL1 T2 TR2 T1 TR2 T2 
BDI-II 24.83 
(12.12) c,3 
(N4 = 18) 
22.19 
(11.46)c 
(N = 16) 
24.72 
(10.77)c 
(N = 18) 
15.53 
(10.97) 
(N = 15) 
14.00 
(10.52) 
(N = 19) 
10.29 
(11.76)  
(N = 7) 
13.25 (10.43) 
(N = 20) 
12.81 (7.65) 
(N = 16) 
PANSS 
POS 
NA NA NA NA 15.07 
(7.55) 
(N = 14) 
13.38 (6.46) 
(N = 8) 
12.56 (4.77) 
(N = 18) 
12.35 (4.83) 
(N = 17) 
PANSS 
NEG 
NA NA NA NA 17.14 
(5.59) 
(N = 14) 
17.38 (4.66) 
(N = 8) 
21.50 (10.96) 
(N = 18) 
20.00  
(10.34) 
(N = 17) 
PANSS 
PSYCHO 
NA NA NA NA 39.64 
(12.20) 
(N = 14) 
37.50 
(10.66)  
(N = 8) 
40.50 (14.65)  
(N = 18) 
37.47 
(12.23) 
(N = 17) 
PANSS 
TOT 
NA NA NA NA 71.93 
(19.52) 
(N = 14) 
68.50 
(18.74)  
(N = 8) 
74.56 
(27.65)  
(N = 18) 
69.82 
(25.30) 
(N = 17) 
Note. a Significantly different from the depression treatment group. 
b Significantly different from the schizophrenia treatment group. 
c Significantly different from the total schizophrenia group. 
1 WL = waitlist condition. 
2 TR = treatment condition. 
3 Standard deviation. 
4 N = number of participants. 
NA = not applicable. 
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The ANOVA of the BDI-II scores showed a significant group effect (F (3,73) = 5.82, p < .001, eta2 
= .19), and post-hoc tests showed that the two groups with depression obviously scored 
higher than the two schizophrenia subgroups. The PANSS scores were only measured for the 
patients with schizophrenia and were not different between the treatment and the waitlist 
subgroups. All BDI-II and PANSS scores at T1 and T2 can be found in Table 2. 
 
Sleep log acupuncture effects 
 
Table 3. 
Overview of the Sleep Log Results After Acupuncture Treatment versus After Waitlist for the 
Depression Treatment Group (N = 10), the Depression Waitlist Group (N = 8) and the 
Schizophrenia Treatment Group (N = 6) 
 After Acupuncture After Waitlist 
Sleep variable Depression (N1 = 10) Schizophrenia (N = 6) Depression (N = 8) 
Total sleep time?2 7.11 (0.72) 7.90 (0.90) 7.28 (1.52) 
How many minutes 
awake during the night? 
11.65 (10.60)   3.36 (4.68) 33.63 (72.96) 
How many minutes awake  
before falling asleep?3 
24.93 (16.38) 13.59 (7.41) 34.69 (19.58) 
How relaxing was your 
sleep?4 
  2.47 (0.17)a 2.37 (0.22) a 3.08 (0.19) 
Did you feel exhausted?5 1.19 (0.48)   0.72 (0.70)   1.57 (0.55) 
How was your average 
performance level 
today?6 
3.135 (0.82) 2.99 (.9.14) 3.29 (0.68) 
Note. 1 N = number of participants. 
2 In hours. 
3 In minutes. 
4 On a 5 point scale (1 = very relaxing; 5 = not at all). 
5 On a 4 point scale (0 = not; 3 = very). 
6 On a 6 point scale (1 = good; 6 = bad). 
a Mean score is significantly different (p < .05) from the mean score for the Depression Waitlist group. 
b Mean score is significantly different (p < .05) from the mean score for the schizophrenia group after acupuncture 
treatment. 
 
The schizophrenia waitlist group was no longer motivated to fill out the sleep log after the 
waitlist period: most patients reported that it was too much of an effort to think of the sleep 
log twice a day for two weeks. In this group, only three persons returned the form; therefore, 
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this group was not included in the statistics at T2. As can be seen in Table 2, the ANOVAs on 
the six sleep variables (“After acupuncture” – “After waitlist”) for the remaining three groups 
(schizophrenia treatment group, depression treatment group and depression waitlist group) 
revealed a significant treatment effect on “How relaxing was your sleep?” (F(2,21) = 3.951, p < 
.05, eta2 = .273) and on “Did you feel exhausted?” (F(2,21) = 1,256, p < .05, eta2 = .274). Post-hoc 
analyses revealed that both acupuncture groups evaluated their sleep as more (p’s < .05) 
relaxed than the waitlist group and that the group with schizophrenia was less exhausted than 
the waitlist group (p < .05). On the variable “How many minutes awake before falling asleep?”, 
a trend (p = .07) was found (F(2,20) = 2.996, p = .07, eta2 = .231): the schizophrenia acupuncture 
group tended to be awake for less time than the waitlist group. Differences within the groups 
between T1 and T2 were analyzed, but no significant differences were found, partly due to 
large data loss related to the dropout. 
 
Acupuncture effects on the clinical tests 
The paired samples t-tests showed a significant lower BDI-II score on T2 (compared to T1) for 
the depression treatment group (t (14) = 3.48, p < .01) only. Neither the PANSS subscales nor 
the PANSS total score showed any within-group or between-group effects. 
 
DISCUSSION 
 
The aim of this study was to investigate whether acupuncture has a positive influence on 
sleep in patients with schizophrenia or depression. The hypotheses were that at baseline, 
patients with depression or schizophrenia would sleep less than the healthy controls and 
that the patients with depression would have the worst sleep of the three groups. 
Moreover, we expected that acupuncture would have a beneficial effect both on sleep and 
depressive symptoms in patients with depression or schizophrenia and on the positive and 
the negative symptoms in patients with schizophrenia. 
At baseline, the sleep log results of the present study (see also Table 1) showed that, as 
was expected based on previous reports (Cohrs, 2008; Reynolds & Kupfer, 1987; Tsuno, 
Besset, & Ritchie, 2005), the patients with depression reported more sleep problems than 
the patients with schizophrenia and the healthy control participants. This pattern was visible 
in both the more objective sleep measures, the shorter length of sleep, the longer period of 
lying awake longer during the night and the longer sleep latency, and the more subjective 
sleep measures on which participants with depression evaluated their sleep, i.e., being less 
relaxed, feeling more tired, and functioning less well during the day. Patients with 
depression slept just as long as the healthy controls, but showed worse results on all other 
variables. In addition, they felt more exhausted and slept shorter than the patients in the 
schizophrenia group. 
In contrast to previous research (Hofstetter, Lysaker, & Mayeda, 2005; Lunsford-Avery 
et al., 2013; Royuela et al., 2002) and therefore against our hypothesis, the patients with 
schizophrenia evaluated their sleep as being rather similar to that of the healthy control 
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participants. The only exception was that they evaluated their average performance level of 
the day as worse than that of the healthy control group. The fact that patients with chronic 
schizophrenia score more in the normal range than one might expect is in line with a recent 
clinical study on personality and psychopathology in patients with long-term schizophrenia; 
that study also showed relatively few deviations from the healthy control group (Bosch et al., 
2014). 
With respect to the possible acupuncture effect on sleep, a second main finding of this 
study was that the depression and the schizophrenia treatment groups evaluated their sleep 
at T2 as being more relaxed than that of the waitlist group while the evaluations of the two 
treatment groups did not differ. Furthermore, the individuals with schizophrenia felt less 
exhausted than the patients with depression in the waitlist subgroup at T2. Acupuncture had 
a positive effect on these two subjective variables, confirming the findings by Spence and 
colleagues that acupuncture seems to have a relaxing effect on patients with psychiatric 
problems (Spence et al., 2004). In addition, for a more objective variable, a tendency 
towards acupuncture having a positive effect was found: The individuals with schizophrenia 
tended to lie awake for a shorter time than the waitlist group that had not received any 
additional treatment whereas the times lying awake for both depression groups were not 
different. No beneficial effects of acupuncture were found for the other two objective 
variables (the total sleep time and the number of minutes being awake during the night) or 
for the third subjective variable (the average performance level) (see Table 3). These results 
are partly in line with the results by Reshef and colleagues (Reshef et al., 2013; Zhao, 2013), 
who found no significant improvements on questionnaires that patients had to fill in, but did 
find improvements on actiwatch data for their patients with schizophrenia. 
With respect to the clinical symptoms, at baseline, the groups with depression had the 
expected elevated BDI-II scores, often in the clinical range, and did not differ from each 
other. The groups with schizophrenia naturally scored as being less depressed and did not 
differ from each other at baseline (Beck et al., 1996). In general, the patients with depression 
scored in the range 20-28, indicating moderate depression, while the patients with 
schizophrenia scored in the range 14-19, indicating mild depression (Beck, Steer, Ball, & 
Ranieri, 1996). The PANSS (Kay et al., 1987) scores were only assessed for the patients with 
schizophrenia and were not different between the treatment and the waitlist subgroups (see 
also Table 2). In general, the PANSS scores showed that the patients were suffering from 
mildly to moderately severe positive and negative symptoms (the cut-off PANSS TOT score is 
75 for moderate symptoms, with a lower score indicating symptoms that are less severe) 
(Leucht et al., 2005). 
With respect to the possible acupuncture effect on clinical symptoms, the depression 
acupuncture group improved significantly more on the BDI-II (Beck et al., 1996) than the 
depression waitlist group at T2 and differed significantly from its own score at T1, indicating 
a positive effect of the acupuncture treatment. The schizophrenia groups did not differ from 
each other, and no differences within and between the schizophrenia treatment and 
waitlist groups were found on the PANSS (Kay et al., 1987) on T2. 
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In sum, acupuncture treatment was found to improve the depressive symptoms of the 
patients with depression but not the symptoms of the patients with schizophrenia. The 
depression treatment group moved from “moderate depression” to “mild depression”, and 
these clinically- relevant treatment effects were also visible on an individual level, showing 
that patients moved from one clinical cut-off score to another (for instance, from “moderate 
depression” to “mild depression”). Moreover, acupuncture did not have a beneficial effect 
on the positive and the negative symptoms in patients with schizophrenia (see Table 2). This 
might be explained by their relatively low scores at T1 (mildly to moderately severe, even 
below the cut-off PANSS TOT score of 75) (Leucht et al., 2005). The supposed normalizing 
effect of acupuncture would cause more differences in patients that show more severe 
scores than in those that show only mild scores. 
Naturally, the present study has several limitations. In line with previous clinical 
acupuncture studies (Fogarty, Harris, Zaslawski, McAinch, & Stojanovska, 2010; Shin et al., 
2013), as well as previous clinical studies on depression (Ibrahim et al., 2012) and 
schizophrenia (Egan et al., 2013), a design with an experimental (three months of 
acupuncture treatment) and a control (waitlist) group was chosen. Unfortunately, during 
our study, most participants in the waitlist subgroup of the schizophrenia group dropped 
out. Participants turned out not to be willing to wait for three months before filling out the 
same forms again, even though they would have been allowed to receive acupuncture 
treatment after the second test period. Of the 40 participants in the total waitlist group, 29 
(73%) participants were lost for the sleep log data, the dropout rate being greater for the 
patients with schizophrenia (85%) than for the patients with depression (60%). Especially, 
the patients with schizophrenia felt that too much effort was required to fill in the sleep log 
every day. This is further supported by the fact that a much higher percentage (60% in total) 
of the patients with schizophrenia could be motivated to fill in the BDI-II (Beck et al., 1996), 
more than twice as many as those who could be motivated to fill in the sleep log (25%) 
(Fischer et al., 2002). It would have been better to have used a less time-consuming sleep 
questionnaire, such as the Pittsburgh Sleep Quality Inventory (PSQI) (Buysse, Reynolds, 
Monk, Berman, & Kupfer, 1989) or the Epworth Sleepiness Scale (Johns, 1991), or even 
better to have used actiwatches (Van de Wouw, Evenhuis, & Echteld, 2013) because 
actiwatches provide an opportunity to collect objective sleep quality data (van de Wouw et 
al., 2013) from patients with depression and patients with schizophrenia without requiring 
for a daily effort. 
All patients continued their medication during the study. For ethical reasons (Fulford & 
Howse, 1993), stopping the treatment of psychiatric patients with antipsychotic and 
antidepressant drugs was not possible. In addition, because the participants in the present 
study used a wide variety of medications, better control of the type and the doses of the 
medications was impossible. 
Finally, the sample sizes in the present psychiatric study are relatively small (Streiner, 
1990). For practical reasons (Patel, Doku, & Tennakoon, 2003), the recruitment of more 
patients with schizophrenia and more patients with depression at our clinic was not possible, 
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which is a common problem in clinical acupuncture research (Pilkington, 2010). In future 
research, a multicenter study (Alcolea et al., 2014; López et al., 2004; Messerer, Porzsolt, 
Hasford, & Neiss, 1987; Reid, Hely, Morris, Loy, & Halliday, 2011) seems to be an interesting 
alternative not only to increase the sample size but also to exclude effects of practitioner 
bias and the experimental/clinical atmosphere (Messerer et al., 1987). 
 
Conclusions 
The present preliminary clinical data suggest that acupuncture seems to be a safe and useful 
non-pharmacological clinical intervention technique for improving sleep to some extent in 
patients with depression, but not in patients with schizophrenia. Acupuncture treatment 
was found to improve the depressive symptoms of the patients with depression, but not the 
symptoms of the patients with schizophrenia; moreover, it did not have a beneficial effect 
on the positive and the negative symptoms in the patients with schizophrenia. The question 
of whether the anti-depressive effects in the group with depression are caused by their 
improved quality of sleep or whether the improved quality of sleep is caused by the 
alleviation of the depressive symptoms cannot be answered with the present data because 
of the cause-and-effect problem resulting from the bidirectional associations between sleep 
and depression that has been reported in the literature (Franzen & Buysse, 2008). Further 
and more extensive research using more objective sleep measurements and more extensive 
scales for depression might be able to answer this question. All in all, these data justify 
further research into the possible use of acupuncture in the treatment of depression. 
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Chapter 6 
 
The effect of acupuncture on mood and working memory in patients with 
depression and schizophrenia 
 
Based on: 
Bosch, P., Van den Noort, M., Staudte, H., Yeo, S., Lim, S., Coenen, A., & van Luijtelaar, G., (in 
press/2015d). The effect of acupuncture on mood and working memory in patients 
with depression and schizophrenia. Journal of Integrative Medicine. 
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ABSTRACT 
 
OBJECTIVE: This study investigates the mood and the working memory performance in 
patients with depression or schizophrenia and whether acupuncture can improve these. 
METHODS: A pragmatic clinical trial design was used. The study was conducted in a 
psychiatric clinic. Fifty patients with depression and 50 with schizophrenia were randomly 
divided into an experimental and a waiting-list group. Additionally, 25 healthy control 
participants were included. Twelve weeks of individualized acupuncture treatment was used 
as clinical intervention. All patients were tested before (T1) and after acupuncture treatment 
(T2) on a mood scale (Becks Depression Inventory-II, BDI-II), a simple working memory task 
(digit span), and a complex working memory task (letter-number sequencing); the healthy 
controls were tested at T1 only. 
RESULTS: Patients with depression scored worse than the others on the BDI-II, and patients 
with schizophrenia scored worse than the healthy controls. On the digit span, patients with 
schizophrenia did not differ from healthy controls whereas they scored worse of all on the 
letter-number sequencing. With respect to the acupuncture findings, first, the present study 
showed that the use of acupuncture to treat patients with schizophrenia is both practical and 
safe. Moreover, acupuncture had a positive effect on the BDI-II for the depression group, but 
acupuncture had no effect on the digit span and on the letter-number sequencing 
performance for the two clinical groups. 
CONCLUSION: The clinical improvement in patients with depression after acupuncture 
treatment was not accompanied by any significant change in a simple working memory task 
or in a more complex working memory task; the same was true for the patients with 
schizophrenia. 
-124- 
1 Introduction 
 
Acupuncture is increasingly used as a complementary medicine treatment for psychiatric 
illnesses (Samuels, Gropp, Singer, & Oberbaum, 2008). Previous research showed that 
acupuncture affects mood; a reduction of depressive symptoms in patients with depression 
after acupuncture treatment was revealed by a meta analysis based on 8 randomized trials 
(Wang et al., 2008). Recently, researchers have also started to investigate acupuncture for 
the treatment of schizophrenia (Bosch et al., 2013) and lower positive, negative, and general 
symptoms in patients with schizophrenia have been reported after acupuncture treatment 
(Reshef et al., 2013). However, despite its long tradition and wide applications, many 
questions remain; for instance, is acupuncture able to improve cognitive functioning? In 
studies on cognitively-impaired animals, acupuncture was found to have a restoration and 
protection effect (Kim et al., 2009, 2011). Other studies reported improvements in 
cognitively-impaired patients (Soliman, 2008; Zhong, Su, Liu, & Zhu, 2009). 
Therefore, one important cognitive process that will be investigated in the present study 
is working memory (WM). WM is known to play an important role in higher-level cognitive 
functioning (Bowles & Salthouse, 2003), like reasoning (Kyllonen & Christal, 1990) and spatial 
visualization (Salthouse, Babcock, Mitchell, Palmon, & Skovronek, 1990). WM was originally 
assumed to consist of a central executive that was responsible for monitoring and 
coordinating two slave systems: the phonological loop and the visuo-spatial sketchpad. The 
phonological loop temporarily buffers spoken and written material whereas the visuo-spatial 
sketchpad stores and processes visual or spatial information (Baddeley & Hitch, 1974). Later, 
the episodic buffer was added as a third slave system and was responsible for linking 
information across domains to form integrated units of verbal, visual and spatial information 
with time sequencing (Baddeley, 2000). A recent two-group, randomized, single-blind study 
on 90 healthy students showed that acupuncture significantly increased WM performance 
on an automated operation span task in comparison with the control group (Bussell, 2013). 
If acupuncture can improve WM performance in healthy participants, it might perhaps 
also be beneficial for the psychiatric population. For this reason, two long-term (illness 
duration longer than five years) patient groups that were known to have decreased WM 
performances, namely, patients with schizophrenia (Mayer, Fukada, Vogel, & Park, 2012) 
and patients with depression (Christopher & MacDonald, 2005), were investigated by 
addressing the following research questions: What are the moods of long-term patients with 
depression or schizophrenia, and what are their WM performances? Also, can acupuncture 
change mood (Wang et al., 2008) and WM performance (Bussell, 2013) in patients with 
depression and in patients with schizophrenia? 
The first hypothesis is that patients with depression score worse on mood than the 
patients with schizophrenia and the healthy controls. The second hypothesis is that both 
patients with schizophrenia and those with depression score worse on WM than the healthy 
controls. Thirdly, we hypothesize that acupuncture treatment will improve mood in patients 
with depression and perhaps also in patients with schizophrenia. Fourthly, the WM 
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performance in patients with schizophrenia and in patients with depression is expected to 
be improved after acupuncture treatment. 
 
2 Subjects and Methods 
 
2.1 Experimental design 
 
2.1.1 Design 
A pragmatic, clinical trial design (MacPherson, 2004) was used to address the 
effectiveness of acupuncture as a health care intervention in treating patients with 
schizophrenia or depression in real clinical practice (Godwin et al., 2003). 
 
2.1.2 Acupuncture treatment as clinical intervention 
The participants were treated weekly for twelve consecutive treatments. Individualized 
acupuncture according to traditional Chinese medicine principles was applied after careful 
diagnosis (Bosch et al., 2013) by a licensed Oriental medical practitioner with more than five 
years of clinical experience (MacPherson et al., 2002). Needles were left in place for one 
hour after insertion. 
 
2.1.3 Testing 
The tests were completed by the patients in the experimental groups before (T1) and 
after (T2) acupuncture treatment. For the patients in the waiting-list groups, the tests were 
also conducted twice, but without treatment. The healthy control participants only 
completed the test at T1. Testing was conducted in the LVR-Klinik Bedburg-Hau by 
apprentices that were not informed about the rest of the project. 
 
2.2 Operationalizations 
2.2.1 Mood scale 
The Becks Depression Inventory-II (BDI-II) (Beck, Steer, & Brown, 1996) was used to 
measure (depressed) mood (Berna, Lang, Goodwin, & Holmes, 2011; Peirson & Heuchert, 
2001). The BDI-II was found to have an excellent test-retest reliability of 0.96 (Sprinkle et al., 
2002). 
 
2.2.2 Simple working memory task 
The digit-span forward subtask (Wechsler, 2000) was conducted in order to measure WM 
(Wechsler, 2000). The digit span has a good (0.80) test-retest reliability (Groth-Marnat, 
1997). 
 
2.2.3 Complex working memory task 
Complex span tasks (Redick et al., 2012), like the letter-number sequencing task (Van den 
Noort, Bosch, & Hugdahl, 2006), have been developed to measure WM capacity (Redick et 
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al., 2012), and its norm score was used in the present study (Van den Noort et al., 2006). The 
test-retest reliability of the letter-number sequencing task was found to be good (0.80) 
(Groth-Marnat, 1997). 
 
2.3 Sample 
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Table 1. 
Participants’ demographic information specified for the experimental depression group, the experimental schizophrenia group,  
the healthy control group, the depression waiting-list group, and the schizophrenia waiting-list group 
 
 Depression 
Experimental 
Group 
N1 = 25 
Schizophrenia 
Experimental 
Group 
N = 25 
Healthy 
Control 
Group 
N = 25 
Depression 
Waiting-list 
Group 
N = 25 
Schizophrenia 
Waiting-list 
Group 
N = 25 
Gender 
(males/female
s) 
3/22 8/17 7/18 2/23d 11/14d 
Age (in years) 48.68a (10.60)2 41.80 (10.30) 38.88a (12.15) 46.32 (8.12) 43.96 (10.87) 
Length of 
illness (in 
years) 
7.99a (5.83) 10.00b (4.30) 0ab 6.75c (5.21) 10.70c (5.47) 
Note. 1Number of participants. 
2Standard deviation. 
aSignificant difference between the experimental depression group and the healthy control group, p ≤0.05. 
bSignificant difference between the experimental schizophrenia group and the healthy control group, p ≤0.05. 
cSignificant difference between the waiting-list depression group and the waiting-list schizophrenia group, p ≤0.05. 
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In total, 50 patients with schizophrenia and 50 patients with depression were selected by 
their psychiatrists and asked to participate voluntarily; moreover, 25 healthy control 
participants entered the study (see Table 1). All patients with schizophrenia were randomly 
divided into an experimental group and a waiting-list group, as were the patients with 
depression, and we used the random number generator program in Microsoft Excel for the 
randomization. The patients in the waiting-list group received no treatment other than their 
normal psychiatric treatment. According to the 10th revision of the International 
Classification of Diseases and Related Health Problems (ICD-10) (World Health Organization, 
1992), the patients with schizophrenia were diagnosed with schizophrenia F20.0 (paranoid 
schizophrenia) or F20.5 (schizophrenic residuum), and the patients with depression were 
diagnosed with depression F33.2 (recurrent depressive disorder, current episode severe 
without psychotic symptoms). The patients with schizophrenia had a total score of 73.65 (SD 
= 23.43) on the Positive and Negative Syndrome Scale (PANSS) (Kay, Fiszbein, & Opler, 1987). 
Exclusion criteria were addiction (other than nicotine), epilepsy or other neurological 
disorders, and other co-morbid psychiatric disorders. 
As can be seen in Table 1, no significant gender differences were observed between the 
three experimental groups (p = 0.222, partial η2 = 0.041). However, a significant difference in 
age did exist (see also Table 1) (p = 0.008, partial η2 = 0.126), and that was due to the fact 
that the patients with depression were significantly older than the healthy control 
participants (p = 0.007). As can also be seen in Table 1, the lengths of illness for the patients 
with depression and the patients with schizophrenia in the experimental groups were not 
different (p = 0.171, partial η2 = 0.039). Thus, because both groups had lengths of illness of > 
5 years, both could be classified as long-term psychiatric groups (Bosch et al., 2014). An 
overview of the exact medications used for each individual is given in Table 2. None of the 
participants had ever received acupuncture treatment. All participants gave written consent, 
and the ethics committee of the Ärztekammer Nordrhein approved the study beforehand 
(number 2008331); moreover, the clinical trial has been officially registered under number 
NTR3132 at the Dutch Trial Register (see also 
http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=3132). Finally, the study was 
conducted according to the Declaration of Helsinki (World Medical Organization, 2008). 
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Table 2. 
Overview of the medication used per individual at the start of the study specified for the 
experimental depression group and the experimental schizophrenia group 
Group Patients Medication Daily dose 
Depression group D11 Doxepin 
Citalopram 
2 x 25 mg 
1 x 20 mg 
D2 Citalopram 1 x 20 mg 
D3 Trevilor Retard 1 x 150 mg 
D4 Mirtazapin 1.5 x 30 mg 
D5 No medication No medication 
D6 Zoloft 
Amineurin 
1 x 50 mg 
1 x 25 mg 
D7 Zoloft 
Chlorprothixen 
3 x 50 mg 
2 x 15 mg 
D8 Citalopram 1 x 20 mg 
D9 Lyrica 
Doxepin 
Diazepan 
1 x 75 mg 
3 x 10 mg 
0.5 x 10 mg 
D10 Venlafaxin Retard 
Venlafaxin 
Seroquel Prolong 
Chlorprothixen 
1 x 75 mg 
1 x 150 mg 
2 x 50 mg 
2 x 15 mg 
D11 Trevilor Retard 1 x 75 mg 
D12 Doxepin 
Citalopram 
2x 25 mg 
1 x 30 mg 
D13 Promethazin 
Venlafaxin Retard 
1 to 2 x 25 mg 
1 x 75 mg 
D14 No medication No medication 
D15 Valdoxan 2 x 25 mg 
D16 
 
Cymbalta 
Doxepin 
1 x 30 mg 
1 x 15 mg 
D17 Seroquel Prolong 
Lamotrigin 
Abilify 
1 x 50 mg and 1 x 150 mg 
1 x 50 mg and 1 x 100 mg 
1 x 10 mg 
D18 No medication No medication 
D19 No medication No medication 
D20 Trevilor Retard 
Promethazin 
1 x 150 mg 
1 x 50 mg 
Table continues 
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Group Patients Medication Daily dose 
Depression Group D21 Venlafaxin 
Melneurin 
1 x 150 mg 
1 x 25 mg 
D22 Valdoxan 
Circadin 
2 x 25 mg 
1 x 2 mg 
D23 Citalopram 1 x 20 mg 
D24 Pipamperon 
Timonil 
Zoloft 
1.5 x 40 mg 
3 x 200 mg 
3 x 50 mg 
D25 Trenitor Retard 1 x 37.5 mg and 1 x 75 mg 
Schizophrenia 
group 
S21 Zeldox 
Nipolept 
Dogmatil Forte 
Amitriptylin 
2 x 20 mg 
2 x 50 mg 
0.5 
1 x 25 mg 
S2 Orifril 
Solian 
Zyprexa Velotab 
2 x 600 mg 
1 x 200 mg 
1 x 5 mg 
S3 Zeldox 
Seroquel Prolong 
1 x 60 mg and 1 x 40 mg 
1 x 50 mg 
S4 Nipolept 
Lithium-Ion 
Zyprexa 
(Fluanxol) 
3 x 25 mg 
2 x 12.2 mmol 
2 x 7.5 mg 
(every two weeks 10% 1 ml) 
S5 Zyprexa Velotab 1 x 5 mg and 1 x 10 mg 
S6 Xeplion 
Levomepromazin 
1 x 25 mg 
2 x 10 mg 
S7 Seroquel Prolong 
Seroquel 
Chlorprothixen 
(Xeplion) 
1 x 400 mg 
1 x 100 mg 
1 x 50 mg 
(1 x 100 mg per month) 
S8 Leponex 2 x 100 mg and 1.5 x 25 mg 
S9 Leponex 
Paroxetin Beta 
2 x 100 mg 
3 x 10 mg 
S10 Amisulprid 
Zyprexa Velotab 
2 x 400 mg 
2 x 10 mg 
S11 Clozapine Beta 
Dipiperon 
Ergenyl Chrono 
Seroquel 
Citalopram 
1 x 25 mg 
1 x as-needed 
1.5 x 300 mg 
2 x 25 mg 
1 x 20 mg 
Table continues 
-131- 
Group Patients Medication Daily dose 
Schizophrenia 
group 
S12 Abilify 
Citalogram 
Risperdal 
(Xeplion) 
1 x 10 mg 
0.5 x 20 mg 
1 x 2 mg 
(1 x 75 mg per month) 
S13 Pipamperon 
Sertralin 
Solian 
Trimineurin 
0.75 x 40 mg 
3.5 x 50 mg 
2 x 200 mg 
3 x 25 mg 
S14 Solvex 
Nipolept 
Melperon 
Edronax 
0.5 x 4 mg 
2 x 100 mg 
25 mg as needed 
1 x 4 mg 
S15 Zopiclon 
Risperdal 
Promethazin 
Fluanxol 
Akineton 
0.5 x 7.5 mg as needed 
2.5 x 2 mg as needed 
1 x 10 mg 
2 x 5 mg 
0.5 x 2 mg 
S16 Zyprexa 
Lihium-Ion 
Nortrilen 
Abilify 
1 x 5 mg 
2 x 12.2 mmol 
3 x 25 mg 
1 x 10 mg 
S17 Zeldox 
Truxal 
Sertralin 
Seroquel Prolong 
Risperdal 
Lithium-Ion 
Cipralex 
Mirtazapin 
1 x 60 mg and 1 x 40 mg 
15 mg up to 3 x daily 
2 x 50 mg 
1 x 200 mg 
2 x 2 mg 
2 x 12.2 mmol 
1 x 10 mg 
1 x 15 mg 
S18 Zeldox 
Seroquel Prolong 
Ergenyl Retard 
2 x 60 mg 
1 x 200 mg 
2 x 500 mg 
S19 Risperdal 
Mirtazapin 
Haldol 
Dominal Forte 
Pipiperon 
2 x 3 mg 
1 x 30 mg 
3 x 5 mg 
1 x 40 mg 
2 x 40 mg 
Table continues 
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Group Patients Medication Daily dose 
 S20 Pipamperon 
Sertralin 
Solian 
Trimineurin 
0.75 x 40 mg 
3.5 x 50 mg 
2 x 200 mg 
3 x 25 mg 
S21 Zyprexa 
(Dapotum) 
2 x 7.5 mg 
(every 21 days x 25 mg) 
S22 Solian 
Clozapin 
1 x 400 mg 
2.5 x 200 mg 
S23 Clozapin 
Lamotrigin 
Risperdal 
5 x 25 mg 
2 x 50 mg 
1 x 2 mg 
S24 Leponex 
(Haldol) 
1 x 50 mg and 1.5 x 25 mg 
(1 x per month) 
S25 Zyprexa 
Truxal 
1 x 5 mg and 1 x 10 mg 
1 x 50 mg 
Note. 1D = Patient with depression. 
2S= Patient with schizophrenia. 
 
2.4 Acupuncture treatment 
2.4.1 Needles 
Depending on the place of needling, 0.25 x 25 mm or 0.20 x 15 mm stainless-steel single-
use needles (AcuPro C, Wujiang City Cloud & Dragon Medical Device Co., Ltd., China) were 
used. 
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2.4.2 Acupuncture points that were used 
 
 
Figure 1a. An overview of the acupuncture points that 
were most frequently used (> 50%) during the 12 weekly 
individual acupuncture treatments in the group with 
depression 
 
An overview of the acupuncture points that were most frequently used (> 50%) during 
the 12 weekly individual acupuncture treatments is given in Figure 1a for the depression 
group and in Figure 1b for the schizophrenia group. In total, 56 acupuncture points were 
used in the depression group, of which the 15 most frequently used points were LI-4 (96%), 
SP-6 (96%), SP-9 (96%), HT-7 (95%), KI-3 (95%), EX-HN-I (92%), ST-36 (91%), LR-3 (78%), LI-11 
(53%), KI-6 (53%), CV-4 (46%), GB-34 (36%), SP-4 (34%), SP-10 (34%), LU-7 (32%), whereas 
for the schizophrenia group, a total of 61 acupuncture points were used, of which the 15 
most frequently used points were EX-HN-I (89%), SP-6 (60%), SP-9 (60%), LI-4 (56%), KI-3 
(55%), LR-3 (54%), HT-7 (53%), DU-20 (49%), ST-36 (47%), KI-6 (44%), LI-11 (37%), LU-7 
(35%), CV-18 (28%), ST-45 (23%), LI-7 (22%). A complete list of all acupuncture points used 
per individual treatment and a detailed justification for point selection (Bosch, Staudte, van 
den Noort, & Lim, 2014) can be obtained from the corresponding author. 
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Figure 1b. An overview of the acupuncture points that 
were most frequently used (> 50%) during the 12 weekly 
individual acupuncture treatments in the group with 
schizophrenia 
 
2.5 Analysis design 
Before acupuncture treatment (T1), differences between the patients with depression 
and the patients with schizophrenia in both the experimental and the waiting-list groups and 
the healthy control participants on the BDI-II (Beck et al., 1996), digit-span forward 
(Wechsler, 2000), and letter-number sequencing (Van den Noort et al., 2006) were analyzed 
by using the analysis of variance (ANOVA). For those analyses, first, the patients with 
depression, patients with schizophrenia, and healthy controls were compared; then, further 
analyses were conducted for more detailed comparisons. Considering that a relatively large 
number of patients in the waiting-list groups had dropped out by the end of acupuncture 
treatment, T2, we decided against a within group factor design. For the psychiatric groups, 
the results after acupuncture treatment (T2) were also pooled in order to answer the 
questions whether acupuncture treatment improved mood in a psychiatric population and 
whether group (treatment and waiting-list groups) differences existed. Next, paired t tests 
were used to establish within group effects. Because of the difference in age that existed 
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between the depression and the healthy control groups, an analysis of covariance (ANCOVA) 
was conducted in order to determine if the results were affected by this variable. 
 
3 Results 
 
3.1 Mood 
The analysis (ANOVA) of the BDI-II scores at the baseline (T1) showed a significant 
difference in total BDI-II score between the depression group, the schizophrenia group, and 
the healthy control group (p = 0.000, partial η2 = 0.676). As can be seen in Table 3, patients 
with depression had higher BDI-II scores than both patients with schizophrenia (p = 0.000) 
and healthy control participants (p = 0.000); moreover, patients with schizophrenia had 
higher BDI-II scores than healthy control participants (p = 0.000). 
After acupuncture treatment (T2), the patients with depression still had higher scores 
than the patients with schizophrenia (p = 0.000, partial η2 = 0.456). With respect to the 
“acupuncture effect” (i.e., before versus after acupuncture treatment), the analysis of the 
total psychiatric group scores (which was used in order to maintain as much statistical power 
as possible) on the BDI-II showed that those scores were significantly lower after 
acupuncture treatment (p = 0.027, partial η2 = 0.058). An analysis (ANCOVA) revealed that 
age did not have a significant influence on this result (p = 0.170, partial η2 = 0.023), nor did 
length of illness (p = 0.057, partial η2 = 0.046). Moreover, the analysis of the waiting-list 
groups revealed that the total psychiatric group effect after acupuncture could not be 
explained by the fact that the participants were tested twice (p = 0.429, partial η2 = 0.008). 
Finally, when the depression and the schizophrenia groups were analyzed separately, the 
patients with depression show significantly lower BDI-II scores after acupuncture treatment 
(p = 0.014, partial η2 = 0.141), but the patients with schizophrenia did not (p = 0.121, partial 
η2 = 0.059). 
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Table 3. 
Overview of the mean BDI-II scores and the corresponding standard deviations at baseline (T1) specified for the depression group, the 
schizophrenia group, and the healthy control group. Moreover, for the depression group and the schizophrenia group, an overview of the 
BDI-II scores after acupuncture treatment (T2) is given. In addition, the mean BDI-II scores and the corresponding standard deviations of 
the waiting-list groups for the first testing (T1) and for the second testing (T2) are given 
 
Scale T1 (BEFORE ACUPUNCTURE) T2 (AFTER ACUPUNCTURE) T1 (WAITING LIST) T2 (WAITING LIST) 
Group Depression 
Group 
N1 = 25 
Schizophrenia 
Group 
N = 25 
Healthy 
Control Group 
N = 25 
Depression 
Group 
N = 17 
Schizophrenia 
Group 
N = 17 
Depression 
Group 
N = 25 
Schizophrenia 
Group 
N = 25 
Depression 
Group 
N = 16 
Schizophrenia 
Group 
N = 10 
BDI-II3 30.48abd 
(9.06)2 
14.12ac 
(10.70) 
2.12bc 
(2.37) 
23.00d 
(7.83) 
9.35 
(7.54) 
25.04 
(11.43) 
17.52 
(13.74) 
21.56 
(11.34) 
14.60 
(9.89) 
Note. 1Number of participants. 
2Standard deviation. 
3BDI-II = Becks Depression Inventory. 
aSignificant difference between the experimental depression group and the experimental schizophrenia group, p ≤0.05. 
bSignificant difference between the experimental depression group and the healthy control group, p ≤0.05. 
cSignificant difference between the experimental schizophrenia group and the healthy control group, p ≤0.05. 
dMean BDI-II score at T1 is significantly different (p ≤0.05) from the mean BDI-II score at T2.
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3.2 Simple working memory task 
An analysis (ANOVA) of the digit-span scores at baseline (T1) showed significant 
differences between the depression group, the schizophrenia group, and the healthy control 
group (p = 0.003, partial η2 = 0.148). As can be seen in Table 4, patients with depression had 
lower digit-span scores than healthy control participants (p = 0.002), but their scores did not 
differ from the scores of patients with schizophrenia (p = 0.181). Moreover, no differences in 
digit-span scores were found between the patients with schizophrenia and the healthy 
control participants (p = 0.278). After acupuncture treatment (T2), the scores of the patients 
with depression again did not differ from the scores of the patients with schizophrenia (p = 
0.949, partial η2 = 0.000). 
With respect to the “acupuncture effect”, an analysis of the total psychiatric group scores 
before versus after acupuncture treatment showed no significant differences (p = 0.528, 
partial η2 = 0.005). Similarly, non-significant results on the digit-span tasks performed before 
and after acupuncture treatment were found when the depression group (p = 0.194, partial 
η2 = 0.039) and the schizophrenia group (p = 0.740, partial η2 = 0.003) were analyzed 
separately. 
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Table 4. 
Overview of the mean scores on the digit span task and the corresponding standard deviations at baseline (T1) specified for the depression 
group, the schizophrenia group, and the healthy control group. Moreover, for the depression group and the schizophrenia group, an overview of 
the digit span scores after acupuncture treatment (T2) is given. In addition, the mean scores on the digit span task and the corresponding 
standard deviations of the waiting-list groups for the first testing (T1) and for the second testing (T2) are given. 
 
Scale T1 (BEFORE ACUPUNCTURE) T2 (AFTER ACUPUNCTURE T1 (WAITING LIST) T2 (WAITING LIST) 
Group Depression 
Group 
N1 = 25 
Schizophrenia 
Group 
N = 25 
Healthy 
Control 
Group 
N = 25 
Depression 
Group 
N = 20 
Schizophrenia 
Group 
N = 20 
Depression 
Group 
N = 25 
Schizophrenia 
Group 
N = 23 
Depression 
Group 
N = 16 
Schizophrenia 
Group 
N = 8 
Digit 
span 
task 
8.28a 
(1.97)2 
9.28 
(1.90) 
10.16a 
(1.77) 
9.10 
(2.20) 
9.05 
(2.70) 
9.00 
(2.65) 
9.26 
(1.76) 
9.00 
(2.45) 
8.38 
(2.77) 
Note. 1Number of participants. 
2Standard deviation. 
aSignificant difference between the experimental depression group and the healthy control group, p ≤0.05. 
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3.3 Complex working memory task 
An analysis (ANOVA) of the scores on the letter-number sequencing task at baseline (T1) 
showed significant differences in those scores between the depression group, the 
schizophrenia group, and the healthy control group (p = 0.000, partial η2 = 0.192). The 
patients with schizophrenia scored significantly lower than both the patients with 
depression (p = 0.025) and the healthy control participants (p = 0.000); the data are 
presented in Table 5. This difference between two psychiatric groups had vanished by the 
end of acupuncture treatment (T2) (p = 0.122, partial η2 = 0.062). 
With respect to the “acupuncture effect” (i.e., before versus after acupuncture 
treatment), the analysis of the total psychiatric group scores before versus after acupuncture 
treatment showed no improvements after acupuncture treatment (p = 0.264, partial η2 = 
0.014). Finally, the analysis of the subgroups after acupuncture treatment did not reveal 
significant differences on the letter-number sequencing task for the depression group (p = 
0.719, partial η2 = 0.003) and for the schizophrenia group (p = 0.178, partial η2 = 0.042). 
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Table 5. 
Overview of the mean scores on the letter-number sequencing task and the corresponding standard deviations at baseline (T1) specified 
for the depression group, the schizophrenia group, and the healthy control group. Moreover, for the depression group and the 
schizophrenia group, an overview of the mean scores on the letter-number sequencing task after acupuncture treatment (T2) is given. In 
addition, the mean scores on the letter-number sequencing task and the corresponding standard deviations of the waiting-list groups for 
the first testing (T1) and for the second testing (T2) are given. 
 
Scale T1 (BEFORE ACUPUNCTURE) T2 (AFTER ACUPUNCTURE) T1 (WAITING LIST) T2 (WAITING LIST) 
Group Depression 
Group 
N1 = 25 
Schizophrenia 
Group 
N = 25 
Healthy 
Control 
Group 
N = 25 
Depression 
Group 
N = 20 
Schizophrenia 
Group 
N = 20 
Depression 
Group 
N = 25 
Schizophrenia 
Group 
N = 22 
Depression 
Group 
N = 16 
Schizophrenia 
Group 
N = 8 
Letter-
number 
sequencing 
task 
9.44a 
(3.73)2 
7.12ab 
(2.52) 
10.60b 
(2.68) 
9.80 
(2.71) 
8.30 
(3.26) 
10.32 
(4.02) 
6.95 
(3.32) 
10.81 
(3.64) 
7.38 
(2.62) 
Note. 1Number of participants. 
2Standard deviation. 
aSignificant difference between the experimental depression group and the experimental schizophrenia group, p ≤0.05. 
bSignificant difference between the experimental schizophrenia group and the healthy control group, p ≤0.05. 
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4 Discussion 
 
This pragmatic, clinical trial (MacPherson, 2004) investigated mood (Wang et al., 2008) 
and WM (Bussell, 2013) in a psychiatric sample and attempted to determine if acupuncture 
might be able to improve mood and WM. Differences were found between the psychiatric 
groups and the healthy control group, but not on all measures. The most relevant 
acupuncture outcome was that acupuncture treatment significantly improved BDI-II (Beck et 
al., 1996) scores in patients with depression. 
We confirmed the low BDI-II scores for the depressed population, and interestingly, the 
patients with schizophrenia showed signs of better mood, although their average score was 
still below what is considered clinically relevant. In line with our hypothesis, after 12 weeks 
of acupuncture treatment, patients with depression reported an improved mood on the BDI-
II, which is one of the most widely used instruments for measuring the severity of depression 
(Joe, Woolley, Brown, Ghahramanlou-Holloway, & Beck, 2008). Moreover, previous research 
has shown that the BDI-II has excellent test-retest reliability (Sprinkle et al., 2002). This 
finding and our waiting-list results (i.e., no significant difference in BDI-II between two 
measurements) are further support for the hypothesis that the different scores before and 
after acupuncture treatment are a result of the acupuncture intervention. This finding is in 
line with previous acupuncture research on depression and confirms that acupuncture is 
effective in reducing depressive symptoms (Lyons, van der Watt, Shen, & Janca, 2012). In 
contrast to the depression group, and against our hypothesis, however, the patients with 
schizophrenia did not show lower BDI-II (Beck et al., 1996) scores after acupuncture 
treatment. An explanation for their stable mood might be the fact that the patients with 
schizophrenia have much lower scores on the BDI than the depressed group, M = 14.12 
versus M = 30.48, so those patients do not have much room for improvement. This is in 
sharp contrast to the data on the patients with depression who had plenty of room for 
improvement as a result of acupuncture. Nevertheless, as can also be seen in Table 3, both 
experimental groups show a reduction of more than 4.5 points in the total BDI-II score, and 
although this result may not be significant for the group with schizophrenia, it may have 
clinical relevance, particularly for the individual patient in daily clinical practice, and 
warrants further research. 
As can be seen in Table 4, the WM results showed that, at baseline, only the patients with 
depression scored lower than the healthy controls on the simple WM task; the patients with 
schizophrenia surprisingly scored within the normal range. This was not expected because 
research has shown that patients with schizophrenia show relatively stable problems within 
broad neurocognitive domains (Corigliano et al., 2014), and evidence even exists for ongoing 
neurocognitive deterioration as the disease progresses (Corigliano et al., 2014). Moreover, 
cognitive dysfunction is seen as a biomarker that is even visible in healthy relatives of 
patients with schizophrenia (Lett, Voineskos, Kennedy, Levine, & Daskalakis, 2014). On the 
other hand, patients that have been ill for a long time have been studied less, which might 
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explain the unexpected performance (Herold et al., 2015). In contrast to our hypothesis, the 
scores on the digit span did not change after acupuncture treatment, showing that 
acupuncture did not influence performance on a simple WM task. The reason for this might 
be that the baseline scores (particularly for the schizophrenia group) were already in the 
normal range, and as a result, acupuncture could not further improve them. 
The results of the complex WM task revealed that, at baseline, as we expected, the 
patients with schizophrenia performed worse on the letter-number sequencing task (Van 
den Noort et al., 2006) than both the patients with depression and the healthy controls (see 
also Table 5); however, surprisingly, the patients with depression did not perform worse than 
the healthy controls. More importantly, after acupuncture treatment, no WM improvements 
were found in both clinical groups. Future research with a more complex WM task (such as 
the reading-span task (Van den Noort, Bosch, Haverkort, & Hugdahl, 2008)) is needed in 
order to exclude the possibility that the letter-number sequencing task, which was used in 
the present study, did not tap enough processing elements (in addition to the storage 
elements) (Van den Noort et al., 2008), and as a result, no effect of acupuncture on the 
complex WM task could be found. 
One of the possible mechanisms of action is that the (beneficial) effect of acupuncture in 
depression may work via the neurotransmitters dopamine, norepinephrine, and serotonin; 
neurotransmitters that are often reported in the literature because of their role in 
depression (Dunlop & Nemeroff, 2007; Nutt, 2006; Young, 2007). Previous research found 
evidence for the fact that in cases of shortage, acupuncture causes the release of dopamine, 
norepinephrine, and serotonin (Chang, Hsieh, & Cheng, 1996; Han, 1986; Lee et al., 2002). As 
a result, a modulating and normalizing effect occurs (Bosch, Van den Noort, Staudte, & Lim, 
2015), leading to a decrease of depressive symptoms (Zhang, Chen, Yip, NG, & Wong, 2010). 
Another possible mechanism of action is that the (beneficial) effect of acupuncture in 
depression might work via an indirect working mechanism, namely the improvement of 
sleep (Bosch et al., in press). Sleep disorders are often reported in patients with depression 
or schizophrenia (Bosch et al., 2012); moreover, sleep was found to improve after 
acupuncture in patients with depression or schizophrenia (Bosch et al., 2013; Reshef et al., 
2013). Future research on those possible mechanisms of action is needed in order to firstly 
explain the (beneficial) effect of acupuncture in depression that is reported in the literature 
(Zhang et al., 2010) and was found in the present study and secondly, why no beneficial 
effect of acupuncture was found in schizophrenia in this study. Perhaps the effects of strong 
medication use of the patients with schizophrenia with the acupuncture treatment may be 
an explaining factor. Especially in typical antipsychotics, dopamine D2 receptors are blocked 
(Seeman, 2002), thereby possibly interfering the mechanism of acupuncture. 
The present study has several limitations. For instance, based on the present study, how 
long the improved mood in patients with depression lasts after finishing the acupuncture 
treatment is unclear. Future studies (with follow-up measurements) on the clinically relevant 
long-term effects of acupuncture treatment are, therefore, needed (Carlsson, 2002). Another 
limitation of our study is that all participants were on medication during the study (see also 
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Table 2), and medications could not be stopped due to ethical reasons (Fulford & Howse, 
1993) (raised by the ethics committee of the Ärztekammer Nordrhein). Finally, the sample 
sizes in the present study are relatively small (Streiner, 1990) due to practical reasons (Patel, 
Doku, & Tennakoon, 2003). Therefore, in future research, larger clinical groups need to be 
investigated in multiple-center studies. 
 
5 Conclusions 
The clinical improvement in the patients with depression after acupuncture treatment 
was not accompanied by significant changes in either a simple or a more complex working 
memory task; the same was true for patients with schizophrenia. 
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Chapter 7 
 
A case study on acupuncture in the treatment of schizophrenia 
 
Based on: 
Bosch, P., Staudte, H., Van den Noort, M., & Lim, S. (2014). A case study on acupuncture in 
the treatment of schizophrenia. Acupuncture in Medicine, 32(3), 286–289. 
doi:10.1136/acupmed-2014-010547 
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ABSTRACT 
This report describes the use of acupuncture as an add-on treatment for a chronic patient 
with schizophrenia. The 63 year old female patient suffered from persistent hallucinations 
and even physical pain, as a result of the hallucination of a black bird that kept pecking her 
back. The patient received 12 weekly acupuncture treatments. A clinical diagnostic interview 
and psychological testing (on sleep quality, depression, and on positive and negative 
symptoms) were conducted before, immediately after, and three months after the 
acupuncture treatment. The results of the diagnostic interview gave important insights in 
the treatment effects. The patient experienced improved daily functioning and noticed a 
change in hallucinations. Although the hallucinations still occurred, she felt less disturbed by 
the hallucinations. Interestingly, the pain decreased markedly. In addition, the results show 
that the overall score of the positive and negative symptoms did not change immediately; 
however, a decrease in symptoms occurred three months after acupuncture treatment. 
Moreover, the patient described an immediate improvement of sleep; this was confirmed by 
a daytime sleepiness questionnaire. Interestingly, the patient was not able to fill in a (longer) 
test on sleep quality beforehand, but could fill it in after the treatment period. Finally, a 
delayed improvement in the depression scale was found. Although larger clinical 
intervention studies on acupuncture and schizophrenia are needed, the results of this case 
study indicate that acupuncture may be beneficial as an add-on treatment tool in patients 
with schizophrenia. 
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INTRODUCTION 
 
Acupuncture is increasingly used in Western medicine as an add-on treatment for various 
psychiatric diseases (Bosch et al., 2013), particularly in the treatment of patients with 
depression (Andreescu, Glick, Emeremni, Houck, & Mulsant, 2011). However, the use of 
acupuncture in patients with schizophrenia is rare (Schmid & Brunisholz, 2006). We report a 
case from a large German psychiatric clinic. We were interested in examining if acupuncture 
was helpful as an add-on treatment in a patient with schizophrenia, and assessed which 
psychological tests were suitable to capture the effects of the acupuncture treatment. 
 
CASE DESCRIPTION 
In November 2003, our patient (aged 56 years) experienced compulsory admission to a 
psychiatric clinic for the first time. This was necessary to prevent danger to the patient and 
others due to severe delusions. The psychotic symptoms were disrupted only after she was 
compulsorily injected with a high dose of neuroleptics. After she left the psychiatric clinic 
she received regular treatment as an outpatient for several years, and her situation was 
continually characterised by significantly decreased performance, exhaustion, increased 
psychophysical vulnerability, reduced concentration, and reduced attention. She showed 
increasing periods of extreme tiredness and mentioned pain in the back, legs, shoulders, and 
ribs in particular. She described the pain as resulting mainly from one of her hallucinations; a 
black bird that kept pecking at her back, which caused the pain. Moreover, she spoke of the 
bird that continually sat next to her and kept swearing and calling her names. As a result of 
her continued suffering, the patient decided to participate in an acupuncture project. The 
study was approved by the ethical committee of the Ärztekammer Nordrhein. The patient 
drank about 2 litres of coffee a day (sometimes more) and smoked heavily. 
 
Medication 
The patient was on medication during the whole of the study period. She used Melperone 75 
mg at night, Risperdal 3 mg daily dose (1 mg in the morning, afternoon, and evening), and 
Risperidone 37.5 mg every 14 days. 
 
Psychological investigation 
To measure the severity of her schizophrenic symptoms, the Positive and Negative Symptom 
Scale (PANSS) (Kay, Fiszbein, & Opler, 1987) was used (including the cognitive component) 
(Lindenmayer, Bernstein-Hyman, & Grochowski, 1994). The results showed that the patient 
was suffering from serious positive and negative symptoms and from general 
psychopathology at the start of the study. The Epworth Sleepiness Scale (Johns, 1991) which 
measures subjective experience of daytime sleepiness, revealed that she was very sleepy 
during the day. Before treatment, she was not able to complete the Pittsburgh Sleep Quality 
Index (PSQI) (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989) that measures sleep quality 
and possible disturbances in sleep patterns during the previous month. She was too 
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disturbed by her increasing hallucinations and asked whether it was possible to skip the test. 
Finally, the severity of depressive symptoms was measured with the Becks Depression 
Inventory II (BDI-II) (Beck, Steer, & Brown, 1996). The patient’s score was 27, showing that 
she was suffering from moderate depression at the beginning of the study. 
 
Treatment and outcome 
The patient was given individualised acupuncture treatment once a week for twelve weeks 
and points were punctured bilaterally. The needles used were 0.25 x 25 mm or 0.20 x 15 mm 
stainless steel (depending on the place of needling) single use needles (AcuPro C, Wujiang 
City Cloud & Dragon Medical Device Co., Ltd., China) and were placed according to TCM 
principles. De qi was obtained and the needles were not stimulated after that, but left in 
place for one hour. 
 
Acupuncture diagnosis and point selection 
Due to the thin, (mostly) pale, flaccid, (mostly) moist tongue with many cracks and hardly 
any coating, and the weak and sometimes rapid pulse, a Qi and Blood deficiency was 
diagnosed. From time to time, local stagnation of Qi and Blood presented as a purple colour 
of the tongue and lips (and an increase in pain related to hallucinations) together with some 
heat symptoms (noticeable foremost in the pulse in the Spleen/Stomach position and then 
in the stronger pulse). Although she mostly presented with symptoms of depletion, there 
were also symptoms of excess (Phlegm misting the Mind or even at some point Fire 
harassing the Mind). In addition, years of heavy medication (continuing during treatment), 
and coffee and cigarette consumption were taken into consideration, as also reported by 
others (Ronan, Harbinson, MacInnes, Lewis, & Robinson, 2010). A careful individual 
diagnosis (at each treatment) was conducted by a licensed oriental medical practitioner with 
more than five years of clinical experience (Bosch et al., 2013). 
 
RESULTS 
 
Figure 1 provides an overview of the acupuncture points used (and the frequency). 
Treatment was based on the following primary points: LI4, LI11, ST8, ST36, SP6, SP9, BL67, 
KI3, LV3, DU20, and EX-HN1 (Sishencong) (detailed justification for point selection can be 
obtained from the author). 
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Figure 1. An overview of the acupuncture points (and frequency) that were used during 12 
weekly acupuncture treatments. 
 
The diagnostic interview gave important insights into the treatment effects of a patient 
suffering from schizophrenia and persistent hallucinations. She experienced better daily 
functioning and noticed a change in hallucinations. Although the black bird was still sitting 
next to her, he did not speak during the first three days after treatment and he did not pick 
her back. Her pain and suffering therefore, decreased markedly during those three days and 
she was able to sleep. At the end of the three days, the bird started to swear again and took 
up his usual pecking, causing the same pain as before. This happened in the same way, 12 
weeks in a row. 
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Table 1. 
Psychological test results of the patient with schizophrenia on the Epworth, PANSS, BDI, and 
PSQI before and after acupuncture treatment and at follow-up. 
Test Before Acupuncture After Acupuncture  Follow-Up 
PANSS cognitive 7 7 6 
PANSS positive 14 20 16 
PANSS negative 16 16 10 
PANSS psychopathology 39 34 30 
PANSS total 69 70 56 
Epworth 12 6 13 
PSQI total - 8 12 
BDI 27 28 24 
Note. - Means that it was not possible to conduct the psychological test in the patient with 
schizophrenia, due to increased hallucinations when she started to read the text. 
 
Table 1 shows the results of the psychological testing. The overall score for positive and 
negative symptoms did not change directly after acupuncture treatment, indicating that her 
psychiatrist (not involved in the project) did not notice large differences. However, three 
months after acupuncture treatment a large effect was noted (70 versus 56), and this was 
the case for all three subscales of the PANSS. The most striking result was found on the 
PANSS negative subscale (a decrease from 16 to 10), meaning that the number of negative 
symptoms decreased. The PANSS positive (a decrease from 20 to 16) and the PANSS 
psychopathology (a decrease from 34 to 30) show similar results, implying that the number 
of positive symptoms decreased and the amount of psychopathology was also decreased. 
Moreover, the score on the Epworth Sleepiness Scale showed less sleepiness after 
acupuncture; however, three months after the acupuncture treatment this beneficial effect 
is back to the level before the acupuncture treatment. The results of the PSQI showed that 
our patient was not able to complete the questionnaire before treatment. She responded 
with increased hallucinations and could not continue filling it in. After treatment, she 
experienced no problems with the list and we found a total score of eight, indicating poor 
sleep quality (Six is increasingly seen as the cut-off score for good sleep quality, Hametner et 
al., 2012). Three months after acupuncture treatment, however, sleep quality had 
decreased. The total score on the PSQI increased to 12, which can be characterised as very 
poor sleep quality and the patient described this as the way as before treatment. 
No differences were found on the depression scale, indicating that her depressed mood 
did not improve directly after acupuncture treatment; however, a small improvement is 
noticeable at follow up. 
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DISCUSSION 
The results of this case study indicate that acupuncture may be beneficial as an add-on 
treatment tool for patients with schizophrenia, as a number of positive and negative 
symptoms decreased three months after acupuncture treatment and it appeared to have an 
effect on sleep and daytime sleepiness. The results of this case study seem to support the 
idea that one of the underlying treatment mechanisms of acupuncture in schizophrenia is an 
indirect one, namely through improving sleep (which is what the patient described). From a 
Western point of view, it seems logical that when patients sleep better, their concentration 
improves and they feel better. Interestingly, previous neuroimaging research revealed that 
the “limbic-paralimbic-neocortical network”, consisting of the amygdala, hypothalamus, and 
default mode network, is involved in response to acupuncture. These areas are known for 
their role in the regulation of sleep and wakefulness; moreover, it was found that 
acupuncture had a modulating and normalising effect on these areas (Hui, Marina, Liu, 
Rosen, & Kwong, 2010). 
However, larger studies on acupuncture and schizophrenia are needed (Rathbone & Xia, 
2005) in order to test the effectiveness of acupuncture in schizophrenia and to unravel the 
possible underlying working mechanisms. To date, a systematic review (Lee, Shin, Ronan, & 
Ernst, 2009) on thirteen studies showed only limited evidence for the effectiveness of 
acupuncture in treating the symptoms of schizophrenia. In future studies, care should be 
given to the type of psychological tests used to measure effects within this group. Due to the 
hallucinations present, long tests are unsuitable. Moreover, in the study design, the short-
term and long-term effects of acupuncture should be considered. Our patient would likely 
have given different answers on, for example, a pain scale, during the first three days 
immediately following acupuncture treatment, compared with after those three days. 
Moreover, although the patient described having fewer problems, due to the fact that her 
bird sat silently, it was still there, probably causing less difference on the PANSS, since she 
was still hallucinating. 
 
CONCLUSION 
This case report suggests that acupuncture may be a suitable add-on treatment in patients 
with chronic schizophrenia, visible in the lower number of positive and negative symptoms, 
improved daytime sleepiness, and improvement in mood. Acupuncture may also change the 
hallucinations themselves; the hallucinations still occurred, but the pain and distress caused 
by the hallucinations decreased markedly. 
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Abstract 
 
Psychiatric disorders can be described and treated from both a Western (allopathic) and an 
Eastern perspective, which should be taken into account when conducting research. Patients 
with schizophrenia or depression are likely to be undergoing Western treatment when they 
are referred to an acupuncturist for (add-on) treatment, and knowledge of both types of 
treatments is necessary to integrate them successfully. In this study, the different Traditional 
Oriental Medicine (TOM) diagnostic patterns in patients with a Western diagnosis of 
schizophrenia, depression, or sleep disorders are described from a literature and a clinical 
perspective. The data on 30 depression and 30 schizophrenia patients from a German study 
are presented. Our results show that if a psychiatric group, sorted in accordance to Western 
diagnostic principles, is diagnosed on the basis of TOM diagnostic patterns, it can be 
categorized into different groups of patients with psychiatric disorders; this finding has far-
reaching consequences in scientific research on acupuncture. Moreover, we found a high 
prevalence of sleep disorders in patients with both schizophrenia and depression, which 
could be explained from a TOM diagnostic patterns perspective. Finally, we discuss sleep 
quality as a treatment objective that may play a crucial role in mediating acupuncture-
induced treatment effects in patients with schizophrenia and depression. 
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1. Introduction 
 
Psychiatric disorders can be described from both a Western (allopathic) and an Eastern 
perspective. In particular, patients with a Western diagnosis of schizophrenia or depression 
are likely to be undergoing Western treatment when they are referred to an acupuncturist 
for (add-on) treatment; therefore, knowledge of both types of treatments is needed for 
integrating them. Sleep disorders are comorbid with most psychiatric disorders. It is well 
known that sleep disorders occur in depression, but they are often underestimated in 
schizophrenia (Bosch et al., 2012). Research on acupuncture and depression is more difficult 
than one might think because of the fact that, although patients seem to have the same 
Western diagnosis, they have different Traditional Oriental Medicine (TOM) diagnostic 
patterns, creating a heterogeneous group. From a TOM point of view, some patterns are 
more severe than others, making it logical that acupuncture results differ between the 
various patient groups within the overall group of patients with depression. In patients with 
schizophrenia, this is even more extreme because this patient group is already 
heterogeneous from a Western point of view. Moreover, if standardized treatments are 
used, these may be more suitable for some patterns than for others. Therefore, in order to 
further illustrate this point, we discuss the results from two different psychiatric groups 
(patients with schizophrenia and those with depression), in order to anser the following 
research questions: what TOM diagnostic patterns can be distinguished in patients who 
would receive a Western diagnosis of schizophrenia, depression, or sleep disorders; how are 
these disorders related; and how can acupuncture treatment results be explained both from 
an Eastern and a Western perspective (Bosch & van den Noort, 2008)? 
 
2. Materials and methods 
 
Thirty patients with schizophrenia and 30 patients with depression participated in this study. 
All patients were outpatients at the LVR-Klinik Bedburg-Hau, which is a large psychiatric 
clinic in Germany. The patients with schizophrenia were diagnosed with schizophrenia F 20.0 
(paranoid schizophrenia – 28 patients) or F20.5 (schizophrenic residuum – two patients), and 
the patients with depression were diagnosed with depression F33.2 according to the ICD-10 
(World Health Organization, 1992). Of the 30 patients with schizophrenia, 13 were males 
and 17 were females, and of the 30 patients with depression, three were males and 27 were 
females. Note that it is common in Western Medicine (WM) that significantly more female 
han male patients represent with depression (Schuch, Roest, Nolen, Penninx, & de Jonge, 
2014). Patient ages were within the range of 19 – 62 years (mean age = 42.90 years, SD = 
10.34 years) for the schizophrenia group and from 34 – 64 years (mean age = 49.60 years, SD 
= 7.51 years) for the depression group. Moreover, the mean duration of illness was 11.40 
years (SD = 6.73 years) for the schizophrenia group with a minimum of 1 year and a 
maximum of 26 years, and 8.00 years (SD = 6.79 years) for the depression group, with a 
minimum of 1 year and a maximum of 30 years. None of the participants had ever 
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experienced acupuncture treatment previously. Oral and written informed consent were 
obtained from all participating adult subjects, and all of them signed a consent form. The 
ethics committee of the Ärztekammer Nordrhein approved the study beforehand; moreover, 
the study was conducted according to the Declaration of Helsinki (World Medical 
Organization, 1996). The Standard Acupuncture Nomenclature 
(http://www.wpro.who.int/publications/ pub_9290611057.htm) and the WHO International 
Standard Terminologies on Traditional Medicine in the Western Pacific Region 
(http://www.wpro.who.int/ publications/PUB_9789290612487.htm) published by the World 
Health Organization Regional Office for the Western Pacific were used in our study. 
 
   In TOM, schizophrenia is seen in the context of depression-mania (diān-kuáng). As early as 
during the Ming Dynasty, Lĭ Chān stated the following in Yī Xué Rù Mén: “Mania patients are 
ferociously mad. In mild cases they act self-important and self-righteous, and they like to 
sing and like to dance; in more serious cases they throw off their clothes and run amok, 
climb walls and mount the roof. In even more serious cases they beat their head (against a 
wall) and scream, are negligent around fire and water, or can have inclinations to murder. 
This naturally results from inordinate exuberance of the Heart Fire, a superabundance of 
Yang Qi, the spirit failing to keep to its abode, and Phlegm-Fire congestion and exuberance. 
The crux of treating mania is to descend Phlegm and down bear Fire” (Dey, 1999, p.2). 
During the Tang Dynasty, Sūn Sī Miăo stated the following in Qiān Jīn Yào Fāng: “When wind 
enters the Yin channels, there is withdrawal (diān). The forms can have many extremes. 
(Some patients) are taciturn and make no sound, (while others) say many things in effusive 
speeches. They also may sing or cry, moan or laugh. They may also sleep or sit in ditches, eat 
feces and filth, show their naked bodies (in public), move around all day and night, and 
ceaselessly curse and cuss” (Dey, 1999, p. 2). 
 
   Patients with schizophrenia often have symptoms of both kuάng and diān illnesses. Their 
diān symptoms include problems in persistence, less self motivation, feeling less up for 
society, deep silence/mutism, weakness in answering questions, problems in forming an 
opinion about their surroundings, and disinterest in their own appearances. These patients 
have what Western medicine calls negative symptoms, and they seem to be absent. They 
can also show kuάng behavior, such as excited movements, disordered speech, explosive 
behavior and spontanious outbursts in which things are destroyed or people are hurt (Dey, 
1999, pp. 2‒3). In TOM, bipolar disorders are often described as Diān and Kuάng (‘mania and 
withdrawal’). ‘Mania’ means a hyperactive state in which a patient is excited; the state is 
characterized by loud, inappropriate and possibly aggressive behavior. Mania is mainly 
caused by a hyperactivity of Yang-Qi caused by several patterns, such as Fire because of Qi 
stagnation or empty heat due to Yin deficiency. ‘Withdrawal’ means a state of emotional 
depression, loss of interest, and loss of appetite and reduced fluid intake (Dey, 1999, p. 9). 
As can be seen in Table 1, several patterns can be distinguished in patients who receive a 
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Western diagnosis of schizophrenia. Table 1 was created based on information from several 
textbooks (Flaws & Lake, 2001; Maciocia, 2005). 
 
Table 1. 
Patterns that might receive a Western diagnosis of schizophrenia (Flaws & Lake, 2001; 
Maciocia, 2005). 
Yang illness/excess pattern (Acute phase) 
Yin illness/excess pattern 
Liver Qi stagnation with or without Liver-Blood stasis  
Liver-Blood heat 
Liver-Fire 
Qi deficiency 
Qi and Blood deficiency 
Phlegm and Qi stagnation (with Qi emptiness) 
Internal Pleghm/Dampness, causing an obstruction 
Phlegm (and) Fire that attack the upper body/Phlegm heat harassing the mind 
Phlegm misting the mind 
Heart-Spleen deficiency 
Heart-Blood heat 
Heart-Blood stasis 
Heart-Fire 
Heart-Yin deficiency (with or without empty heat) 
Heart and Kidney Yin deficiency with Heart empty-heat 
Stomach and Heart Phlegm-Fire 
Yang emptiness with Spleen and Kidney deficiency (including phlegm) 
Kidney Essence deficiency 
Yin deficiency not controlling fire 
(Internal) Blood stasis  
Stasis of Blood in the Lower Burner 
 
   From a TOM point of view, almost all patients who suffer from depression from a western 
point of view present Liver Qi stagnation, however, mostly this stagnation is complicated by 
Stomach disharmony, empty heat, Spleen and/or Blood deficiency, Yin and/or Yang 
deficiency, Phlegm, Dampness, etc. As can be seen in Table 2 (Flaws & Lake, 2001; Maciocia, 
2005), several patterns can be distinguished in patients that might have received a diagnosis 
of depression accoriding to WM. 
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Table 2.  
Patterns that might receive a Western diagnosis of depression (Flaws & Lake, 2001; 
Maciocia, 2005). 
Liver Qi depression and binding 
Liver depression transforming Fire 
Liver Blood deficiency 
Liver Yin deficiency (with empty heat) 
Liver-Fire 
Blood movement depression and stagnation  
Phlegm misting the Mind 
Phlegm Qi depression and binding 
Phlegm Fire (obstructing the Qi) 
Depression causing detriment to the Heart Qi  
Heart-Spleen dual vacuity  
Heart & Lung Qi stagnation 
Heart-Blood deficiency 
Heart-Yin deficiency 
Stomach and Heart Phlegm-Fire 
Spleen Yin deficiency 
Spleen-Kidney Yang deficiency 
Kidney Yang deficiency 
Kidney Yin deficiency 
Kidney and Liver Yin deficiency 
Kidney Essence deficiency 
Lung and Kidney Yin deficiency 
Lung Yin deficiency 
Yin vacuity Fire effulgence  
Qi deficiency 
Qi and Blood deficiency 
 
   In TOM, insomnia and other sleep disorders are caused by a dysfunction of the Heart. 
Worrying, thinking, or feeling distressed can weaken Heart and Spleen, leading to Qi and 
Blood deficiency and failing to nourish the Heart and to house the shen, thus causing 
insomnia. Too much sexual activity weakens the Kidneys, and Kidney Yin deficiency causes 
Fire, which results in a disbalance of Heart and Kidneys, leading to sleep disorders. Another 
cause can be a poorly functioning Stomach and Spleen, resulting in Dampness and Pleghm 
obstruction and in heat followed by Phlegm heat, which disturbs the Heart such that it 
cannot house the shen. Moreover, anger leads to Liver Qi stagnation; this may lead to Liver 
Fire, which disturbs the shen, and it cannot be housed in the Heart; hence, sleep disorders 
follow. Table 3 (Deng, 1999; Flaws & Lake, 2001; Maciocia, 2005) presents an overview of 
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the patterns that may be found in patients who are diagnosed with a sleep disorder 
according to WM. 
 
Table 3. 
Patterns that might receive a Western diagnosis of a sleep disorder (Deng, 1999; Flaws & 
Lake, 2001; Maciocia, 2005). 
Liver Blood deficiency transforming vacuity heat 
Liver Fire harassing internally (also called internal heat)/upflaring Liver Fire 
Liver Qi stagnation 
Liver Blood stasis 
Liver Yin deficiency (with empty heat) 
Empty heat/the rising of Minister-Fire/Empty-Fire 
Retained heat (in the diaphragm) 
Phlegm Fire/heat harassing (the Mind) 
Phlegm by a weakness of the Gallbladder 
Heart Fire effulgence/upflaring Heart Fire/Heart-Fire blazing 
Heart-Spleen (Blood) deficiency 
Heart Yin deficiency 
Heart-Gallbladder (Qi) deficiency 
Heart-Blood deficiency 
Heart-Blood stasis 
Heart-Blood heat 
Heart & Lung Qi stagnation 
Non-interaction or disbalance between the Heart and Kidneys 
Food stagnation/disharmony of Stomach Qi 
Stomach and Heart Phlegm Fire 
Kidney Essence deficiency 
Yin deficiency (general) 
Qi stagnation (general) 
Qi deficiency 
Qi and Blood deficiency 
Blood stasis (general) 
 
   Several sleep-tests, such as the Epworth Sleepiness Scale (Johns, 1991), Munich 
Parasomnia Screening (MUPS) (Fulda et al., 2008), Multiple Sleep Latency Test (Carskadon et 
al., 1986), Pittsburgh Sleep Quality Index (PSQI) (Buysse, Reynolds, Monk, Berman, & Kupfer, 
1989), and Sleep diaries (Carney et al., 2012) have been developed in WM in order to 
diagnose sleep disorders. In our study, the PSQI (Buysse et al., 1989) was used in order to 
indicate the presence of possible sleep disorders from a WM perspective. The PSQI is a self-
rated questionnaire that assesses sleep disturbances and sleep quality over a 1-month 
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period. It consists of 19 self-rated questions, and these items are grouped into seven 
component scores, each weighted equally on a 0-3 scale. The global PSQI score is a 
summation of these seven component scores, and as a result, the global PSQI score can 
range from 0 to 21. Five was originally used as the cut-off score (Buysse et al., 1989), 
meaning that participants who score below five have good sleep quality; however, in recent 
years, six has become the preferred cutt-off score, in order to be more selective (Hametner 
et al., 2012). Note that in WM, the PSQI is frequently used as a clinical sleep instrument in 
schizophrenia (Afonso, Brissos, Cañas, Bobes, & Bernardo-Fernandez, 2014) as well as in 
depression (Lai et al., 2014) and has been found to have high test-retest reliability and a 
good validity (Backhaus, Junghanns, Broocks, Riemann, & Hohagen, 2002). In this study, a 
cut-off score of 6 was used. 
 
3. Results 
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Table 4.  
The TOM diagnosis results with the TOM diagnostic patterns of our total psychiatric sample 
(n = 60) specified for the patients with (PSQI ≥ 6) and without sleep disorders. 
Group with WM Diagnosis of Schizophrenia 
TOM Diagnostic Pattern 
Number of 
Patients 
PSQI < 6 PSQI ≥ 6 
Phlegm misting the Mind          4      1      3 
Phlegm heat harrassing the Mind         4      1      3 
Qi & Blood deficieny resulting in Phlegm misting the 
Mind 
        4      2      2 
Stomach and Heart Phlegm Fire         4      3      1 
Qi & Blood deficiency         3      1      2 
Heart-Blood (Yin) deficiency         2       2 
Liver Fire         2       2 
Liver Yin deficiency with Liver Yang rising         2       2 
Heart and Kidney Yin deficiency         1      1  
Heart & Stomach Yin deficiency         1      1  
Kidney Essence deficiency with upflaring Liver Fire         1       1 
Kidney Yang and Yin deficiency         1       1 
Liver Qi stagnation from Liver Blood and Yin deficiency         1     1  
Group with WM Diagnosis of Depression  
TOM Diagnostic Pattern 
Number of 
patients 
PSQI <6 PSQI ≥ 6 
Qi & Blood deficiency         8      2      6 
Kidney Essence deficiency         4      1      3 
Heart Yin deficiency         2       2 
Blood deficiency         2       2 
Kidney Yang deficiency         2       2 
Phlegm Fire flaring upwards         2       2 
Heart Fire with empty heat         1      1  
Heart and Kidney Yin deficiency with empty heat         1       1 
Liver Fire         1       1 
Liver & Kidney Yin deficiency with Liver Wind         1       1 
Liver Qi stagnation leading to Liver Blood Stasis         1       1 
Lung & Spleen Qi deficiency resulting in Phlegm misting 
the Mind 
        1      1  
Qi & Blood deficiency resulting in Phlegm misting the 
Mind 
        1       1 
Table continues 
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TOM Diagnostic Pattern 
Number of 
patients 
PSQI <6 PSQI ≥ 6 
Stagnation of Hearth & Lung Qi with accompanying 
Phlegm 
        1       1 
Stomach Phlegm Fire with Wind Phlegm         1       1 
Stomach & Spleen Yin deficiency         1      1  
 
The 30 patients with schizophrenia showed several main patterns (for a complete overview, 
see Table 4). The most frequent ones were the following: Phlegm misting the Mind, Phlegm 
heat harrassing the Mind, Qi & Blood deficiency, and Stomach and Heart Phlegm Fire. In 
diagnosing these patients, it is important to note that most patients had been ill for a long 
time (more than five years). They had taken heavy medication for many years, which 
complicated the process of diagnosis. As Ronan, Harbinson, MacInnes, Lewis, and Robinson 
described (2010), a tongue diagnosis sometimes displayed symptoms of stagnation and heat 
whereas pulses were weak. Moreover, patterns tend to change with treatments. Therefore, 
only the patterns that were present at the first treatment are presented here. 
 
   The 30 patients with depression displayed the following main patterns (for a complete 
overview, see Table 4): Qi & Blood deficiency and Kidney Essence deficiency. Note that, also 
in the patients with depression, diagnosis was sometimes complicated due to long-standing 
disease patterns and the use of Western medication over long periods of time. 
 
   As can be seen in Table 4, the results of the PSQI (with a cut-off score of six) (Hametner et 
al., 2012) showed that of the 30 patients with schizophrenia, 19 patients (63.33%) suffered 
from sleep disorders whereas of the 30 patients with depression, 24 patients (80.00%) 
suffered from sleep disorders. In addition, the TOM diagnosis results of our total psychiatric 
sample (n = 60) show the following main TOM diagnostic patterns for the patients with sleep 
disorders: Qi & Blood deficiency, Kidney Essence deficiency, Phlegm heat harrassing the 
Mind, and Phlegm misting the Mind. 
 
4. Discussion 
 
In this study, we described the different TOM diagnostic patterns in patients with a Western 
diagnosis of schizophrenia, depression, or sleep disorders from a literature and a clinical 
perspective. As the results of our study showed, several main TOM diagnostic patterns for 
schizophrenia and depression could be observed in the study population (see Table 4). The 
most frequent TOM diagnostic patterns in schizophrenia were Phlegm misting the Mind, 
Phlegm heat harrassing the Mind, Qi & Blood deficiency, and Stomach and Heart Phlegm 
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Fire. The most frequent TOM diagnostic patterns in depression were found to be Qi & Blood 
deficiency, Heart Yin deficiency, and Kidney Essence deficiency. 
   Research on acupuncture and depression or schizophrenia is difficult to design, conduct 
and interpret because of the fact that different patterns can be found within these groups of 
patients. Some patterns are more severe from a TOM point of view, indicating that 
acupuncture results may differ between different groups of patients. This finding suggests 
that the group being treated is very heterogeneous in nature and that the results obtained 
from any particular group may not be generalizable. To solve this problem, a very large 
number of patients need to be included, or inclusion criteria need to be very strict. Both 
points create recruiting problems in clinical practice (Patel, Doku, & Tennakoon, 2003). One 
more point that needs attention in conducting a clinical research is the possibility of an 
appreciable age difference between the groups. In this case, the analysis of variance showed 
that our group with depression was (on average) significantly older (M age = 49.59 years; SD 
= 7.60 years) than our group with schizophrenia (M age = 42.90 years; SD = 10.30 years), 
F(1,59) = 7.938, p < .01. 
   In addition, as expected, the study results of our psychiatric sample showed a high 
percentage of sleep disorders in both the depression group (>80%) and the schizophrenia 
group (>63%) (see Table 4). It is well known in WM, that sleep disorders occur in depression 
(Nutt, Wilson, & Paterson, 2008), but they are often underestimated in schizophrenia (Bosch 
et al., 2012). From a Western point of view, logically, when patients sleep better, their 
concentration improves and they feel better. From a TOM point of view, explaining why both 
psychiatric groups suffer from sleep disorders is logical and easy. Sleep disorders occur when 
the Spirit and Mind are not calm, and Shen cannot house in the Heart. When these problems 
are solved, sleep normalizes, and the whole body moves towards equilibrium. Based on the 
clinical results of our psychiatric sample, we hypothesize that the effects of acupuncture 
treatment on patients with schizophrenia and those with depression may be partially 
mediated through improvement in sleep (Bosch, Staudte, Van den Noort, & Lim, 2014; Bosch 
et al., 2013; Reshef et al., 2013). 
   However, more international (Lee, Shin, Ronan, & Ernst, 2009) and larger studies on 
acupuncture and schizophrenia (Rathbone & Xia, 2005) and on acupuncture and depression 
(Smith, Hay, & MacPherson, 2010) are needed, in order to better understand the effects of 
acupuncture in these patient groups and to test the hypothesis that there is a mediating role 
of sleep improvement in the treatment of patients with schizophrenia and depression (Bosch 
et al., 2013, 2014; Reshef et al., 2013). The sleep hypothesis may explain the positive effects 
of acupuncture treatment observed in patients with schizophrenia (Bosch & van den Noort, 
2008) and in depression (MacPherson et al., 2013); thus, treatment of patients with 
schizophrenia and depression using acupuncture seems to be a promising option. 
   In this research, we showed that several main TOM diagnostic patterns can be found in 
patients with schizophrenia and depression. Acupuncture research on patients with 
depression or schizophrenia is difficult to design, conduct and interpret; in addition, due to 
the different TOM diagnostic patterns that are treated within the schizophrenia and 
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depression groups, results differ. Finally, we showed a high prevalence of sleep disorders in 
our psychiatric sample, and discussed sleep quality as a treatment objective that may play a 
crucial role in mediating acupuncture-induced treatment effects (symptom reductions) in 
patients with schizophrenia and depression. 
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Chapter 9 
 
Schizophrenia and depression: A systematic review on the effectiveness and 
working mechanisms behind acupuncture 
 
Based on: 
Bosch, P., Van den Noort, M., Staudte, H., & Lim, S. (2015). Schizophrenia and depression: A 
systematic review on the effectiveness and working mechanisms behind acupuncture. 
Explore: The Journal of Science and Healing, 11(4), 281–291. 
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Abstract 
 
Objective: This systematic review assessed clinical evidence for the use of acupuncture as an 
add-on treatment in patients with depression and schizophrenia and for its underlying 
working mechanisms. 
Data Sources: Four databases (Medline, Scopus, ERIC, and the Cochrane Library) were 
searched with a cut-off date of March 31, 2014. 
Study Selection: Systematic reviews and meta-analyses of acupuncture treatment for 
depression and schizophrenia were considered for inclusion. The scarcity of acupuncture 
research involving schizophrenia led to the inclusion of randomized controlled trials and case 
studies. 
Data Extraction: The primary and secondary aims of this study were to evaluate the effects 
of acupuncture in treating patients with depression or schizophrenia and the possible 
working mechanisms underlying acupuncture through a systematic literature review. 
Data Synthesis: The overall clinical results on using acupuncture to treat depression are 
promising, but only limited evidence for its effectiveness in treating schizophrenia was 
found. Acupuncture improves the quality of life, particularly that of sleep, in psychiatric 
patients. Brain research has revealed that acupuncture has a modulating and normalizing 
effect on the limbic-paralimbic-neocortical network (LPNN), including the default mode 
network. Because the LPNN is related to sleep and emotions, this might explain the 
improved qualities of life and sleep after acupuncture. 
Conclusions: From the evidence found in this study, acupuncture seems to be an effective 
add-on treatment in patients with depression and, to a lesser degree, in patients with 
schizophrenia, but large well-designed studies are needed to confirm that evidence. 
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INTRODUCTION 
 
Depression and schizophrenia are both severe psychiatric disorders. In the world population, 
the lifetime prevalence of schizophrenia is estimated to be about 1% (Bromet & Fennig, 
1999), and in most countries 8% to 12% will suffer from depression at some point (Andrade 
et al., 2003; Kessler et al., 2003); however, note that the lifetime prevalence of depression 
varies widely, from 3% in Japan to 17% in the United States (Andrade et al., 2003). In 
Western medicine, treatment for these patients varies from pharmacological interventions 
(Kane & Correll, 2010; Kupfer, 2005), psycho-social therapy (Cuijpers et al., 2013; Dickerson 
& Lehman, 2006; Roder, Mueller, & Schmidt, 2011; Wolf & Hopko, 2008), and 
electroconvulsive therapy (Wang, Lin, Chiu, & Tseng, 2013), to light therapy for depression 
(Oldham & Ciraulo, 2014), etc. During the last two decades, the use of complementary and 
alternative medicine (CAM), including acupuncture (Yeo et al., 2012), as an add-on 
treatment in Western medicine (Eisenberg et al., 1998) has been on the rise, especially 
among psychiatric patients (Deligiannidis & Freeman, 2014; Samuels, Gropp, Singer, & 
Oberbaum, 2008). CAM is particularly used in the treatment of depression (Kessler et al., 
2001). It is not surprising that in line with this trend, the number of scientific studies on 
acupuncture has increased as well (Lu, Dean-Clower, Doherty-Gilman, & Rosenthal, 2008). 
Traditional Chinese medicine (TCM) has its own theoretical background in which its 
mechanisms are explained (Maciocia, 2005). In TCM, the forces of nature are described in 
terms of yin, yang, qi, and the five phases (Switala, 2008). In cases where these forces are 
not in harmony, disease occurs (Switala, 2008). TCM offers theories and mechanisms based 
on these theories that describe how one can return harmony within and between people 
and between them and the world around them (Switala, 2008). Because these theories are 
difficult to measure, modern science has been searching for biological mechanisms behind 
acupuncture (Beissner, Deichmann, Henke, & Bär, 2012) that can be measured, tested, and 
observed. What do these studies reveal? To which extend does acupuncture appear to be a 
feasible non-pharmacological clinical intervention in patients with depression and 
schizophrenia? What might its measurable and observable underlying working mechanisms 
be? In order to address these questions, the use of acupuncture as an add-on treatment in 
patients with depression and schizophrenia is reviewed in this paper, and competing 
theoretical paradigms are discussed. 
 
METHODS 
 
Database and search strategies 
Four databases (Medline, Scopus, ERIC, and the Cochrane Library) (Xiong, Liu, Yang, Feng, & 
Wang, 2014; Zeng, Luo, Xie, Huang, & Cheng, 2014) were searched with a cut-off date of 
March 31, 2014, and all papers with at least an abstract in English were included (Franconi, 
Manni, Schröder, Marchetti, & Robinson, 2013). Systematic reviews and meta-analyses on 
acupuncture treatment for depression and schizophrenia were considered for inclusion. 
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Because of the scarcity of research on the use of acupuncture to treat schizophrenia, 
randomized controlled trials (RCTs) and clinical case studies in addition to the systematic 
reviews and the meta-analyses, were also included in order to illustrate what had been 
found so far and what would be needed in future research to be able to eventually draw firm 
conclusions on the effectiveness of acupuncture in treating this group of patients. Only 
studies that used manual acupuncture were included in order to be able to compare the 
results; therefore, studies with other modalities, for instance electro-acupuncture (An, Chen, 
Ren, & Wu, 2014), laser-acupuncture (Glazov, Yelland, & Emery, 2014), or acupressure (Yeh, 
Morone, & Chien, 2014), were excluded. 
 
Study selection and data extraction 
Two authors (P. Bosch and H. Staudte) independently conducted the literature search in the 
different databases. The study selection and data extraction were also independently 
performed by two authors (P. Bosch and M. Van den Noort). The extracted data included the 
authors, the title of study, the journal in which the study had been published, the year of 
publication, the number of participants, methodological information of the study, the 
treatment process, the details of the control interventions (if any), and finally, the effects of 
acupuncture treatment and conclusions. A third party (S. Lim) was contacted in case of 
disagreement with respect to the study selection and/ or data extraction; in all cases 
consensus was reached. 
 
Aims 
The primary aim of this study was to evaluate the effects of acupuncture treatment for 
patients with depression or schizophrenia through a systematic review. The secondary aim 
was to evaluate possible working mechanisms underlying acupuncture, again through a 
systematic review. 
 
RESULTS 
 
Acupuncture treatment studies on depression 
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Table 1.  
Overview of Systematic Reviews and Meta-Analyses on Acupuncture Treatment in 
Depression: the Year the Study Was Conducted, the Numbers and Kinds of Studies Included, 
the Type of Paper, and the Conclusions that Were Drawn 
Study Year Numbers and kinds of 
studies included 
Type of paper/Conclusions 
Jorm, Christensen, 
Griffiths, & Rodgers 
2002 5 Controlled trials Systematic review: The authors state that 
acupuncture appears promising in the 
treatment of depression, but more research 
is needed. 
Smith & Hay 2005 7 RCTsa Systematic review and meta-analysis: The 
authors conclude that there is lacking 
evidence for the efficiency of acupuncture in 
treating depression in comparison with 
medication, wait list control, or sham 
acupuncture. Moreover, the qualities of the 
study designs are poor, and the sample sizes 
are small. 
Leo & Ligot 2007 9 RCTs Systematic review: The authors conclude 
that it is too premature to suggest a role for 
acupuncture in the treatment of depression; 
the evidence thus far is inconclusive. 
Wang et al. 2008 8 RCTs Meta-analysis: First, this meta-analysis 
shows that the quality of individual trials is 
low. Nevertheless, it is concluded that 
acupuncture is an effective treatment for 
depression. 
Zhang, Chen, Yip, NG, & 
Wong 
2010 207 studies Systematic review and meta-analysis: 
Acupuncture therapy is safe and effective in 
treating major depressive disorders and 
post-stroke depression, and can be 
considered as an alternative treatment for 
the two disorders. 
Smith, Hay, & 
MacPherson 
2010 30 studies Systematic review and meta-analysis: The 
authors conclude that there is insufficient 
evidence to use acupuncture treatment for 
depression. In addition, they state that the 
results should be taken with caution 
because there is a high risk of bias in the 
majority of the trials. 
Wu, Yeung, Schnyer, 
Wang, & Mischoulon 
2012 Not reported Systematic review: The authors conclude 
that acupuncture is a potential effective 
monotherapy for depression, and a safe, 
well-tolerated add-on treatment besides 
antidepressants. However, more, well-
designed studies are needed. 
Note. a RCT = Randomized controlled trial. 
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In Table 1, an overview is given for the selected systematic reviews and meta-analyses on 
the use of acupuncture for treating depression. In total, seven studies fulfilled our inclusion 
criteria. The overall results on using acupuncture to treat depression seem promising; 
acupuncture was found to be an effective and safe therapy in treating major depressive 
disorder (Wang et al., 2008; Zhang et al., 2010). Moreover, it could be used as a safe and 
well-tolerated add-on treatment besides antidepressants (Wu et al., 2012). However, 
caution is required (Smith et al., 2010). For instance, Leo and Ligot (2007) draw the 
conclusion that the effectiveness of acupuncture as a treatment for depression remains 
unproven and is too premature because more and larger methodologically better-designed 
Western studies on acupuncture and depression are needed (Wu et al., 2012). 
 
Acupuncture treatment studies on schizophrenia 
 
Table 2.  
Overview of Systematic Reviews and Meta-Analyses on Acupuncture Treatment in 
Schizophrenia: the Year the Study Was Conducted, the Numbers and Kinds of Studies 
Included, the Type of Paper, and the Conclusions that Were Drawn 
Study Year Numbers and kinds of 
studies included 
Type of paper/Conclusions 
Rathbone & Xia 2005 5 RCTsa Systematic review and meta-analysis: The 
authors state that there is insufficient 
evidence to recommend the use of 
acupuncture to treat patients with 
schizophrenia based on the studies so far. 
However, more and better-designed studies 
on larger sample sizes are needed in order 
to draw firm conclusions. 
Bloch et al. 2010 2 studies Systematic review and case study reports: 
The authors report that sleep improved 
after acupuncture treatment in patients 
with schizophrenia. In addition, the patients 
with schizophrenia showed less anxiety and 
a better mood after acupuncture therapy. 
Note. a RCT = Randomized controlled trial. 
 
As can be seen in Table 2, in total, two recent systematic reviews and meta-analyses on 
acupuncture treatment for patients with schizophrenia fulfilled our inclusion criteria (Bloch 
et al., 2010; Rathbone & Xia, 2005). The reason for this low number is that until now, only a 
few clinical studies have been conducted involving both acupuncture and schizophrenia. In 
the study by Bloch and colleagues (2010), sleep was found to have been improved after 
acupuncture treatment in patients with schizophrenia; moreover, the patients with 
schizophrenia show less anxiety and an improved mood after acupuncture therapy. In their 
study, Rathbone and Xia (2005) found limited evidence for the effectiveness of acupuncture 
-178- 
in treating the symptoms of schizophrenia. However, all authors state that more and better-
designed studies on larger sample sizes are needed in order to draw firm conclusions (Bloch 
et al., 2010; Rathbone & Xia, 2005). In addition to the systematic reviews and meta-analyses, 
only 4 clinical trial studies (see Table 3a), of which 3 are recent Western studies (Bosch et al., 
2013; Bouhlel et al. 2011; Reshef et al., 2013; Wu & Bi, 2004; Xu, Su, & Wang, 2010), and 9 
are case reports (Bosch, Staudte, Van den Noort, & Lim, 2014; Kane & Di Scipio, 1979; 
Ronan, Robinson, Harbinson, & Macinnes, 2011; Shi, 1988, 1989; Shi & Tan, 1986; Tani, 
Suzuki, Takada, Yagyu, & Kinoshita, 2005; Zhang, 1988) (see Table 3b) were found. 
 
Table 3a.  
Clinical Trial Studies on Acupuncture Treatment and Schizophrenia: the Year the Study Was 
Conducted, the Number of Participants, the Kind of Study, and the Conclusions That Can Be 
Drawn 
Study Year Number of 
participants 
Kind of study/Conclusions 
Xu et al. 2010 n = 60 Randomized trial: The authors report that the 
combined therapy of three-step acupuncture 
and a small dose of antipsychotics show the 
same efficacy as a full dose of antipsychotics. 
However, the initiation time is shorter and 
there are fewer side effects than with a full-
dose antipsychotic treatment. 
Bouhlel et al. 2011 n = 31 Randomized trial: The scores on the Positive 
and Negative Syndrome Scale (Kay, Fiszbein, & 
Opler, 1987), the Scale for the Assessment of 
Negative Symptoms (Andreasen, 1984a), and 
the Scale for the Assessment of Positive 
Symptoms (Andreasen, 1984b) did not change 
after acupuncture treatment. Thus, no 
evidence was found for the effectiveness of 
acupuncture in treating schizophrenic 
symptoms. 
Bosch et al. 2013 n = 16 Pilot study: The effectiveness of the 
acupuncture treatment was found to be 
higher for schizophrenia than for depression. 
The authors conclude that acupuncture seems 
able to improve sleep and may be a suitable 
and cost-effective add-on treatment for 
patients with schizophrenia. 
Reshef et al. 2013 n = 20 Pilot study: The conclusion of the study is that 
the overall findings suggest that acupuncture 
has positive effects for treating the symptoms 
of insomnia and psychopathology in patients 
with schizophrenia. 
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So far, the overall results of these clinical trials and case studies have provided limited 
evidence for the effectiveness of acupuncture in treating the symptoms of schizophrenia 
(Bouhlel et al. 2011). Nevertheless, in some studies, positive results in the treatment of 
hallucinations with acupuncture have been reported (Shi, 1988, 1989). In several studies, the 
hallucinations entirely disappeared (Wu & Bi, 2004; Zhang, 1988) or decreased (Wu & Bi, 
2004; Zhang, 1988) whereas in another study, the severity of the hallucination decreased 
(Bosch et al., 2014), and the patient felt less disturbed (see Table 3b). Here, it is important to 
note that with respect to the studies conducted on ethnic Chinese patients suffering from 
hallucinations (Shi, 1988, 1989; Wu & Bi, 2004; Zhang, 1988), the possibility that group 
expectations might have influenced the positive treatment results for those patients cannot 
be excluded. However, several studies have indicated that not only the quality of sleep but 
also the quality of life seemed to be improved in patients with schizophrenia (Bosch et al., 
2013, 2014; Reshef et al., 2013) as a result of acupuncture treatment. Tani and colleagues 
(2005), for instance, found a positive effect when using acupuncture therapy to treat the 
side effects of long-time drug use in a patient with chronic schizophrenia. Acupuncture had a 
positive effect when used to treat tardive dystonia, including axial dystonia; the posture of 
the neck and body improved, and the involuntary movement disappeared completely. 
Moreover, Xu and colleagues (2010) found that a combined therapy of acupuncture and 
small doses of antipsychotics showed an efficacy equal to that for therapy using full doses of 
antipsychotics, but the former was found to have several important advantages: the 
initiation time was shorter and there were fewer side effects. However, it is important to 
note that the results of the systematic reviews, as well as comparative and case studies, 
should be interpreted with caution and that more, larger, and methodologically-sound 
studies on acupuncture and schizophrenia are needed (Rathbone & Xia, 2005) before any 
firm conclusions on the (possible) positive effect of acupuncture in treating patients with 
schizophrenia can be drawn. 
 
Table 3b.  
Clinical Case Studies on Acupuncture Treatment and Schizophrenia: the Year the Study Was 
Conducted, the Number of Participants, and the Conclusions That Can Be Drawn 
Study Year Number of 
participants 
Kind of study/Conclusions 
Kane & Di Scipio 1979 n = 3 Case study: Two patients who had had florid 
schizophrenic symptoms responded positively 
to acupuncture treatment whereas a third 
patient, whose symptoms were primarily 
affective-depressive, showed no significant 
effect. 
Shi & Tan 1986 n = 500 Case study: The authors report that in their 
study, 275 patients with schizophrenia were 
cured after acupuncture treatment, 84 
patients had remarkable improvement, 83 
patients had some improvement, and 58 
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patients had no improvement. 
Shi 1988 n = 120 Case study: Therapeutic effects in the 
treatment of hallucinations with (auricular) 
acupuncture are reported. The author 
recommends the use of (auricular) 
acupuncture in the treatment of 
hallucinations. 
Zhang 1988 n = 296 Case study: This study shows that 209 patients 
with schizophrenia were hallucination free 
after (scalp) acupuncture treatment, in 56 
patients, the hallucinations became indistinct 
(with stable effects), in 19 patients, there was 
a partial disappearance or obscurity of one or 
several kinds of hallucinations (but these 
effects were unstable), and finally, in 12 
patients, the (scalp) acupuncture was 
ineffective. 
Shi 1989 n = 120 Case study: The authors report curative 
effects in treating auditory hallucinations with 
(auricular) acupuncture therapy. The authors 
recommend the use of (auricular) 
acupuncture in the treatment of auditory 
hallucinations. 
Wu & Bi 2004 n = 11 Case study: The authors report that in 4 
patients with schizophrenia, the auditory 
hallucinations disappeared, in 5 patients, the 
number of auditory hallucinations decreased, 
and in 2 patients, there was no effect. They 
concluded that a combination of acupuncture 
and pharmacotherapy in the treatment of 
auditory hallucinations results in marked 
therapeutic effects. 
Tani et al. 2005 n = 1 Case study: The authors report improved 
symptoms and more stability with regard to 
the symptoms in a patient with schizophrenia 
(suffering from severe axial dystonia) after 
acupuncture treatment. They concluded that 
acupuncture therapy has a positive effect on 
tardive dystonia, including axial dystonia. 
Ronan et al. 2011 n = 11 Case study: The patients diagnosed with 
schizophrenia seemed to benefit from 
acupuncture treatment as an add-on 
treatment (in addition to Western medicine). 
Bosch et al. 2014 n = 1 Case study: The authors conclude that 
although larger clinical intervention studies on 
acupuncture and schizophrenia are needed, 
their case study results indicate that 
acupuncture might be beneficial as an add-on 
treatment for patients with schizophrenia. 
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Sleep-ameliorating effects in depression and schizophrenia 
One underlying mechanism of acupuncture when used to treat patients with schizophrenia 
and depression that was found seems to be an indirect one, namely, the improvement of 
sleep (Bloch et al., 2010; Bosch et al., 2013, 2014; Reshef et al., 2013). Bosch and colleagues 
(2013) found a significant improvement of sleep quality, as measured by using The 
Pittsburgh Sleep Quality Index (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989), after 
acupuncture treatment in both patients with depression and patients with schizophrenia 
(Bosch et al., 2013). Moreover, with objective sleep measures (actigraphs), Reshef and 
colleagues (2013) found that acupuncture treatment enabled patients with schizophrenia or 
schizoaffective disorder to fall asleep faster and to sleep better, with less time awake during 
the night and with reduced activity levels while sleeping. Overall, the sleep of patients with 
schizophrenia or schizoaffective disorder was found to be better after acupuncture 
treatment (Reshef et al., 2013). An improvement of sleep was also reported in a recent case 
study (Bosch et al., 2014); less daytime sleepiness was found after acupuncture treatment in 
a patient with chronic schizophrenia, as measured with the Epworth Sleepiness Scale (Johns, 
1991). 
 
Improvement of emotional processing and mood 
Another mechanism of acupuncture when treating patients with schizophrenia and 
depression that was found in the present systematic review seems to be related to emotions 
and to mood in particular. For instance, in a meta-analysis by Wang and colleagues (2008), a 
reduction of depressive symptoms (assessed with the Beck Depression Inventory (Beck, 
Steer, & Brown, 1996) and the Hamilton Rating Scale for Depression (Hamilton, 1967)) was 
found after acupuncture therapy in patients with depression. Moreover, Bloch and 
colleagues (2010) found less anxiety and a better mood after acupuncture therapy in 
patients with schizophrenia. The same pattern was also found in a recent case study (Bosch 
et al., 2014), where the patient with schizophrenia was less depressed (measured by using 
the Beck Depression Inventory (Beck et al., 1996)) after acupuncture treatment. 
 
DISCUSSION 
 
Although more, larger studies involving acupuncture and schizophrenia (Rathbone & Xia, 
2005) and acupuncture and depression (Zhang et al., 2010) are needed in order to better 
understand the effects of acupuncture in these patient groups, the results so far seem to 
support the idea that one underlying mechanism of acupuncture for treating schizophrenia, 
as well as in depression, is an indirect one, namely, improved quality of sleep (Bloch et al., 
2010; Bosch et al., 2013, 2014; Reshef et al., 2013). A well-known fact is that in patients with 
depression (Nutt, Wilson, & Paterson, 2008), sleep disorders occur, but in patients with 
schizophrenia, they are often under-estimated (Bosch et al., 2012). Marked disturbances of 
sleep have been found in both patients with depression (Ebdlahad et al., 2013; Modell & 
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Lauer, 2007; Palagini, Baglioni, Ciapparelli, Gemignani, & Riemann, 2013) and patients with 
schizophrenia (Afonso, Brissos, Cañas, Bobes, & Bernardo-Fernandez, 2014; Cohrs, 2008; 
Monti & Monti, 2004). They cause huge distress, they can have an extensive impact on the 
quality of life (Brissos et al., 2013), and they strongly increase the risk of suicide (Nutt et al., 
2008). Importantly, psychiatric outpatients reporting sleep disturbance were found to show 
greater symptom severity and worse adherence/compliance to treatment (Afonso et al., 
2014). Prevous sleep research showed a relation between sleep and cognitive functioning; a 
decrease in sleep had a significantly negative effect on a wide variety of cognitive functions, 
such as attention, language, reasoning, decision making, learning, and memory (Diekelmann, 
2014). Therefore, it seems logical that when patients sleep better as a result of the 
acupuncture treatment, their cognitive functioning improves; moreover, if their sleep 
becomes normal, they start to feel better (Wrzus, Wagner, & Riediger, 2014), thereby 
improving health-related quality of life (Roeser, Eichholz, Schwerdtle, Schlarb, & Kübler, 
2012). 
A second mechanism of acupuncture when used to treat patients with schizophrenia 
and depression that was found in the present systematic review seems to be related to 
emotions and to mood in particular. A reduction of depressive symptoms was found after 
acupuncture therapy in patients with depression (Wang et al., 2008). Moreover, less anxiety 
and a better mood were found after acupuncture therapy in patients with schizophrenia 
(Bloch et al., 2010; Bosch et al., 2014). From previous research, disturbances in the detection 
of, the response to, and the interpretation of emotions are known to be common in many 
forms of psychopathologies (Monk, 2008), particularly depression (Gotlib, Krasnoperova, 
Yue, & Joormann, 2004; Koster, De Raedt, Goeleven, Franck, & Crombez, 2005; Linden, 
Jackson, Subramanian, Healy, & Linden, 2011; Yang et al., 2011) and in schizophrenia 
(Anticevic & Corlett, 2012; Anticevic, Repovs, & Barch, 2012; Herbener, Song, Khine, & 
Sweeney, 2008; Kring & Moran, 2008). These problems are a major cause of persistent 
functional disability (Herbener et al., 2008). The results of the present systematic review 
seem to indicate that acupuncture is able to improve mood and emotional processing in 
patients with depression and schizophrenia; however, it is important to keep in mind that 
these are preliminary findings based on only the few acupuncture studies so far assessing 
changes in mood. 
These two mechanisms, related to sleep and emotion, seem to be promising in 
explaining the positive effects of acupuncture treatment that are found, particularly, in 
patients with depression (MacPherson et al., 2013) and, to a lesser degree, in patients with 
schizophrenia (Bosch & Van den Noort, 2008) and seem to imply an overall improvement in 
the quality of life. Although it is too premature to draw any firm conclusions, one interesting 
hypothesis that needs further investigation is that both acupuncture treatment mechanisms 
might be based upon and be explained by the “limbic-paralimbic-neocortical network” 
(LPNN) (Hui, Marina, Liu, Rosen, & Kwong, 2010), as we will discuss in the next session on 
brain research. 
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Results of brain research on acupuncture 
How do the clinical acupuncture results in patients with depression and schizophrenia that 
were found in the present systematic review relate to results obtained from brain research? 
If effects of acupuncture treatment are obvious in patients with depression and 
schizophrenia, then an interesting follow-up question is whether these clinical effects might 
be explained with existing brain theories and existing results from brain research involving 
acupuncture. 
Previous neuroscience research found evidence for the existence of a so-called default 
mode network (DMN) (Buckner, Andrews-Hanna, & Schacter, 2008; Gusnard & Raichle, 
2001; Neuner et al., 2014; Raichle et al., 2001; Raichle & Snyder, 2007), which is a system of 
brain regions that is activated during rest or during passive viewing tasks, but is deactivated 
when cognitive tasks are performed (Buckner et al., 2008; Gusnard & Raichle, 2001; Raichle 
et al., 2001). Important components of this network are related to the anterior medial 
prefrontal area, with a special role for the anterior cingulate gyrus and the 
precuneus/posterior cingulate cortex posteriorly. 
Alterations of the DMN have been found in patients with depression (Andreescu et al., 
2013; Wu et al., 2011). In widely-distributed elements of the DMN (e.g., anterior cingulate, 
lateral parietal cortex, lateral temporal cortex, and ventromedial prefrontal cortex), patients 
with depression, but not healthy control participants, were found to be unable to reduce 
activity during an experimental task that included observing and reappraising negative 
pictures (Sheline et al., 2009). Moreover, significantly greater increases in the activities in 
other DMN regions, such as the amygdala, hippocampus, and parahippocampus, were found 
in patients with depression compared to healthy control participants (Sheline et al., 2009). In 
sum, the pathophysiology of depression is characterized by both stimulus-induced 
heightened activity and a failure to normally down-regulate activity broadly within the DMN 
(Sheline et al., 2009). 
In addition, there is accumulating evidence of DMN dysfunction in schizophrenia as well 
(Mingoia et al., 2012; Salgado-Pineda et al., 2011). For instance, a failure of deactivation in 
the DMN was found in an experiment with facial-emotional items (Salgado-Pineda et al., 
2011). Moreover, evidence was found for structural changes in the brain regions of the DMN 
in patients with schizophrenia (Camchong, MacDonald, Bell, Mueller, & Lim, 2011; Pomarol-
Clotet et al., 2010). Finally, it has been suggested that dysfunctional interactions between 
fronto-parietal control systems and the DMN might explain a psychosis. In other words, 
psychosis is a network disturbance that leads to disordered thought because it disrupts the 
fragile balance between the DMN and competing brain systems (Buckner, 2013). In sum, 
although it is too premature to draw any firm conclusions yet, the general findings on the 
DMN and schizophrenia seem to be able to explain at least some of the positive and the 
negative symptoms that are typical for patients with schizophrenia (Mingoia et al., 2012). 
Interestingly (see also Figure 1), previous brain imaging research has revealed that the 
so-called LPNN (Fang et al., 2009; Hui et al., 2005, 2009), consisting of the amygdala (Bai et 
al., 2009; Chae et al., 2013; Dhond, Yeh, Park, Kettner, & Napadow, 2008), the hypothalamus 
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(Hui et al., 2010), and the DMN (Bai et al., 2009; Dhond et al., 2008; You et al., 2013), 
thereby encompassing the limbic system (Hui et al., 2010), is affected in response to 
acupuncture. More precisely, Hui and colleagues showed that sensations constituting deqi 
(the feeling or sensation that is described in TCM as important for effectivity of the 
treatment) are related to decreased brain activity in the limbic system and in the DMN 
whereas sharp pain is related to signal increases (Hui et al., 2010). Note that the 
hypothalamus is known to play a key role not only in the regulation of sleep and wakefulness 
(Saper, Chou, & Scammell, 2001), but also in the control of pain (Melzack & Katz, 2013). 
Within the neuromatrix of pain, a genetic component and a neural-hormonal mechanism of 
stress, which play equally important roles as neural mechanisms of sensory transmission, are 
described (Melzack & Katz, 2013). In cases of injury, the neuromatrix of pain states that the 
body uses several programs of neural, hormonal, and behavior activity in order to turn back 
to homeostasis (Melzack & Katz, 2013). Previous research showed that acupuncture had a 
modulating and normalizing effect on the hypothalamus (Hui et al., 2010), which fits the 
neuromatrix theory of pain (Melzack & Katz, 2013) and seems to support the bodily function 
of reinstalling homeostasis. 
 
 
Figure 1. A brain sketch of the amygdala, hypothalamus, and thalamus, which are part of the 
LPNN (Hui et al., 2009) and are suggested to play key roles in the acupuncture treatment of 
patients with schizophrenia and depression. The functionally anti-correlated task-positive 
areas in response to acupuncture are presented in red whereas the anti-correlated task-
negative areas are presented in blue (Hui et al., 2009). Note that, in general, treatment 
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resulting in deqi is related to decreased brain activity in the limbic system and in the DMN 
whereas sharp pain is related to signal increases (Hui et al., 2010). 
 
Another acupuncture treatment mechanism is related to the LPNN (see also Figure 1) (Fang 
et al., 2009; Hui et al., 2005, 2009, 2010). From previous research, the limbic system is 
known to play a key role in emotions (Phan, Wager, Taylor, & Liberzon, 2002). If 
acupuncture, indeed, influences this network, that would explain its influence on emotions. 
The amygdala, for instance, was found to play a role in encoding positive and negative 
emotions (Fernando, Murray, & Milton, 2013; Koelsch et al., 2013). Evidence indicates that 
the limbic system and the structures within the prefrontal cortex show structural and 
functional alterations in different types of psychopathologies, including schizophrenia and 
depression (Monk, 2008). It is important to note that not only patients with depression but 
also many patients with schizophrenia suffer from depressive symptoms (Buckley, Miller, 
Lehrer, & Castle, 2009). Acupuncture seems to have a modulating and a normalizing effect 
on the limbic system (Hui et al., 2000), including the amygdala (Bai et al., 2009; Dhond et al., 
2008), and a consequence would be that it influences emotions as well. 
 
Limitations 
Naturally, the present systematic review has several limitations. The first limitation is the use 
of only literature published in English. In the present study, all papers with at least an 
abstract in English were included (Franconi et al., 2013). Although focusing only on literature 
published in English is not uncommon for review papers on acupuncture (Franconi et al., 
2013), this might have narrowed the view. Moreover, only studies that used manual 
acupuncture were included in our systematic review whereas other modalities, for instance 
electro-acupuncture (An et al., 2014), laser-acupuncture (Glazov et al., 2014), or acupressure 
(Yeh et al., 2014), were excluded. There was a methodological reason for this; we wanted to 
be able to compare the results of different clinical studies, and comparing different 
modalities would complicate that. However, it is important to note that valid clinical 
research involving electro-acupuncture, laser-acupuncture, and acupressure for the 
treatment of depression and schizophrenia has been conducted as well. For instance, recent 
research with electro-acupuncture showed that it was effective for treating depression and 
affected personality traits (Wang et al., 2013); moreover, research has indicated that 
electro-acupuncture might provide improvement in auditory hallucinations and positive 
symptoms in individuals suffering from schizophrenia (Cheng et al., 2009). Laser acupuncture 
was found to reduce symptoms of depression that could be measured objectively (Quah-
Smith, Smith, Crawford, & Russell, 2013). Not much (recent) research has been conducted 
with laser acupuncture for treating schizophrenia; however, in an older study, Zhang found 
that laser acupuncture was as effective as chlorpromazine in the treatment of schizophrenia 
(Zhang, 1991). Finally, acupressure research showed a significant decrease of depression 
symptoms (Bergmann et al., 2014), but no significant improvements were found in patients 
with schizophrenia (Ching, Wu, Chen, & Hsieh, 2012). 
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In addition, the studies on depression and schizophrenia so far often lack a thorough 
methodology, and larger groups are needed in order to prove the presumed mechanisms 
underlying acupuncture treatment and/or to come to alternative explanations. Moreover, 
the interpretation of the acupuncture findings on depression and schizophrenia so far is 
challenging because the neurobiology of psychiatric disorders has yet to be fully elucidated 
(Pilkington, 2013). Moreover, limitations arise from the fact that there are several pitfalls in 
conducting clinical studies on the effectiveness of acupuncture treatment for patients with 
depression and, particularly, for patients with schizophrenia. These limitations can explain 
why so few clinical studies on acupuncture for the treatment of schizophrenia have been 
conducted and published in Western scientific journals so far. 
Another limitation is the absence of a suitable control group or placebo (Wang et al., 
2008). Often researchers decide to investigate the “normal” or “real-world” manual 
individualized acupuncture treatment that a patient would receive if they visited an Oriental 
medical practitioner (Bosch et al., 2013). However, nonstandardized acupuncture treatment 
(Chen, 2010), with acupuncture points selected on the basis of traditional practice and 
theory, makes it hard to draw firm scientific conclusions because the patients, groups, 
treatments, and studies are hard to compare and data cannot be generalized. On the other 
hand, the use of a standardized protocol for acupuncture (Cui, Wu, & Luo, 2008) in the 
treatment of depression or schizophrenia is unheard of in clinical TCM practice and would 
not be generalizable to routine clinical practice (Schroer & Adamson, 2011). Moreover, 
evaluating care that is not credible to the patients or the practitioners would result in study 
findings with low external validity; thus, it would widen the gap between scientific evidence 
and daily practice, thereby possibly underestimating the potential value or harm of 
acupuncture intervention (Schroer, Kanaan, MacPherson, & Adamson, 2012). 
Another problem for acupuncture research on depression and schizophrenia is that the 
patients are on different kinds of prescribed drugs and use different doses (Weinbrenner et 
al., 2009). Particularly, in schizophrenia, this is a huge problem because these patients often 
use a wide spectrum of medication that can differ from patient to patient and can change 
over time (Ren et al., 2002). For ethical reasons, controlling the medications is impossible. 
When thinking about the different illness patterns from a TCM (theoretical) point of 
view, every patient is different, and it seems logical that some patterns might be treated 
more easily than others (which is one reason TCM uses individualized treatment and not a 
standardized treatment) (Zhang, Sun, Wang, Han, & Wang, 2012). Results might, therefore, 
be different between these heterogenic patient groups. 
Finally, limitations also arise from the fact that many acupuncture studies suffer from 
small sample sizes (Pilkington, 2010). In daily practice, recruiting large samples of patients 
with depression and schizophrenia from a clinic is often not possible (Patel, Doku, & 
Tennakoon, 2003). A solution to this problem might be the use of multicenter studies 
(Messerer, Porzsolt, Hasford, & Neiss, 1987), which are not uncommon in medicine (Alcolea 
et al., 2014; López et al., 2004; Reid et al., 2011), but they do have some pitfalls of their own 
(Messerer et al., 1987); for instance, they create even more heterogeneity (adding a cultural 
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factor) and add possible treatment differences when it comes to atmosphere, structures of 
the clinic, etc. 
 
Future research 
In future research, it will be important to conduct well-designed acupuncture studies using 
randomized controlled trials involving patients with depression and schizophrenia in which 
the subjective experiences of the patients are measured, the impressions of the patients’ 
psychiatrists/therapists are measured, and, at the same time, more objective measurements 
are implemented in the study design. With respect to the subjective experiences of the 
patients, one could think of the use of sleep diaries (Hughes et al., 2009), the Pittsburgh 
Sleep Quality Index (Buysse et al., 1989), the Beck Depression Inventory (Beck et al., 1996), 
the Hamilton Rating Scale for Depression (Hamilton, 1967), etc.; these are instruments that 
have been used in acupuncture research before (Bosch et al., 2014; Reshef et al., 2013; 
Wang et al., 2008) and are filled in by the patients themselves. Moreover, with respect to 
the instruments that are filled in by the patients’ psychiatrists/therapists, one could think of 
the Positive and Negative Syndrome Scale (Kay et al., 1987), the Scale for the Assessment of 
Negative Symptoms (Andreasen, 1984a), and the Scale for the Assessment of Positive 
Symptoms (Andreasen, 1984b) as were, for instance, previously used by Bhoulel and 
colleagues (2011). The collection of more reliable data with instruments that have been used 
in acupuncture studies before is particularly important to collect more comparable data on 
the patients’ subjective impressions of the effects of acupuncture treatment and on the 
psychiatrists/therapists evaluation of its effectiveness. However, in addition, it is important 
to implement more objective instruments and experimental tasks in future studies in order 
to reliably measure the effectiveness of and the working mechanisms behind acupuncture 
therapy. Here, one could think of the use of actigraphs, as was recently used by Reshef and 
colleagues (2013), the monitoring of sleep with an electroencephalogram (Steiger & Kimura, 
2010), and electroencephalogram and functional magnetic resonance imaging studies with 
experimental tasks on the processing of emotions, for instance, emotion judgment tasks of 
faces and words (Frühholz, Jellinghaus, & Herrmann, 2011; Lee et al., 2014). 
 
Conclusion 
In this systematic literature review, only limited evidence was found for the effectiveness of 
acupuncture in treating the symptoms of schizophrenia, but the results for depression were 
more promising, showing that acupuncture was an effective and safe therapy in treating 
major depressive disorders. Particularly, the qualities of sleep and life (involving emotions) in 
patients with depression and schizophrenia were found to be improved after acupuncture 
treatment. Acupuncture seems to be related to the LPNN, including the DMN, which is 
known to be affected in response to acupuncture and on which acupuncture has been found 
to have a modulating and normalizing effect. Due to its presumed effect on this network, 
acupuncture can be expected to improve sleep and to modulate and normalize emotions, 
which validates future research involving patients with depression and schizophrenia. 
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Chapter 10 
 
General Discussion 
 
Discussion 
In allopathic medicine, several methods are used in the treatment of schizophrenia and 
depression. These methods vary from pharmacological interventions (Kane & Correll, 2010; 
Kupfer, 2005), psycho-social therapy (Cuijpers et al., 2013; Dickerson & Lehman, 2006; 
Roder, Mueller, & Schmidt, 2011; Wolf & Hopko, 2008), and electroconvulsive therapy 
(Wang, Lin, Chiu, & Tseng, 2013) for both schizophrenia and depression to light therapy for 
depression (Lieverse et al., 2011; Oldham & Ciraulo, 2014). Since the mid-nineties of the last 
century, complementary and alternative medicine (CAM), including acupuncture (Yeo et al., 
2012) has increasingly been used as an add-on treatment to Western medicine (Eisenberg et 
al., 1998), particularly among patients with psychiatric disorders (Deligiannidis & Freeman, 
2014; Samuels, Gropp, Singer, & Oberbaum, 2008); in particular, patients with depression 
often seek CAM treatments (Kessler et al., 2001). Interestingly, along with the increase of 
add-on treatments that are sought by patients, more and more research has been 
conducted on acupuncture (Lu, Dean-Clower, Doherty-Gilman, & Rosenthal, 2008). At the 
beginning of this project, a custom in this research field was to use the abbreviation CAM for 
complementary and alternative medicine, stressing its difference from Western or allopathic 
Medicine. Lately, developments and changes in this research field have led to a new name: 
“integrative medicine”. The abbreviation CAM is being used less and less because 
researchers now tend to stress their goal of striving for an integrative treatment that uses 
the best of all medicines possible (Rakel, 2012) and to call it as such. The optimal goal for an 
integrative treatment would be the use of both allopathic medicine and that which was 
formerly called CAM at one center. 
 
Traditional Chinese medicine (TCM), as part of integrative medicine, has its own theoretical 
(philosophical) background based on which its mechanisms can be explained (Maciocia, 
2005). In TCM, the forces of nature are described in terms of Yin, Yang, Qi, and the Five 
Elements (Switala, 2008). In cases where these forces are not in harmony, disease occurs 
(Switala, 2008). TCM offers theories and mechanisms based on these forces that describe 
how one can return harmony within and between people and between people and the world 
around them (Switala, 2008). Because these theories are difficult to measure objectively by 
using techniques that are available nowadays, modern science has been searching for 
biological mechanisms behind acupuncture (Beissner, Deichmann, Henke, & Bär, 2012) that 
can be measured, tested, and observed. In the case of schizophrenia, the current Ph.D. 
research is one of the first studies to use acupuncture outside Asia. The research presented 
in this thesis describes the patient groups at risk: Patients with long-term schizophrenia or 
depression. Moreover, this project investigated whether acupuncture could be used as an 
add-on clinical intervention in these psychiatric populations. Because both patient groups 
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suffer from sleep disorders and a treatment thereof would have a positive influence on their 
overall well-being (Benson et al., 1991; Benson, 2006, Buysse et al., 2008), sleep disorders 
are the focus of this project. 
 
First, the sleep behavior and the sleep problems of these long-term psychiatric patients were 
studied along with their psychopathology and personality. Because acupuncture is thought 
to be an overall treatment for the patient, in acupuncture, treating only the patients’ sleep 
disorders or only their psychopathologies is not a viable approach. Acupuncture is thought to 
reestablish equilibrium, which causes the body to move back towards health, thereby 
minimizing the patients’ complaints about their well-being (Gao, 1982). As a result of the 
suggested improved sleep and decreased psychopathology of the psychiatric patients, 
improved cognitive functioning would be expected. Therefore, the four main questions in 
this research were as follows: 1) What possible problems in sleep, psychopathology, and 
working memory performance can be found in a population of patients with long-term 
schizophrenia and patients with depression? 2) Does acupuncture improve the patients’ 
sleep? 3) Does acupuncture decrease the patients’ psychopathology? 4) Does acupuncture 
improve the patients’ working memory performance? 
 
One modality of acupuncture was used throughout all acupuncture studies in this research: 
manual acupuncture based upon TCM treatment principles. At every treatment session, a 
(tongue and pulse) diagnosis was conducted, and acupuncture points were chosen 
accordingly. Needles were inserted (according to TCM principles when it comes to the depth 
of insertion) aiming at a De qi sensation (an electrical or tingling sensation, also described as 
“sweet pain”, that is thought to be a sign of therapeutic effect) and were left in place for one 
hour. All patients were treated once a week for 12 weeks. No other interventions were 
administered, although the patients’ usual treatments were continued. Patients were 
treated in a group and every 15 minutes, two new patients arrived and sat in “rest chairs” 
that made it possible to sit or lie down as the patient wished. Diagnosis was conducted and 
the patients were then treated. Due to the group-wise treatment, the two practitioners that 
were present were always in sight of the patients, and interaction was instantly possible. 
This group-wise setting was required by the ethics committee, the members of which were 
concerned about the thought that patients with schizophrenia might respond nervously or 
even paranoid to needles being inserted and then being left alone for one hour. In this 
research, patients with schizophrenia and depression were randomly assigned to either a 
waiting-list group or a treatment group. 
 
Main Findings 
In the first study (Chapter 2), the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) 
(Butcher, Graham, Ben-Porath, Tellegen, Dahlstrom, & Kaemmer, 2001) was used in order to 
characterize the patients with schizophrenia and depression and to measure the quality of 
their ability to function. The results showed that patients with schizophrenia differed from 
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patients with depression on 14 MMPI-2 scales. In general, patients with schizophrenia 
scored lower on the MMPI-2 scales than the patients with depression, meaning that they 
experienced a higher quality of their ability to function. In addition, patients with 
schizophrenia differed from the healthy controls on 10 scales, showing generally higher 
scores than the healthy control participants, meaning that they experienced a lower quality 
of their ability to function compared to the healthy control participants. Surprisingly, 
however, in general, patients with schizophrenia showed mean UT-scores < 65, indicating a 
subjective experience of (near) normal functioning. Furthermore, patients with depression 
differed from healthy controls on 17 scales, showing higher scores on the MMPI-2 scales and 
mostly UT-scores > 65, indicating impaired functioning. In addition, this first study revealed 
that demoralization was higher in patients with depression than in patients with 
schizophrenia and that both psychiatric groups showed higher demoralization than the 
healthy control group. Based on these results, this study concluded that patients with long-
term depression show impaired functioning and high demoralization while patients with 
long-term schizophrenia surprisingly show near normal functioning and less demoralization 
(Bosch et al., 2014a). In further studies, the question was whether acupuncture could 
normalize functioning in these patient groups, keeping in mind that the responses of the 
group of patients with schizophrenia were nearly normal while the group of patients with 
depression showed higher scores and were more severely impaired. 
 
In the second study (Chapter 3), the parasomnias and other nocturnal behaviors of the 
patients with depression and schizophrenia were assessed because this population often 
complains about sleeping problems. Surprisingly, the results of the parasomnia screening 
test revealed that, although all patients with depression had experienced nocturnal 
behaviors, none had had a previous parasomnia diagnosis or had been treated accordingly. 
In total, 97.6% of the patients in the depression and the schizophrenia groups reported 
nocturnal behaviors, with the prevalence being highest in the depression group. Overall, 
these results indicate a need for more clinical awareness of and better treatments for the 
parasomnias in patients with schizophrenia or with depression. A screening instrument, 
similar to a parasomnia screening test, is essential in filtering out patients who seem to 
experience parasomnias. Nevertheless, despite the fact that in our study, patients with 
depression were to suffer most from parasomnias, patients with schizophrenia and healthy 
individuals often suffer from parasomnias as well (Bosch et al., 2012). Thus, this study 
concluded that sleeping disorders occurred very frequently and were an underestimated 
problem in patients with depression and schizophrenia and even in healthy controls, and 
that the quality of sleep, in general, needed more attention. As a result a natural question is 
whether acupuncture can influence sleeping disorders in these patient groups, a subject that 
was also addressed in this research. 
 
In the pilot study described in Chapter 4, the effects of three months of acupuncture 
treatment on the sleep of 16 patients with schizophrenia and 16 patients with depression 
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were evaluated. In addition, eight healthy control participants were included in the study in 
order to establish reference values (Bosch et al., 2013). Both acupuncture groups were 
found to show significantly lower scores on the Pittsburgh Sleep Quality Inventory (PSQI) 
(Buysse, Reynolds, Monk, Berman, & Kupfer, 1989) after the treatment period, which was 
not the case for the waiting-list group. This indicates that sleep quality was improved after 
twelve weeks of acupuncture treatment. In addition, the effectiveness of the acupuncture 
intervention was found to be slightly higher in patients with schizophrenia than in patients 
with depression. This study concluded that acupuncture improved the subjective quality of 
sleep of patients with chronic depression and schizophrenia and that it might be a suitable 
and cost-effective add-on treatment for these chronic psychiatric groups (Bosch et al., 2013). 
 
Chapter 5 described a preliminary clinical trial that investigated whether acupuncture had a 
positive influence on sleep and symptomatology in patients with schizophrenia or 
depression. In total, one hundred participants were recruited: 40 outpatients with 
schizophrenia, 40 outpatients with depression, and 20 healthy controls. They all completed a 
depression inventory, and the positive and negative symptoms of the patients with 
schizophrenia were evaluated by their psychiatrists. All participants were asked to complete 
a sleep log (Fischer, Mayer, Peter, Riemann, & Sitter, 2002) for two weeks. For the 
psychiatric patients, a randomized design with experimental (three months of acupuncture 
treatment) and control (waiting list) groups was used, after which all measurements were 
conducted once more. Before treatment, patients with depression were awake longer 
during the night, needed more time to fall asleep, evaluated their sleep as less relaxed, felt 
more exhausted, and reported a lower average performance level than healthy controls did. 
Moreover, patients with depression slept less and felt more exhausted than patients with 
schizophrenia. Patients with schizophrenia exhibited a lower average performance level 
compared to only the healthy controls. Acupuncture slightly improved sleep and depressive 
symptoms in patients with depression, but neither affected sleep nor influenced the positive 
and the negative symptoms in patients with schizophrenia. These preliminary data suggest 
that acupuncture can be used in order to reduce the symptoms of sleep disorders and to 
improve the quality of sleep to some extent in patients with depression, but that 
acupuncture does not seem to have beneficial effects for patients with schizophrenia (Bosch 
et al., under review/2015c). 
 
In the study described in Chapter 6, whether acupuncture might be able to improve mood 
and working memory in patients suffering from depression or schizophrenia was 
investigated. In total, 50 patients with depression and 50 patients with schizophrenia were 
randomly divided into an experimental and a waiting-list group. In addition, 25 healthy 
control participants were enrolled the study. The patients in the experimental groups 
received twelve weeks of individualized acupuncture treatment, and a pragmatic clinical trial 
design was used. All patients in the experimental group were tested twice on a mood scale 
(Becks Depression Inventory-II, BDI-II) (Beck, Steer, & Brown, 1996), a simple working 
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memory task (digit span task) (Wechsler, 2000), and a complex working memory task (letter-
number sequencing task) (Van den Noort, Bosch, & Hugdahl, 2006) both before (T1) and 
after (T2) acupuncture treatment; the waiting-list group, which did not receive an 
acupuncture add-on treatment, was also tested twice, but the healthy control participants 
were only tested at T1. The patients with depression scored worse than the others on the 
BDI-II, and the patients with schizophrenia scored worse than only the healthy controls. On 
the digit span test, patients with schizophrenia did not differ from healthy controls, but they 
scored worse of all on the letter-number sequencing. Acupuncture had a positive effect on 
the BDI-II for the depression group, but no effects of acupuncture on the digit span and the 
letter-number sequencing tasks were found. The clinical improvement in depressed patients 
after acupuncture treatment was not accompanied by any significant changes in their 
abilities to perform either a simple or a more complex working memory task (Bosch et al., 
under review/2015d). 
 
Although case studies and qualitative research in general are often seen as “second class 
science” compared to larger quantitative controlled clinical trials (Shuval et al., 2011), they 
have their own role in the progress of medical science (Vandenbroucke, 2001) and can give 
important insights into how a clinical intervention such as acupuncture can affect the daily 
functioning of a patient. A diagnostic interview described in the case study (Bosch, Staudte, 
Van den Noort, & Lim, 2014b) (Chapter 7) revealed that the patient experienced improved 
daily functioning and noticed a change in the experience of the hallucinations after receiving 
acupuncture treatment. Although the hallucinations did not disappear, the patient, a 
woman, felt less disturbed by them; moreover, her physical pain as a result of the 
hallucinations had decreased markedly. The severity of the schizophrenia symptoms was 
measured by using the Positive and Negative Symptom Scale (PANSS) (Kay, Fiszbein, & Opler, 
1987). The positive and the negative symptoms were found not to change immediately, but 
a decrease in symptoms was found three months after acupuncture treatment. The patient 
noticed an immediate improvement in sleep. This subjective experience of the patient was 
further confirmed by the results on the Epworth Sleepiness Scale (Johns, 1991), which is a 
questionnaire that measures daytime sleepiness. The patient was not able to complete the 
PSQI (Buysse et al., 1989), which is a (longer) test on sleep quality, beforehand, but was able 
to do so after the acupuncture treatment period. Finally, a delayed decrease in depression, 
as measured by the Becks Depression Inventory II (BDI-II) (Beck et al., 1996) was found. The 
preliminary conclusion is that acupuncture may be beneficial as an add-on treatment tool for 
patients with schizophrenia (Bosch et al., 2014b). One thing that would not have become 
clear from the tests that were used, but only became clear after the diagnostic interview, 
was the subjective experience with hallucinations. The patient felt less bothered by them, 
but the PANSS after the treatment period did not show this difference instantly due to the 
fact that it emphasizes the presence of hallucinations over their impact. 
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In Western medicine, the diagnosis and the outcomes of schizophrenia are often 
characterized by heterogeneity, meaning that a high degree of variability exists (e.g., Arango, 
Kirkpatrick, & Buchanan, 2000; McGrath, 2008). Although the DSM-V eliminated all subtypes 
of the disorder (The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition; 
American Psychiatric Association, 2013), schizophrenia was again proposed to be not one 
disorder, but many different disorders (Arnedo et al., 2015). In line with this heterogeneity 
issue (Arnedo et al., 2015), a closer look was taken at the patients with depression and 
schizophrenia that were included in our studies. The main finding of our study (Chapter 8) 
was that if a psychiatric group consisting of two subgroups, as was the fact in our sample 
(patients with depression and schizophrenia) according to Western diagnostic principles is 
diagnosed on the basis of Traditional Oriental Medicine (TOM) diagnostic patterns, it can be 
categorized into 28 different groups. This implicates that a very heterogenic group of 
psychiatric patients is being treated, resulting in many different treatment patterns, causing 
the research question to change from a clear one: “What effect does acupuncture have on 
sleep in patients with schizophrenia and on patients with depression?” to a broad and 
unclear one: “What effect does acupuncture have on sleep in a heterogenic group of 
patients with several different diagnoses (i.e., different subtypes of schizophrenia/different 
subgroups of depression)?” Moreover, a high prevalence of sleep disorders was found in 
patients with both depression and schizophrenia, and those disorders could be explained 
from the perspective of a TOM diagnostic pattern, resulting in an explanation per pattern, 
which would explain the different findings in these heterogenic groups. Finally, sleep quality, 
which may play a crucial role in mediating acupuncture-induced treatment effects in 
patients with schizophrenia or with depression (Bosch et al., 2015a), as a treatment 
objective is discussed. This issue will be further discussed later in this thesis. 
 
In the last study (Chapter 9), a literature search was conducted by using four databases, 
Medline, Scopus, ERIC, and the Cochrane Library, in order to give an overview of the 
effectiveness and the possible underlying working mechanisms of acupuncture in patients 
with schizophrenia or with depression. The result showed that the overall clinical results for 
the use of acupuncture to treat patients with depression could be considered promising 
(Bosch et al., in press/2015b). On the other hand, only limited evidence for the effectiveness 
of acupuncture therapy in the treatment of the symptoms of schizophrenia was found 
(Bosch et al., in press/2015b). However, acupuncture was found to improve the quality of 
life for both patients with depression and with schizophrenia, and this was particularly so for 
sleep quality and mood (Bosch et al., in press/2015b). In addition, acupuncture is known to 
have a modulating and normalizing effect on the “limbic-paralimbic-neocortical network” 
(LPNN) (Hui et al., 2009), including the default mode network (DMN) (Dhond, Yeh, Park, 
Kettner, & Napadow, 2008). Because the LPNN is known to behave differently in patients 
with depression (Sheline et al., 2009) and with schizophrenia (Buckner, Andrews-Hanna, & 
Schacter, 2008) and because the activation of this brain network is related to sleep as well as 
emotions, this might explain why quality of life (defined as “The degree to which a person 
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enjoys the important possibilities of his or her life” and involving the experience of 
satisfaction and enjoyment, thereby encompassing emotions more generally) (Laliberte-
Rudman, Hoffman, Scott, & Renwick, 2004) and the quality of sleep improve after the 
normalizing effect of acupuncture has modulated these areas (Bosch et al., in press/2015b). 
Finally, the conclusion of the paper is that acupuncture can be used as an add-on treatment 
in patients with depression, and to a lesser degree in patients with schizophrenia, but larger, 
well-designed, future studies are needed to confirm this (Bosch et al., in press/2015b). 
 
Answers to the Research Questions 
The four main research questions in this study were as follows: 1) What possible problems in 
sleep, psychopathology, and working memory performance can be found in a population of 
patients with long-term schizophrenia and patients with long-term depression? 2) Does 
acupuncture improve the patients’ sleep? 3) Does acupuncture decrease the patients’ 
psychopathology? 4) Does acupuncture improve the patients’ working memory 
performance? 
 
In order to answer the first research question, a population of patients with long-term 
schizophrenia and patients with long-term depression was tested in order to establish 
possible problems in sleep, psychopathology, and working memory performance. This 
research demonstrated that not only patients with depression, but also patients with 
schizophrenia and healthy individuals, suffer from parasomnias. These sleeping disorders 
occur very frequently and are an underestimated problem that requires more research and 
more attention during treatment (Bosch et al., 2012). Moreover, the patients with 
depression were found to sleep for shorter periods of time and to feel more exhausted than 
patients with schizophrenia, and compared to the healthy controls, they were awake longer 
during the night, needed more time to fall asleep, indicated their sleep as being less relaxed, 
felt more exhausted, and had a lower average performance level whereas the patients with 
schizophrenia exhibited only a lower average performance level compared to healthy 
controls. Moreover, patients with long-term depression showed impaired functioning, 
higher levels of psychopathology, and high demoralization while patients with long-term 
schizophrenia surprisingly showed near-normal functioning and psychopathology levels and 
less demoralization (Bosch et al., 2014a). As for working memory performance, the patients 
with depression scored worse than the healthy controls on working memory tasks while the 
patients with schizophrenia only scored worse than the healthy controls and the patients 
with depression on a complex working memory task. Overall, patients with long-term 
depression scored worse than the patients with long-term schizophrenia, who showed some 
elevations in their personality profile and showed some psychopathology, but this was much 
less than what had been expected beforehand (Bosch et al., 2014a). The differences 
between the schizophrenia and the healthy control groups on many subscales of the MMPI-2 
were not that large, and based upon research that was conducted beforehand (on both 
chronic as well as acute cases), this was unexpected. A possible explanation could be that 
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patients had been ill for a long time and had started to see their chronic illness more and 
more as “normal”. On the other hand, patients with depression, who had also been ill for a 
long time, report more problems than patients with schizophrenia when it comes to 
psychopathology and personality. Another possibility may be that patients with 
schizophrenia can be stabilized easier or more effectively by medication than patients with 
depression? In order to answer the other three questions, further studies need to focus on 
acupuncture, which supposedly has a normalizing function. Although some colleagues and 
the local ethics committee doubted the possibility of using acupuncture in a psychiatric 
clinic, the studies reported in this Ph.D. thesis demonstrate that acupuncture can safely be 
used in the treatment of patients with schizophrenia and with depression. None of the 
patients with schizophrenia reported suffering from hallucinations as a result of the needling 
during the project or reported adverse effects. In contrast, the patients with schizophrenia 
were and remained highly motivated to participate during the treatment period of 12 weeks. 
Therefore, the conclusion can be drawn that treating patients with schizophrenia by using 
acupuncture in addition to their regular Western treatment is clinically possible and safe, as 
long as strict guidelines are followed and the patients with schizophrenia are monitored 
carefully. One should note that treatment was given group-wise; patients were not left alone 
with needles inserted. 
 
Acupuncture for Sleep Improvement 
In the introduction of the present Ph.D. thesis, a possible underlying working mechanism of 
acupuncture in the treatment of patients with depression and with schizophrenia was 
suggested. It was thought to be an indirect one, namely, the improvement of sleep (Bloch et 
al., 2010; Bosch et al., 2013; Reshef et al., 2013; Bosch et al., 2014b). In contrast to the 
subjective questionnaires used in the present Ph.D. research, Reshef and colleagues (2013) 
also used objective indicators of movement of the limbs (actigraphs) in their acupuncture 
study on patients with schizophrenia and found that acupuncture treatment enabled 
patients with schizophrenia or schizoaffective disorder to fall asleep faster and to sleep 
better, with less time awake during the night and with reduced activity levels while sleeping. 
Overall, the sleep of patients with schizophrenia or schizoaffective disorder was found to be 
improved after acupuncture treatment (Reshef et al., 2013). 
 
As to sleep, which was the second research question, in Chapter 4, a pilot study was 
reported in which the effectiveness of acupuncture was found to be higher in patients with 
schizophrenia than in patients with depression. In this study, the PSQI was used, resulting in 
a total score, for which there is a cut-off. In the other studies within this Ph.D. thesis, hardly 
any results were found within the group with schizophrenia, specifically not on sleep (see 
Chapter 5). This incongruence raises questions as to how this difference came about. 
However, the results might be due to the method used. The results in Chapter 5 are based 
on a sleep log that was completed by the patients every day for two weeks, and the 
measurement in Chapter 4 was the PSQI, a questionnaire that was completed by the 
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patients in about ten minutes and evaluated their sleep during the previous two weeks. Due 
to the form of the questions that were asked, one instrument might be more sensitive to 
problems and changes within a population. Another possibility may be found in the fact that 
the seriousness of the illnesses, as in the deviation from the norm, was larger for one 
measurement (sleep log) than for the other (PSQI) before treatment. In Chapter 5, the 
patients with schizophrenia reported that they already slept nearly 8 hours per night, with a 
sleep latency of about 26.17 minutes and a time awake during the night of 11 minutes, and 
their sleep was found to be more relaxing than that of the control group. Based on these 
data, acupuncture logically appears to have less effect, and the scores are mostly 
comparable to those of the healthy norm group. On the other hand, in Chapter 4, the total 
PSQI score of the patient group with schizophrenia that was to receive acupuncture showed 
disturbed sleep (larger than 5 or 6, depending on the chosen cut-off score, with a mean 
score of 8.50). These patients might judge their sleep as worse than normal even though 
their actual sleep performance seemed comparable to that of the healthy controls. 
Nevertheless, more deviation would mean more work for acupuncture, which is supposed to 
help the body strive for equilibrium and return to a “normal” state. 
 
In sum, the present Ph.D. thesis did not find proof against the possible working mechanism 
of acupuncture via sleep, but was not able to find solid proof either. Therefore, more 
research with larger, well-developed, clinical studies on the possible working mechanism of 
acupuncture via sleep is needed (Bosch et al., in press/2015b). As to the effects of 
acupuncture on sleep in patients with schizophrenia, acupuncture did not seem to have a 
statistically significant effect on their sleep performance, even though they individually 
seemed to feel that their sleep had improved. As to sleep in patients with depression, their 
sleep seemed to improve slightly (see also Chapter 5); however, their sleep seemed to be 
improved less than the sleep in the patients with schizophrenia. These results need to be 
interpreted with caution due to the limitations that will be discussed later. 
 
Acupuncture on psychopathology 
As for the scores on the BDI-II and the PANSS, in the patients with schizophrenia, no results 
for acupuncture could be found on the BDI-II (see Chapters 5 and 6). Only in the case study 
could a delayed improvement be found (see Chapter 7), and in the literature review, some 
positive results were found (see Chapter 9). No acupuncture results were found on the 
PANSS (see Chapters 5, 6, and 7) for the patients with schizophrenia. When it comes to the 
group with depression, results indicate a positive effect for acupuncture (see Chapters 5, 6, 
and 9) on the BDI-II, which would mean that psychopathology decreased in that group as a 
result of acupuncture. 
 
All in all, the results that were found on psychopathology in patients with long-term 
schizophrenia within this Ph.D. thesis indicate that acupuncture does not do much for these 
patients. In patients with depression, the above-mentioned studies indicate a normalizing 
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effect for acupuncture on their depressive symptoms, which is regarded as the main finding 
of this Ph.D. thesis. However, these studies have several limitations, which will be discussed 
below. 
 
Acupuncture for Working Memory 
In Chapter 6, patients with depression were found to score worse than the others on the 
BDI-II, and the patients with schizophrenia were found to score worse than the healthy 
controls. On the more simple working memory task (digit span), patients with schizophrenia 
did not differ from the healthy controls whereas they scored worse of all on the more 
difficult working memory task (letter-number sequencing). Patients with depression scored 
worse on the digit span task than the healthy controls, but their scores were comparable to 
those of the patients with schizophrenia. Moreover, patients with depression scored higher 
than the patients with schizophrenia on the letter-number sequencing, but their scores were 
comparable to those of the healthy controls. No indications were found for a possible role of 
acupuncture in enhancing working memory performance. In this study as well, patients with 
schizophrenia showed near-normal functioning on the simple working memory test; thus, no 
or very little improvement could be achieved by using acupuncture. On the complex working 
memory test, the scores in both groups were worse than the scores in the healthy control 
group, but no statistically significant effect was found here either. The lack of positive results 
on working memory in the depressed group, together with the positive effects on mood and 
sleep, questions the often assumed relationship between mood and sleep on the one side, 
and cognition, in this case working memory, on the other. 
 
Limitations 
The studies presented in the present Ph.D. thesis have several limitations. One limitation is 
that the samples of patients with depression and with schizophrenia were rather small, a 
common problem in clinical acupuncture research (Pilkington, 2010). A multicenter study 
(e.g., Alcolea et al., 2014; López et al., 2004; Messerer, Porzsolt, Hasford, & Neiss, 1987; Reid 
et al., 2011) is imperative not only to increase the sample size, but also to exclude the effects 
due to the practitioners and the atmosphere (Messerer et al., 1987). 
 
Another limitation is the absence of a suitable control group or placebo treatment group 
(Wang et al., 2008). Placebo needles have some disadvantages of their own; for instance, 
they are rather costly, which made it impossible to include them in the present research. 
However, three placebo needle devices are available and research is ongoing in this area, 
constantly improving the needles and making them more suitable for research purposes 
(Park, White, Lee, & Ernst, 1999; Streitberger & Kleinhenz, 1998; To & Alexander, 2015). 
 
On the one hand, the advantage of the waiting-list approach combined with a group that 
receives treatment according to the immediate diagnosis at each treatment is that one is 
able to draw conclusions based on clinical data that are nearest to those of “real-life” 
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acupuncture. On the other hand, the disadvantage of this approach is that the non-
standardized acupuncture treatment (Chen, 2010) of patients with depression and with 
schizophrenia makes it hard to compare patients, groups, and treatments. However, one 
must keep in mind that the use of a standardized protocol (the same for every patient) for 
acupuncture (Cui, Wu, & Luo, 2008) in the treatment of patients with depression or 
schizophrenia (or any other disorder for that matter) is not accepted in clinical TCM practice 
(Schroer & Adamson, 2011; Schroer, Kanaan, MacPherson, & Adamson, 2012). The 
individualized treatment is being dynamically adjusted to the changing needs of the patient; 
therefore a one-size-fits-all approach cannot be used. 
 
One methodological point that was raised in this Ph.D. thesis is the “fruit basket” problem, 
meaning that TOM diagnostic patterns might be used in acupuncture research aiming to re-
order patient groups and to create groups that might be more comparable than the groups 
based upon Western diagnoses (using the DSM-V) that have been used so far (e.g., 
depression versus schizophrenia). Possible hidden effects of acupuncture might be found 
with a proper re-ordering based on an appropriate Eastern Medicine system instead of the 
Western Medicine system. 
 
Further limitations are that patients used medication during the entire time and the group 
with schizophrenia used more medication than the group with depression. From a TCM 
perspective, medication sometimes does not work towards equilibrium and may even cause 
more or different problems than the initial reasons for taking it; i.e., it might work against 
acupuncture (Yang, 2008). As a result, 12 weeks of acupuncture might not be sufficient to 
make a strong difference, especially because in most cases, the medication and the illness 
had been present for a long time; according to TCM, this would increase the treatment 
period needed to achieve results (e.g., Cheng, 1987; Flaws & Lake, 2003). Note that the 
patients with schizophrenia had been ill longer, thereby possibly explaining their smaller 
effects. Moreover, medication may mediate acupuncture effects in various ways. For 
instance, tricyclic antidepressants are thought to be able to suppress Qi and Yang and to 
cause stagnation and with that an accumulation of dampness and water, eventually even 
causing Phlegm (Yang, 2008). Moreover, several neuroleptic drugs have been reported to 
cause Yin Vacuity with Internal Heat (Flaws & Lake, 2003), which is the opposite of what 
acupuncture is trying to achieve. In TCM, the current clinical picture of the state of the client 
is called a diagnostic pattern. The clinical effect of the state resulting from tricyclic 
antidepressants that was just described would be weight gain, tiredness, and a feeling of 
heaviness in the body (Yang, 2008). Although anti-depressive medications have the goal of 
treating depression, they may cause some other imbalance in the body, which is something 
that acupuncture will try to alleviate. Every medication has its own effects on the body, so 
one medication might cause more problems in the system than another, which might also 
differ from patient to patient, depending on the situation and the level of disturbance. 
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Further limitations were that the study design did not work well due to the large drop-out of 
patients in the waiting-list groups, the patients with schizophrenia showed near-normal 
functioning on some of the tests so that not much could be normalized, and the fact that 
some tests (like the PANSS) did not seem to be sensitive enough. Due to these limitations, 
the results in this Ph.D. thesis should be interpreted with caution and regarded as 
preliminary results. 
 
Future Research 
TCM/TOM Diagnostic Patterns and Western Diagnosis: The Fruit Basket Problem 
Using larger groups would help in solving or demonstrating the previously discussed “fruit 
basket problem” (Bosch et al., 2015a) because within larger groups of patients, the 
subgroups according to TCM/TOM patterns will be larger as well, so sufficient statistical 
power will be retained to answer the question whether patients with a similar pattern 
respond similarly to acupuncture. Moreover, larger homogenous groups might allow the 
question whether these patterns can predict whether patients respond well to acupuncture 
to be answered. In TCM/TOM, as was previously described in Chapter 8, several main TOM 
diagnostic patterns can be found in patients with schizophrenia and patients with depression 
(Bosch et al., 2015a). Different TCM/TOM researchers may organize their patients according 
to Western diagnoses, resulting in several different TOM diagnostic patterns within the 
groups (TOM diagnostic patterns are the conclusions that a practitioner draws after 
extensive TOM diagnosis on the Tongue and the Pulse by listening and smelling, observing, 
and touching). Thus, in TOM, the groups may differ markedly, even though their Western 
diagnoses are comparable, thereby causing the research results on acupuncture to be less 
comparable and generalizable than they otherwise would have been if this information 
regarding their TCM/TOM diagnostic patterns had been added to the research articles. 
Nearly no TCM or TOM articles so far have stated the diagnostic patterns that they included. 
In future research, a table should be added stating all patterns within the sample, and 
groups that are homogeneous according to TCM/TOM patterns should be evaluated and 
compared. 
 
A second problem is the question how these patterns came about. Little research has been 
conducted on the inter-rater reliability of TCM practitioners when it comes to TCM 
diagnostics. One study on three practitioners with extensive experience showed that 
agreement on TCM diagnosis was low (Zhang et al., 2004). If this problem is to be solved, a 
pulse measurement machine (Chen, Chang, Jwo, Hsu, & Tsao, 2015) and a standardized 
tongue measurement (Bosch, Van den Noort, Staudte, Yeo, & Lim, to be submitted) should 
be used, and those results, in addition to the TCM patterns that were found, should be 
reported. In our studies, we reported the points that were used, which is also something 
that will enhance research in the acupuncture field by making clearer what was actually 
done during the experiment. Moreover, if medication is used, a clear overview should be 
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presented of the type and the dose of the medication, which might be used to establish 
homogenous large groups. 
 
Moreover, how can scientific conclusions be drawn about the usefulness of acupuncture 
when TCM and Western medicine differ in how the depression and the schizophrenia groups 
should be clinically described? Note that even in Western medicine lively debate on how to 
best deal with the heterogeneity of the schizophrenia group is ongoing (e.g., Arango et al., 
2000; McGrath, 2008); should this patient group be described as one clinical group or should 
it be further divided into subgroups of schizophrenia (Arnedo et al., 2015)? Homogenous 
groups need to be created, and research must be conducted accordingly. 
 
One of the problems within the present Ph.D. project was the number of participants that 
were lost in the waiting-list groups. One statistical method that might be a promising 
solution to (at least a part of) this problem might be the use of a multilevel analysis (e.g., 
Jongsma et al., 2011; Pfeffermann, Skinner, Holmes, Goldstein, & Rasbash, 1998; Snijders, 
2003; Snijders & Bosker, 1999). When using repeated measures within individuals, the 
repeated measures constitute the lower (first) and the individuals the higher (second) levels. 
Time can be used as a factor of change. Especially for non-balanced longitudinal data 
structures, such as are often seen in acupuncture research in which the numbers and the 
times of observations differ between individuals (possibly due to dropout), multilevel 
modeling may be the most suitable method and seems to be a promising new direction for 
analyzing clinical acupuncture research data. 
 
The instruments that have been used in the present Ph.D. project have the disadvantage 
that they are only able to collect subjective sleep quality data. In future research, the use of 
actiwatches (van de Wouw, Evenhuis, & Echteld, 2013) seems to be an interesting next step 
because actiwatches give the opportunity to collect objective sleep quality data (van de 
Wouw et al., 2013) for the patients with depression and with schizophrenia without having 
to have them admitted to a sleep laboratory. In addition, the use of melatonin measures 
(Benloucif et al., 2008) seem to be promising because melatonin levels are known to be 
disturbed in patients suffering from sleep disorders (U.S. Department of Health and Human 
Services, 2004). Thus, comparing the melatonin levels of patients with depression to those of 
patients with schizophrenia, who were found to suffer markedly from sleep disorders in the 
present Ph.D. thesis, before and after acupuncture treatment in order to get an objective 
(biological) measure of possible acupuncture effects would be interesting. Moreover, 
placebo needles (Park et al., 1999; Streitberger & Kleinhenz, 1998; To & Alexander, 2015) 
might be used in order to establish a more suitable control group. 
 
Finally, conducting fMRI research on acupuncture intervention in patients with depression 
and with schizophrenia would be highly interesting. This is particularly important in order to 
test the modulating and the normalizing effects of acupuncture on the LPNN, including the 
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default mode network (DMN) (see Figure 1). Alternatively, one could also make use of skin 
conductance measures (Park & Kim, 2011), event-related potentials (ERP) (Liddell, Williams, 
Rathjen, Shevrin, & Gordon, 2004), fMRI (Mothersill et al., 2014), combined skin 
conductance/fMRI (Williams et al., 2007), or combined EEG/fMRI recordings (Trautmann-
Lengsfeld, Domínguez-Borràs, Escera, Herrmann, & Fehr, 2013) in order to test the 
previously-discussed LPNN hypothesis (Bosch et al., in press/2015b). 
 
 
 
Figure 1. A brain sketch of the amygdala, hypothalamus, and thalamus, which are part of the 
LPNN (Hui et al., 2009) and are suggested to play key roles in the acupuncture treatment of 
patients with schizophrenia and depression (Bosch et al., in press/2015b). The functionally 
anti-correlated task-positive areas in response to acupuncture are presented in red whereas 
the anti-correlated task-negative areas are presented in blue (Hui et al., 2009). Note that, in 
general, treatment resulting in De qi is related to decreased brain activity in the limbic 
system and in the DMN whereas sharp pain is related to signal increases (Hui, Marina, Liu, 
Rosen, & Kwong, 2010). 
 
Conclusions 
Stronger indications were found for acupuncture’s effectiveness in patients with long-term 
depression than in those with long-term schizophrenia, for whom only the PSQI positive 
effects of acupuncture on sleep were established. In patients with depression, acupuncture 
helped to improve their mood, which might have been due to its positive effect via sleep. 
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For future research, objective (Western) measuring techniques, such as polysomnography, 
actiwatches, and brain imaging studies, are necessary for progress in the field. These 
techniques should be used in multicenter studies in which randomized (possibly partly 
blinded by using placebo needles) trials are used with sufficient numbers of patients to be 
able to divide them into groups according to TCM diagnostics. Western measuring 
techniques combined with Eastern diagnostics techniques with large groups of patients 
should reveal the real effects of acupuncture. 
 
Building a bridge between East and West in order to come to a true integrative treatment 
that helps patients more than Eastern or Western treatment alone can do seems to be a goal 
that is worth working towards. Despite the pitfalls and strong criticisms that belong to a road 
less travelled, these patients are worth every step it takes. 
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English Summary 
 
During the last two decades, the use of acupuncture as an alternative additional treatment 
in Western medicine has been on the rise, especially among practitioners treating psychiatric 
patients. Acupuncture is particularly used as a therapy in patients with depression, and 
recently clinicians have also started to use it to treat patients with schizophrenia. However, 
solid scientific research on the effectiveness of acupuncture in the treatment of patients 
with depression and with schizophrenia is scarce, and in particular, research on the efficacy 
of acupuncture in the treatment of patients with long-term psychiatric disorders is 
completely missing. The research question of the present PhD thesis is, therefore, whether 
acupuncture can be successfully used as an add-on in the treatment of patients with long-
term depression and of patients with long-term schizophrenia. However, before testing the 
possible efficacy of a new treatment, good insight into the patient groups under 
investigation, patients with schizophrenia and patients with depression, is important. Many 
patients suffer from depression or schizophrenia for a long time, and these disorders can be 
seen as chronic when they last at least five years. An overview of the diagnostic criteria used 
for patients with schizophrenia and for patients with depression is given in Chapter 1. Within 
the chronic schizophrenia group, as well as the chronic depression group, patients often 
differ in their signs and symptoms. When it comes to schizophrenia, different outcomes 
were found in several studies, and those outcomes might be explained by the heterogeneity 
of the patient group in focus; the same problem of clinical heterogeneity was found for 
patients with depression. Factors of chronicity might be responsible for different outcomes 
between studies because patients might function and feel different in the first five years 
after having been diagnosed with a psychiatric disorder than in the years that follow, and in 
many studies, the years of illness are not reported, and mixed groups are used. Moreover, 
ample evidence exists for a correlation between psychiatric disorders and various sleep 
disorders, which is another aspect that needs consideration as it can partially explain why 
heterogeneous clinical results are found within the schizophrenia group and within the 
depression group. This is further supported by the fact that previous research has shown 
that when sleep disorders are untreated, the risk of developing psychiatric disorders 
increases. The aim of the current thesis is to investigate whether acupuncture can be used as 
an add-on clinical intervention in the treatment of patients suffering from chronic 
schizophrenia or depression and sleep disorders. In order to do so, the problems behind 
heterogeneous groups are taken into account, and the patient groups are studied more into 
detail when it comes to psychopathology and sleep. 
 
In Chapter 2, a study is presented that investigated whether the long-term illness of the 
patients with depression or with schizophrenia might itself influence the way these patients 
present their psychopathology and personality on the MMPI-2 (Minnesota Multiphasic 
Personality Inventory-2), a personality inventory. Moreover, the question was whether 
demoralization, which can be described as a response that may follow chronification of the 
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disorder, affects the scales of the personality inventory. The patients with long-term 
schizophrenia, the patients with long-term depression, and the healthy participants 
completed the MMPI-2 and were compared on the Clinical Scales and on the Restructured 
Clinical Scales. Demoralization was higher in patients with depression than in patients with 
schizophrenia, and both psychiatric groups differed from the healthy control group. It is 
concluded that patients with long-term depression show impaired functioning and high 
demoralization while patients with long-term schizophrenia, surprisingly, show near normal 
functioning and less demoralization. The latter may have serious consequences for whether 
and how much improvement can be achieved with an add-on therapy in the chronic 
schizophrenia group. Moreover, this finding gives rise to several questions when it comes to 
the MMPI-2 because a severely disturbed patient group that scores (nearly) normal is 
something that clearly warrants further research. 
 
In Chapter 3, another aspect is considered, namely, the question whether our psychiatric 
patient groups, indeed, suffer from sleep disorders as is often reported in the literature; 
moreover, when this is the case, from what kinds of sleep disorders do they suffer? The 
subjective experience with parasomnias and other nocturnal behaviors in patients with 
depression and with schizophrenia is investigated by using a parasomnia screening test. In 
total, 21 parasomnias and other nocturnal behaviors were assessed. Although all patients 
with depression had experienced nocturnal behaviors, none were found to have had a 
previous parasomnia diagnosis or to have been treated accordingly. Of all participants, 
97.6% had experienced nocturnal behaviors. The prevalence of nocturnal behaviors was 
highest in patients with depression, indicating a need for more clinical awareness and 
thereby better future treatments for better outcomes. A screening instrument like a 
parasomnia screening test is essential in filtering patients who seem to experience 
parasomnias. Nevertheless, the fact that patients with schizophrenia, as well as healthy 
persons, also have parasomnias must be kept in mind. In sum, this study clearly showed that 
both patient groups suffer from sleep disorders, making this an important issue that needs 
to be taken into account when developing and testing new treatments for patients with 
chronic schizophrenia and with chronic depression. 
 
After gaining insights into our chronic psychiatric patient groups, we investigated one of the 
main questions of this thesis. Acupuncture, which is a Traditional Chinese Medicine (TCM) 
technique, is used as an add-on (in addition to the standard allopathic medicine) treatment 
for patients suffering from chronic schizophrenia and from chronic depression. Chapter 4 
describes a preliminary clinical trial, in which the question of whether acupuncture has a 
positive influence on sleep in patients with schizophrenia or with depression was 
investigated. As was discussed in Chapter 3, these patient groups suffer from sleep 
disorders. All participants with psychiatric disorders were asked to complete the Pittsburgh 
Sleep Quality Inventory before and after the acupuncture treatment that had been 
individualized based on traditional Chinese medicine principles; participants on the waiting 
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list also completed the Inventory. Both acupuncture groups showed significant lower scores 
on the sleep inventory, which was not the case for the participants on the waiting list. 
Moreover, the effectiveness of the acupuncture treatment was found to be higher in the 
patients with schizophrenia than in the patients with depression. From this study, 
acupuncture seemed to improve sleep in patients with long-lasting psychiatric problems and 
may be a suitable and cost-effective add-on (in addition to the standard allopathic) 
treatment for this group, particularly if conducted group-wise. 
 
In Chapter 5, the possible clinical effect of acupuncture on sleep is further investigated. The 
study again describes a preliminary clinical trial investigating whether acupuncture has a 
positive influence on sleep and symptomatology in patients with schizophrenia or with 
depression. This time, all participants were asked to complete a sleep log for two weeks. In 
addition, the psychiatric patients filled in a depression scale, and the psychiatrists filled in a 
scale on the positive and the negative symptoms of the patients with schizophrenia. Then, 
the patients with schizophrenia and the patients with depression were randomly divided 
into an acupuncture group (three months, once a week) and a control group, and after three 
months, all tests were repeated. Patients with depression are found to sleep for less time 
and to feel more exhausted compared to patients with schizophrenia; moreover, compared 
to the healthy controls, patients with depression are awake more during the night, need 
more time to fall asleep, have sleep that is seen as being less relaxed, feel more exhausted, 
and have a lower average performance level whereas the patients with schizophrenia solely 
report a lower average performance level compared to healthy controls. Acupuncture 
slightly improved sleep and depressive symptoms in patients with depression, but did not 
affect sleep nor influence positive or negative symptoms in patients with schizophrenia. 
These data suggest that acupuncture can be used in order to reduce symptoms and to 
improve sleep to some extent in patients with depression, but does not seem to have 
beneficial effects for patients with schizophrenia. 
 
In Chapter 6, besides the question whether acupuncture is able to improve mood in patients 
with long-term depression or long-term schizophrenia, whether acupuncture is also able to 
improve cognitive functioning (working memory performance) was addressed. The patients 
received twelve weeks of individualized acupuncture treatment, and a pragmatic clinical trial 
design was used. All participants were tested twice on a mood scale and on a simple and a 
complex working memory task before (T1) and after (T2) acupuncture treatment. The results 
showed that acupuncture treatment significantly improved mood, but not working memory, 
in patients with depression; moreover, patients with schizophrenia seemed to have neither 
improved mood nor improved working memory after acupuncture treatment. 
 
Not only is it important to establish quantitatively the group effects of acupuncture but also 
to look at individual patients. What effects does acupuncture have on the number and the 
kinds of hallucinations experienced by a patient suffering from chronic schizophrenia? In 
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Chapter 7, this question is investigated; moreover, sleep quality, depressive feelings, and 
positive and negative symptoms are further assessed. The 63-year-old woman in the case 
study of chapter 7 suffered from persistent hallucinations and even physical pain resulting 
from a hallucination of a black bird continuously pecking on her back. The patient received 
12 weekly acupuncture treatments as an add-on treatment. A clinical diagnostic interview 
and psychological testing on sleep quality and depression were conducted before, 
immediately after, and 3 months after the acupuncture treatment; moreover, her 
psychiatrist filled in a PANSS (Positive and Negative Syndrome Scale). The results of the 
diagnostic interview showed that the patient experienced improved daily functioning and 
noticed a change in hallucinations. Although the hallucinations still occurred, she felt less 
disturbed by them. Interestingly, pain decreased markedly. In addition, the results showed 
that the overall score of the positive and the negative symptoms did not change 
immediately; however, a decrease in symptoms occurred three months after acupuncture 
treatment. Moreover, the patient described an immediate improvement in sleep; this was 
confirmed by her responses on a daytime sleepiness questionnaire. The patient was not able 
to complete a (longer) test on sleep quality beforehand, but did so after the treatment 
period. Also, a delayed improvement in the depression scale was found. Conclusively, the 
results of this case study indicate that acupuncture may be beneficial as an add-on 
treatment tool in patients with schizophrenia. 
 
Previous allopathic research showed heterogeneous clinical results within the schizophrenia 
group and within the depression group, so the question that is investigated in Chapter 8 is 
how this can be explained from a Traditional Oriental Medicine (TOM) perspective. In this 
study, the different TOM diagnostic patterns in patients with a Western diagnosis of 
schizophrenia, depression, or sleep disorders are described from a TOM literature and a 
clinical perspective. Psychiatric disorders can be described and treated from both a Western 
(allopathic) and an Eastern perspective, which is important when research on acupuncture in 
psychiatry is conducted. Patients with schizophrenia or with depression are likely to be 
undergoing Western treatment when they are referred to an acupuncturist for (add-on) 
treatment, so knowledge of both types of treatments is necessary to integrate them 
successfully. In this study, data on 30 patients with depression and 30 patients with 
schizophrenia are presented. It was found that if a psychiatric group, sorted in accordance 
with Western diagnostic principles, is diagnosed on the basis of TOM diagnostic patterns, the 
group can be categorized into different groups of patients with psychiatric disorders; this 
finding has far-reaching consequences in scientific research on acupuncture. Finally, sleep 
quality is discussed as a treatment objective that may play a crucial role in mediating 
acupuncture-induced treatment effects in patients with schizophrenia and patients with 
depression. 
 
In Chapter 9, the clinical evidence for the use of acupuncture as an add-on treatment for 
patients with depression and patients with schizophrenia and the evidence on its working 
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mechanisms were assessed. Four databases (Medline, Scopus, ERIC, and the Cochrane 
Library) were searched until March 31, 2014. All systematic reviews and meta-analyses on 
acupuncture treatment in patients with depression and patients with schizophrenia were 
considered for inclusion. Randomized controlled trials (RCTs) and case studies on 
acupuncture and patients with schizophrenia were also included because the number of 
papers on the effects of acupuncture in patients with schizophrenia is very low. The primary 
aim of this study was to evaluate the effects of acupuncture treatment for patients with 
depression and patients with schizophrenia through a systematic review. The secondary aim 
was to evaluate possible underlying working mechanisms behind acupuncture, again 
through a systematic review. The results show that the overall clinical results for the use of 
acupuncture in treating patients with depression are promising, but only limited evidence 
for its effectiveness in treating patients with schizophrenia was found. Acupuncture 
improves the quality of life of psychiatric patients, particularly sleep quality. Brain research 
revealed that acupuncture has a modulating and normalizing effect on the “limbic-
paralimbic-neocortical network” (LPNN), including the default mode network (DMN). 
Because the LPNN is related to sleep as well as emotions, this can explain why life quality 
and sleep are improved after acupuncture treatment. 
 
To conclude, stronger indications were found for acupuncture’s effectiveness in patients 
with long-term depression than for its effectiveness in patients with schizophrenia, in which 
only some positive effects on sleep were found. In patients with depression, acupuncture 
helps to improve their mood, and this might work through a positive effect via sleep. Future 
research on the working mechanisms of acupuncture in the treatment of patients with 
depression would be helpful in order to identify the processes through which acupuncture 
acts and to answer the question why patients with schizophrenia are seemingly less sensitive 
to this therapy. Possibly, acupuncture may have more effects in patients with schizophrenia 
that show a psychopathology more severe than those shown by the patients in the studies 
reported in the current thesis. Specifically, research comparing the effects of acupuncture 
treatment on patients with a first episode of schizophrenia to its effects on patients with 
chronic schizophrenia is warranted. 
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Deutsche Zusammenfassung 
 
In den letzten zwanzig Jahren wird Akupunktur immer häufiger als eine alternative 
zusätzliche Behandlungsmethode in der Westlichen Medizin eingesetzt. Akupunktur wird 
besonders in der Therapie von Depressionen und seit kurzem auch bei Patienten mit 
Schizophrenien angewendet. Allerdings gibt es nur wenig solide wissenschaftliche Forschung 
nach der Effektivität von Akupunktur in der Behandlung von Patienten mit chronischen 
Depressionen und chronischen Schizophrenien. Die Forschungsfrage dieser Doktorarbeit ist 
deswegen, ob Akupunktur erfolgreich als zusätzliche Behandlungsmethode bei der 
Behandlung von Patienten mit chronischer Depression/Schizophrenie eingesetzt werden 
kann. Bevor die mögliche Effektivität einer neuen Behandlung geprüft werden kann, ist es 
allerdings wichtig, einen umfassenden Einblick in die Problematik der Patientengruppen zu 
erhalten, die untersucht werden: Patienten mit Schizophrenie und Patienten mit einer 
Depression. Viele Patienten leiden lange an einer Depression oder Schizophrenie und 
können deshalb als chronisch krank bezeichnet werden. Eine Störung wird als chronisch 
bezeichnet, wenn der Patient mindestens 5 Jahre an der Störung leidet. Im ersten Kapitel 
wird eine Übersicht der diagnostischen Kriterien von Schizophrenie und Depression 
vorgestellt. Innerhalb der Gruppe chronisch schizophrener Patienten als auch innerhalb der 
chronischen Depressionsgruppe unterscheiden Patienten sich oft in Merkmalen und 
Symptomen. Verschiedene Studien zeigten unterschiedliche Resultate für Schizophrenie, die 
durch die Heterogenität dieser Patientengruppe erklärt werden könnten. Auch für 
Depression wurde das gleiche Problem der klinischen Heterogenität gefunden. Das Maß an 
Chronizität könnte für die wechselnden Resultate unterschiedlicher Studien verantwortlich 
sein, weil Patienten sich während der ersten 5 Jahre nach der Diagnose einer psychiatrischen 
Störung vielleicht anders fühlen und verhalten, als in den darauffolgenden Jahren. In vielen 
Studien wird nicht vermerkt, wie lange die Patienten schon an einer Krankheit leiden, 
außerdem werden auch gemischte Gruppen untersucht. Ein weiterer wichtiger Aspekt, der 
unsere Aufmerksamkeit verdient und der unter anderem teilweise die festgestellte 
Heterogenität innerhalb der Schizophrenie-Gruppe und innerhalb der Depressionsgruppe 
erklären könnte, ist der vielfache Beleg für eine Korrelation zwischen psychiatrischen 
Störungen und Schlafstörungen. Frühere Forschung hat diese These unterstützt, indem sie 
gezeigt hat, dass unbehandelte Schlafstörungen das Risiko für die Entwicklung von 
psychiatrischen Störungen verstärken. Neben der Beschreibung der Probleme heterogener 
Gruppen und der Beschreibung spezifischer Patientengruppen, ist das Ziel dieser 
Doktorarbeit vor allem zu erforschen, ob Akupunktur als zusätzliche klinische Intervention 
für die Behandlung chronisch depressiver oder chronisch schizophrener Patienten eingesetzt 
werden kann. 
 
Im zweiten Kapitel wird eine Studie präsentiert, in der untersucht wird, ob die lange Dauer 
der Krankheit der Patienten mit Depression und Schizophrenie die Art, wie diese Patienten 
selbst ihre Psychopathologie und Persönlichkeit mithilfe des MMPI-2 (Minnesota Multiphasic 
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Personality Inventory-2), einer Persönlichkeitsliste, bewerten, beeinflusst. Auch war die 
Frage, ob Demoralisierung 'assoziiert mit der langen Dauer der Krankheit' die Skalen des 
Persönlichkeitsfragebogens beeinflusst. Die Patienten mit chronischer Schizophrenie, die 
Patienten mit chronischer Depression und die gesunden Versuchspersonen füllten den 
MMPI-2 aus und wurden auf den Klinischen Skalen (auf English „Clinical Scales“) und auf den 
RC-Skalen (auf Englisch „Restructured Clinical Scales“) miteinander verglichen. Die 
Demoralisierung war höher bei Patienten mit Depression als bei Patienten mit Schizophrenie 
und beide psychiatrischen Gruppen unterschieden sich von der Gruppe gesunder 
Versuchspersonen. Daraus folgt, dass Patienten mit einer chronischen Depression ein 
vermindertes Funktionieren und eine hohe Demoralisierung zeigen, während Patienten mit 
chronischer Schizophrenie überraschenderweise ein fast normales Funktionieren und 
weniger Demoralisierung zeigen. Letzteres hat ernsthafte Konsequenzen für die Möglichkeit 
mit Hilfe von Akupunktur den Zustand der chronisch schizophrenen Patienten zu verbessern. 
Außerdem führt dieses Ergebnis zu verschiedenen Fragen in Bezug auf den MMPI-2, wobei 
eine ernsthaft gestörte Patientengruppe laut diesem Persönlichkeitsfragebogen ein fast 
normales Funktionieren zeigt. Zu diesem Thema ist daher mehr Forschung erwünscht. 
 
Im dritten Kapitel richten wir uns auf einen anderen Aspekt, der die Aufmerksamkeit 
verdient, nämlich die Frage, ob unsere psychiatrischen Gruppen, wie so oft in der 
Fachliteratur berichtet, tatsächlich an Schlafstörungen leiden; und falls dies der Fall ist, an 
was für einer Art von Schlafstörungen leiden sie? In dieser Studie wird die subjektive 
Erfahrung von Parasomnien und anderen nächtlichen Verhaltensweisen bei Depression und 
Schizophrenie mit Hilfe eines Parasomnie Screening Fragebogens untersucht. Insgesamt 
wurden 21 Parasomnien und andere nächtliche Verhaltensweisen untersucht. Die Resultate 
zeigen, dass, obwohl alle Patienten mit Depression nächtliche Parasomnien erfahren hatten, 
keiner der Patienten zuvor eine Parasomnie Diagnose bekommen hatte oder deswegen 
behandelt worden war. 97.6% aller Versuchspersonen gaben an, nächtliche Parasomnien 
erfahren zu haben. Dies war am stärksten ausgeprägt bei Depression, was nach mehr 
klinischem Bewusstsein und besseren zukünftigen Behandlungen und Resultaten verlangt. 
Ein Forschungsinstrument, wie der Parasomnie Screening Fragebogen, ist essentiell, um die 
Patienten herauszufiltern, die an Parasomnien leiden. Es ist außerdem wichtig, sich bewusst 
zu sein, dass sowohl Patienten mit Schizophrenie als auch gesunde Versuchspersonen 
ebenfalls an Parasomnien leiden. Kurz zusammengefasst zeigt dieser Studie deutlich, dass 
beide Patientengruppen an Schlafstörungen leiden. Dieses Resultat zeigt, dass 
Schlafstörungen eine wichtige Problematik sind, die berücksichtigt werden muss, wenn neue 
Behandlungsformen für Patienten mit chronischer Schizophrenie und für Patienten mit 
Depression entwickelt und getestet werden. 
 
Nachdem diese Einsichten in unseren chronisch psychiatrischen Patientengruppen erworben 
waren, wird eine der Hauptfragen in dieser Doktorarbeit erforscht. Akupunktur, eine 
Traditionelle Chinesische Medizin-Technik, wird als eine zusätzliche Behandlung (neben der 
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Standard-Westlichen medizinischen Behandlung) von Patienten eingesetzt, die an 
chronischer Schizophrenie oder Depression leiden. Kapitel 4 beschreibt eine erste klinische 
Pilotstudie, worin untersucht wird, ob Akupunktur einen positiven Einfluss auf den Schlaf 
von Patienten mit Schizophrenie und Depression hat. Wie in Kapitel 3 schon besprochen, 
leiden diese Patientengruppen an Schlafstörungen. Alle Versuchspersonen wurden gebeten, 
vor und nach einer experimentellen Kondition (wöchentliche Behandlung mit Akupunktur in 
einem Zeitraum von drei Monaten) oder einer Kontroll-Kondition (Warteliste) das Pittsburgh 
Schlaf Qualität Inventar auszufüllen. Es wurde festgestellt, dass beide Akupunktur Gruppen 
nach der Behandlung signifikant niedrigere Werte auf dem Fragebogen zeigten, was bei der 
Wartelistekondition nicht der Fall war. Außerdem zeigte sich, dass die Effektivität der 
Akupunktur Behandlung für die Patienten mit Schizophrenie höher war als für die Patienten 
mit Depression. Kurz zusammengefasst zeigt diese Studie, dass Akupunktur den Schlaf in 
dieser Stichprobe, die von chronisch psychiatrischen Problemen gekennzeichnet wird, zu 
verbessern scheint und es wird suggeriert, dass Akupunktur vielleicht eine geeignete und 
kosteneffektive zusätzliche (neben der Standard westlichen) Behandlung für diese Gruppe 
sein könnte, vor allem wenn Akupunktur in Gruppen angewendet wird. 
 
In Kapitel 5 wird der mögliche klinische Effekt von Akupunktur auf Schlaf weiter untersucht. 
Diese Studie beschreibt nochmals eine klinische Pilotstudie, worin untersucht wird, ob 
Akupunktur einen positiven Einfluss auf den Schlaf und die Symptome von Patienten mit 
Schizophrenie und von Patienten mit Depression hat. Diesmal wurden alle 
Versuchspersonen gebeten, in einem Zeitraum von zwei Wochen täglich ein Schlaftagebuch 
auszufüllen, außerdem wurden sie gebeten, einen Stimmungsfragebogen auszufüllen und 
die behandelnden Psychiater wurde gebeten, eine Liste auszufüllen in Bezug auf die 
positiven und negativen Symptome der Patienten mit Schizophrenie. Danach wurden sie 
nach dem Zufallsprinzip einer drei Monate dauernden (wöchentlichen) experimentellen 
Akupunktur Kondition oder einer Warteliste Kondition zugeteilt. Nach drei Monaten wurden 
alle Tests wiederholt. Patienten mit Depression schliefen kürzer und fühlten sich erschöpfter 
im Vergleich zu den Patienten mit Schizophrenie. Außerdem waren sie im Vergleich zu den 
gesunden Versuchspersonen während der Nacht länger wach, brauchten mehr Zeit um 
einzuschlafen, beurteilten ihren Schlaf als weniger erholsam, fühlten sich erschöpfter und 
hatten sie ein niedrigeres durchschnittliches Leistungsvermögen, während die Patienten mit 
Schizophrenie im Vergleich zu den gesunden Versuchspersonen lediglich ein niedrigeres 
durchschnittliches Leistungsvermögen berichteten. Außerdem wurde festgestellt, dass 
Akupunktur den Schlaf und die depressiven Symptome von Patienten mit Depression leicht 
verbesserte, aber den Schlaf und die positiven und negativen Symptome von Patienten mit 
Schizophrenie nicht beeinflusste. Diese vorläufigen Resultate suggerieren, dass Akupunktur 
gebraucht werden kann, um die Symptome von Patienten mit Depression teilweise zu 
vermindern und den Schlaf von Patienten mit Depression zu verbessern, aber Akupunktur 
scheint keinen nennenswerten Effekt bei Patienten mit Schizophrenie zu haben. 
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In Kapitel 6 wird, neben der Frage ob Akupunktur die Stimmung von Patienten mit 
chronischer Depression oder Schizophrenie verbessern kann, die Frage gestellt, ob 
Akupunktur auch kognitives Funktionieren (die Arbeitsgedächtnis-Leistung) von Patienten 
mit chronischer Depression und Schizophrenie verbessern kann. Die Patienten bekamen in 
einem Zeitraum von zwölf Wochen eine individuelle Akupunktur Behandlung und in der 
Studie wurde von einem pragmatischen, klinischen, Studie-Design gebrauch gemacht. Alle 
Versuchspersonen wurden sowohl vor (T1) als auch nach der Akupunktur Behandlung (T2) 
mit Hilfe einer Stimmungsliste und einer einfachen und einer komplizierten 
Arbeitsgedächtnis-Aufgabe getestet. Die Resultate zeigen, dass die Akupunktur Behandlung 
zwar die Stimmung, aber nicht das Arbeitsgedächtnis der Patienten mit Depression 
signifikant verbessert. Die Stimmung und das Arbeitsgedächtnis von Patienten mit 
Schizophrenie verbesserten sich nicht nach der Akupunktur Behandlung. 
 
Es ist nicht nur wichtig, die quantitativen Effekte von Akupunktur auf Gruppeniveau zu 
untersuchen, sondern auch die Wirkung auf individuellem Niveau zu betrachten. Was sind 
zum Beispiel die Effekte von Akupunktur auf (die Zahl und die Art) der Halluzinationen eines 
Patienten mit chronischer Schizophrenie? In Kapitel 7 wird diese Frage näher untersucht und 
außerdem werden die Qualität des Schlafs, die depressiven Gefühle und die positiven und 
negativen Symptome des Patienten erforscht. Es handelt sich bei dem Kasus um eine 63 
jährige Frau, die an persistierenden Halluzinationen und sogar an physischen Schmerzen 
leidet, die durch Halluzination einer Krähe hervorgerufen werden, die immer wieder in ihren 
Rücken pickt. Die Patientin wurde während 12 Wochen zusätzlich (neben der Standard 
Westlicher) mit Akupunktur behandelt. Ein klinisches, diagnostisches Interview wurde bei ihr 
durchgeführt und sie wurde psychologisch getestet (auf die Qualität des Schlafs und auf 
Depression), auch wurden ihre positiven und negativen Symptome von ihrem Psychiater 
mittels des PANSS (auf Englisch „Positive and Negative Syndrome Scale“) eingeschätzt. Dies 
fand sowohl direkt vor und direkt nach der 12 wöchentlichen Akupunktur Behandlung statt, 
als auch drei Monate, nachdem die Akupunktur Behandlung abgeschlossen war. Die 
Ergebnisse des diagnostischen Interviews zeigen, dass die Patientin ein verbessertes 
Funktionieren während des Tages erfuhr und sie beobachtete eine Veränderung ihrer 
Halluzinationen. Sie hatte zwar noch immer Halluzinationen, aber sie fühlte sich dadurch 
weniger belastet. Interessant war auch, dass der Schmerz der Patientin beträchtlich weniger 
wurde. Außerdem zeigten die Resultate, dass sich der gesamt Score der positiven und der 
negativen Symptome direkt nach der Akupunktur Behandlung zwar nicht änderte, aber drei 
Monate nach Abschluss der Akupunktur Behandlung eine Verminderung der Symptome 
stattfand. Auch gab die Patientin an, eine sofortige Verbesserung des Schlafs zu spüren, was 
auch vom Schlaffragebogen bestätigt wurde. Die Patientin war vor der Akupunktur 
Behandlung nicht in der Lage, einen längeren Schlafqualitätsfragebogen auszufüllen, aber 
nach der Behandlungsperiode war sie wohl dazu in der Lage. Auch wurde eine Verbesserung 
auf der Depressionsskala gefunden, die sich zwar nicht direkt nach der Behandlung, aber drei 
Monate nach Abschluss der Behandlung zeigte. Es wird daraus geschlossen, dass die 
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Resultate dieser Fallstudie zeigen, dass Akupunktur einen positiven Effekt bei Patienten mit 
Schizophrenie haben könnte, wenn sie als zusätzliche Behandlung (neben der Westlichen 
Behandlung) eingesetzt wird. 
 
In früheren Westlichen Studien wurden heterogene klinische Resultate innerhalb der 
Schizophrenie Gruppe und innerhalb der Depressionsgruppe gefunden. In Kapitel 8 wird 
untersucht, wie diese Heterogenität aus der Traditionellen Östlichen Medizinischen 
Perspektive erklärt werden könnte. In dieser Studie werden die unterschiedlichen 
Traditionellen Östlichen Medizinischen (diagnostischen) Muster bei Patienten beschrieben, 
die eine Westliche Diagnose der Schizophrenie, oder eine Diagnose der Depression, oder 
eine Diagnose der Schlafstörung haben. Diese Verhaltensmuster werden sowohl aus der 
Perspektive der Fachliteratur, als auch aus der klinischen Perspektive beschrieben. 
Psychiatrische Störungen können sowohl aus Westlicher, als auch aus Östlicher Perspektive 
beschrieben und behandelt werden, was wichtig ist, wenn man nach der Wirkung von 
Akupunktur in der Psychiatrie forscht. Patienten mit Schizophrenie und Patienten mit 
Depression stehen nämlich höchstwahrscheinlich unter Westlicher Behandlung, wenn sie zu 
einem Akupunkteur oder einer Akupunkteurin für eine (zusätzliche) Behandlung überwiesen 
werden. Deswegen sind Kenntnisse beider Behandlungsmethoden dringend erforderlich, um 
eine erfolgreiche Integration zu ermöglichen. In dieser Studie werden die Daten von 30 
Patienten mit Depression und 30 Patienten mit Schizophrenie präsentiert. Es wurde 
festgestellt, dass wenn eine psychiatrische Gruppe, diagnostiziert konform der Westlichen 
diagnostischen Kriterien, auf Grund von Traditionell Östlichen (diagnostischen) Mustern 
diagnostiziert wird, die gleiche psychiatrische Gruppe in verschiedenen Gruppen von 
Patienten mit psychiatrischen Störungen kategorisiert werden kann. Diese Erkenntnis hat 
weitreichende Konsequenzen für die wissenschaftliche Forschung mit Akupunktur. 
Schließlich wird die Schlafqualität als Behandlungsziel besprochen, die eine entscheidende, 
beeinflussende Rolle für die durch Akupunktur induzierten Behandlungseffekte bei Patienten 
mit Schizophrenie und bei Patienten mit Depression spielen könnte. 
 
In Kapitel 9 werden sowohl der klinische Beleg für den Gebrauch von Akupunktur als 
zusätzliche Behandlung bei Patienten mit Depression und Schizophrenie, als auch der Beleg 
für die zugrundeliegenden Wirkungsmechanismen näher betrachtet. Dafür werden vier 
Karteien (Medline, Scopus, ERIC, und Cochrane Library) bis zum 31. März, 2014 durchsucht. 
Diese Studie umfasst alle systematischen Review Studien und Meta-Analysen im Bereich der 
Akupunktur Behandlung von Depression und Schizophrenie. Randomisierte, kontrollierte 
Studien und Fallstudien im Bereich der Akupunktur und Schizophrenie wurden auch mit 
eingeschlossen, weil die Anzahl der Studien, in denen Akupunktur bei Patienten mit 
Schizophrenie erforscht wird, sehr klein ist. Das Hauptziel dieser Studie war das Bewerten 
der Behandlungseffekte von Akupunktur bei Depression und Schizophrenie mittels eines 
systematischen Reviews. Das zweite Ziel war das Bewerten möglicher, zugrundeliegender 
Wirkungsmechanismen der Akupunktur, ebenfalls mit Hilfe eines systematischen Reviews. 
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Die allgemeinen Resultate für den Gebrauch von Akupunktur bei Depression sind 
vielversprechend, aber die Effektivität von Akupunktur bei Schizophrenie konnte nur wenig 
belegt werden. Akupunktur verbessert die Lebensqualität von psychiatrischen Patienten und 
vor allem die Schlafqualität. Hirnforschung hat gezeigt, dass Akupunktur einen 
modulierenden und normalisierenden Effekt auf das “Limbische-Paralimbische-Neocorticale 
Netzwerk” und das „Default-Mode Netzwerk“ hat. Weil das “Limbische-Paralimbische-
Neokorticale Netzwerk“ sowohl mit Schlaf als auch mit Emotionen in Verbindung gesetzt 
wird, kann dieses Netzwerk die Verbesserung der Lebensqualität und des Schlafs nach 
Akupunktur erklären. 
 
Abschließend kann der Schluss gezogen werden, dass es stärkere Indizien für die Effektivität 
von Akupunktur in der Behandlung von Patienten mit Depression gibt, als in der Behandlung 
von Patienten mit Schizophrenie, wo lediglich kleine Effekte auf Schlaf gefunden wurden. Bei 
Patienten mit Depression scheint Akupunktur die Stimmung zu verbessern und dies könnte 
sich positiv auf den Schlaf auswirken. Zukünftige Forschung nach den Wirkmechanismen von 
Akupunktur bei Patienten mit Depression ist nützlich um zu sehen, welche Prozesse der 
Akupunktur zugrunde liegen und um die Frage zu beantworten, warum Patienten mit 
Schizophrenie offensichtlich weniger sensibel auf die Therapie reagieren. Möglicherweise 
hat Akupunktur mehr Effekte bei schizophrenen Patienten, die ernsthaftere 
psychopathologische Symptome zeigen, als die Patienten, die in den hiesigen Studien 
aufgenommen wurden. Vor allem Forschung, die ersterkrankte Patienten mit Schizophrenie 
und Patienten mit chronischer Schizophrenie in der Behandlung mit Akupunktur miteinander 
vergleicht, ist indiziert. 
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Nederlandse Samenvatting 
 
Gedurende de laatste twee decennia is het gebruik van acupunctuur als een alternatieve 
extra behandeltechniek in de Westerse geneeskunde aan het toenemen. Acupunctuur wordt 
vooral gebruikt als een therapie voor depressie en recent zijn clinici ook gestart om het als 
een extra behandeling van schizofrenie in te zetten. Echter, solide wetenschappelijk 
onderzoek naar de effectiviteit van acupunctuur in de behandeling van patiënten met 
depressie en schizofrenie is schaars, omdat in het bijzonder de werkzaamheid in de 
behandeling van chronische stoornissen compleet ontbreekt. De onderzoeksvraag van het 
huidige proefschrift is daarom of acupunctuur succesvol kan worden gebruikt als een extra 
behandeltechniek in de behandeling van chronische patiënten met depressie en in de 
behandeling van chronische patiënten met schizofrenie. Echter, voordat de mogelijke 
effectiviteit van een nieuwe behandeling kan worden getest, is het belangrijk om een goed 
inzicht te verkrijgen in de problematiek van de patiënten groepen die worden onderzocht: 
patiënten met schizofrenie en depressie. Veel patiënten lijden lang aan depressie of 
schizofrenie en daarom kunnen deze worden getypeerd als chronisch. Een stoornis wordt 
chronisch genoemd, wanneer de patiënt minstens 5 jaar aan die stoornis lijdt. In Hoofdstuk 
1 wordt een overzicht van de diagnostische criteria van schizofrenie en depressie gegeven. 
Binnen de chronische schizofrenie groep evenals binnen de chronische depressie groep 
verschillen patiënten vaak in kenmerken en symptomen. In verscheidende studies werden 
uiteenlopende resultaten voor schizofrenie gevonden; deze resultaten zouden wellicht 
kunnen worden verklaard door de heterogeniteit van de desbetreffende patiënten groep. 
Echter, voor depressie werd hetzelfde probleem van klinische heterogeniteit gevonden. De 
mate van chroniciteit zou verantwoordelijk kunnen zijn voor de wisselende resultaten tussen 
studies, omdat patiënten wellicht anders functioneren en zich anders voelen gedurende de 
eerste 5 jaar nadat ze zijn gediagnosticeerd met een psychiatrische stoornis, dan in de jaren 
die daarop volgen. In vele studies wordt niet genoemd hoe lang de patiënten al aan een 
ziekte leden en ook worden gemengde groepen gebruikt. Een ander belangrijk aspect dat 
onze aandacht verdient en dat mede de gevonden heterogeniteit binnen de schizofrenie en 
depressie groep zou kunnen verklaren, is dat er veel bewijs is voor een correlatie tussen 
psychiatrische stoornissen en slaap stoornissen. Dit wordt verder ondersteund door het feit 
dat eerder onderzoek heeft aangetoond dat wanneer slaapstoornissen niet behandeld 
worden, het risico voor het ontwikkelen van psychiatrische stoornissen toeneemt. Naast het 
in kaart brengen van de problemen achter de heterogene groepen en naast de beschrijving 
van de specifieke patiëntengroepen, is het doel van dit proefschrift bovenal, te onderzoeken 
of acupunctuur kan worden toegepast als extra klinische interventie bij de behandeling van 
patiënten, die lijden aan chronische schizofrenie of depressie en slaap stoornissen. 
 
In Hoofdstuk 2 wordt een studie gepresenteerd waarin wordt onderzocht of de lange duur 
van de ziekte van de depressie en schizofrenie patiënten de manier waarop deze patiënten 
zelf hun psychopathologie en persoonlijkheid op de MMPI-2 (Minnesota Multiphasic 
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Personality Inventory-2), een persoonlijkheidsvragenlijst weergeven, beïnvloedt. Verder was 
het de vraag of demoralisatie, hetgeen kan worden omschreven als een reactie dat op de 
chroniciteit van de stoornis kan volgen, de schalen van de persoonlijkheidsvragenlijst 
beïnvloedt. De chronische patiënten met schizofrenie, de chronische patiënten met 
depressie en de gezonde proefpersonen vulden hiervoor de MMPI-2 in en werden op de 
Klinische Schalen (Clinical Scales) en op de Geherstructureerde Klinische (Restructured 
Clinical) Schalen vergeleken. Demoralisatie was hoger bij de patiënten met depressie dan bij 
de patiënten met schizofrenie en beide psychiatrische groepen verschilden van de groep 
met gezonde proefpersonen. Er wordt geconcludeerd dat patiënten met een chronische 
depressie een verminderd functioneren en een hoge demoralisatie laten zien, terwijl 
patiënten met chronische schizofrenie verrassend genoeg een bijna normaal functioneren 
laten zien en minder demoralisatie. Dit laatste zou ernstige consequenties kunnen hebben 
voor de mogelijkheid voor acupunctuur om de toestand in de chronische schizofrenie groep 
te verbeteren. Bovendien geeft dit resultaat aanleiding tot verschillende vragen met 
betrekking tot de MMPI-2, omdat een ernstig gestoorde patiëntengroep (bijna) normaal 
scoort op deze persoonlijkheidsvragenlijst, vraagt dit duidelijk om nader onderzoek. 
 
In Hoofdstuk 3, komt een ander aspect dat de aandacht verdient aan bod, namelijk de vraag 
of onze psychiatrische groepen inderdaad aan slaap stoornissen lijden, zoals vaak in de 
literatuur wordt gerapporteerd en mocht dit het geval zijn; aan wat voor een soort slaap 
stoornissen lijden ze dan? In deze studie wordt de subjectieve ervaring van parasomnieën en 
andere nachtelijke gedragingen in depressie en schizofrenie onderzocht met behulp van een 
parasomnie screening lijst. In totaal werden 21 parasomnieën en andere nachtelijke 
gedragingen onderzocht. Er werd gevonden, dat hoewel alle depressie patiënten nachtelijke 
gedragingen hadden ervaren, geen van de patiënten een eerdere parasomnie diagnose had 
gekregen of hiervoor was behandeld. 97.6% van alle proefpersonen gaven aan dat ze 
nachtelijke gedragingen ervaren hadden. Dit bleek het hoogst bij depressie, hetgeen om 
meer klinisch besef vraagt en om betere toekomstige behandelingen en resultaten. Een 
onderzoeksinstrument, zoals een parasomnie screening lijst is essentieel in het er uit filteren 
van patiënten, die last van parasomnieën lijken te hebben. Desalniettemin is het belangrijk 
om te beseffen dat zowel schizofrenie patiënten als gezonde proefpersonen ook aan 
parasomnieën lijden. Kort samengevat, laat deze studie duidelijk zien dat beide 
patiëntengroepen aan slaapstoornissen lijden. Dit resultaat geeft aan dat slaapstoornissen 
een belangrijke problematiek zijn, waarmee rekening moet worden gehouden wanneer 
nieuwe behandelingsvormen voor chronische schizofrenie en depressie patiënten worden 
ontwikkeld en getest. 
 
Na deze inzichten in onze chronische psychiatrische patiëntengroepen te hebben verkregen, 
wordt vervolgens een van de hoofdvragen van de thesis onderzocht. Acupunctuur, een 
Traditionele Chinese Geneeskunde techniek, wordt als een extra behandeling (naast de 
standaard Westerse geneeskunde behandeling) ingezet bij de behandeling van patiënten die 
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lijden aan chronische schizofrenie en depressie. Hoofdstuk 4 beschrijft een eerste klinische 
pilotstudie, waarin wordt onderzocht of acupunctuur een positieve invloed op de slaap van 
patiënten met schizofrenie en depressie heeft. Zoals in Hoofdstuk 3 werd besproken, lijdt 
deze patiëntengroep aan slaapstoornissen. Alle proefpersonen werd gevraagd de Pittsburgh 
Slaap Kwaliteits Vragenlijst in te vullen voor en na de experimentele (drie maanden 
wekelijkse acupunctuur behandeling) of controle (wachtlijst) conditie. Er werd gevonden, dat 
beide acupunctuur groepen significant lagere scores op de slaapvragenlijst lieten zien, wat 
niet het geval was voor de wachtlijstconditie. Bovendien werd gevonden dat de effectiviteit 
van de acupunctuurbehandeling voor de schizofrenie patiënten hoger was dan voor de 
depressie patiënten. Kort samengevat, laat deze studie zien, dat acupunctuur in staat lijkt te 
zijn de slaap in deze steekproef, die gekenmerkt wordt door chronische psychiatrische 
problemen, te verbeteren en wordt gesuggereerd dat acupunctuur wellicht een geschikte en 
kosteneffectieve extra (naast hun standaard Westerse) behandeling voor deze groep zou 
kunnen zijn, vooral als acupunctuur groepsgewijs wordt toegepast. 
 
In Hoofdstuk 5 wordt het mogelijke klinische effect van acupunctuur op slaap verder 
onderzocht. Deze studie beschrijft opnieuw een eerste klinische, pilotstudie waarin wordt 
onderzocht of acupunctuur een positieve invloed op de slaap en de symptomen van 
schizofrenie en depressie patiënten heeft. Dit keer werden alle proefpersonen gevraagd 
gedurende twee weken een slaapdagboek bij te houden, daarnaast werd gevraagd of ze een 
stemmingsvragenlijst in konden vullen en aan de behandelende psychiaters werd gevraagd 
om een lijst in te vullen betreffende positieve en negatieve symptomen van de patiënten 
met schizofrenie. Daarna werden zij at random toebedeeld aan een drie maanden durende 
(wekelijkse) experimentele acupunctuur conditie, of aan een wachtlijst conditie. Na de drie 
maanden werden alle testen herhaald. Patiënten met depressie sliepen korter en voelden 
zich meer uitgeput in vergelijking tot de patiënten met schizofrenie. Bovendien waren zij in 
vergelijking tot de gezonde proefpersonen langer wakker gedurende de nacht, hadden zij 
meer tijd nodig om in slaap te vallen, beoordeelden ze hun slaap als minder ontspannen, 
voelden zij zich meer uitgeput en hadden zij een lager gemiddeld prestatievermogen, terwijl 
de schizofrenie patiënten enkel een lager gemiddeld prestatievermogen rapporteerden in 
vergelijking tot de gezonde proefpersonen. Daarnaast werd gevonden dat acupunctuur slaap 
en depressieve symptomen van patiënten met depressie licht verbeterde, maar de slaap en 
de positieve en negatieve symptomen van de patiënten met schizofrenie niet beïnvloedde. 
Deze voorlopige resultaten suggereren dat acupunctuur kan worden gebruikt om tot op 
zekere hoogte de symptomen te verminderen en slaap te verbeteren in patiënten met een 
depressie, maar acupunctuur lijkt geen noemenswaardig effect te hebben voor patiënten 
met schizofrenie. 
 
In Hoofdstuk 6 wordt, naast de vraag of acupunctuur in staat is de stemming van chronische 
depressie en schizofrenie patiënten te verbeteren, de vraag gesteld of acupunctuur ook het 
cognitief functioneren (de werkgeheugen prestatie) van chronische depressie en 
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schizofrenie patiënten kan verbeteren. De patiënten kregen twaalf weken een individuele 
acupunctuurbehandeling en in het onderzoek werd gebruik gemaakt van een pragmatisch, 
klinisch, studiedesign. Alle proefpersonen werden twee keer op een stemmingsschaal, een 
simpele en een complexe werkgeheugentaak getest, een keer voor (T1) en een keer na de 
acupunctuurbehandeling (T2). De resultaten tonen aan dat de acupunctuurbehandeling wel 
de stemming, maar niet het werkgeheugen van de depressie patiënten significant verbetert. 
Verder bleken de stemming en het werkgeheugen van de schizofrenie patiënten niet te 
verbeteren na de acupunctuurbehandeling. 
 
Het is niet alleen belangrijk om naar de kwantitatieve effecten van acupunctuur op 
groepsniveau te kijken, maar ook naar de uitwerking ervan op individueel niveau. Wat zijn 
bijvoorbeeld de effecten van acupunctuur op (het aantal en het soort) hallucinaties van een 
patiënt met chronische schizofrenie? In Hoofdstuk 7, wordt deze vraag nader onderzocht en 
daarnaast worden de kwaliteit van de slaap, de depressieve gevoelens en de positieve en 
negatieve symptomen van de patiënt in kaart gebracht. De casus gaat over een 63 jarige 
vrouw, die aan persistente hallucinaties lijdt en zelfs last van fysieke pijn heeft, als gevolg 
van de hallucinatie van een kraai, die alsmaar in haar rug blijft pikken. De patiënte kreeg 
gedurende 12 weken een acupunctuurbehandeling als extra (naast de standaard Westerse) 
behandeling. Een klinisch, diagnostisch interview werd bij haar afgenomen en ze werd 
psychologisch getest (op de kwaliteit van de slaap en op depressie) daarnaast werden de 
positieve en negatieve symptomen door haar psychiater ingeschat middels de PANSS 
(Positive and Negative Syndrome Scale). Dit vond zowel direct voor, direct na de 12 weken 
acupunctuurbehandeling, als ook 3 maanden na het beëindigen van de 
acupunctuurbehandeling plaats. Uit de resultaten van het diagnostisch interview bleek dat 
de patiënte een verbeterd functioneren gedurende de dag ervoer en ze merkte een 
verandering in haar hallucinaties op. Hoewel ze nog steeds hallucinaties had, voelde ze zich 
daar minder door belast. Interessant was ook dat haar pijn aanzienlijk verminderde. 
Bovendien lieten de resultaten zien, dat de totale score van de positieve en de negatieve 
symptomen onmiddellijk na de acupunctuurbehandeling niet veranderde, echter 3 maanden 
na het beëindigen van de acupunctuurbehandeling vond er een vermindering in van de 
symptomen plaats. Ook beschreef de patiënte een onmiddellijke verbetering van de slaap, 
wat verder bevestigd werd door een slaperigheidsvragenlijst. De patiënte was niet in staat 
om vooraf aan de acupunctuurbehandeling een langere slaapkwaliteitsvragenlijst in te 
vullen, maar was hiertoe wel in staat na de behandelperiode. Ook werd een verbetering op 
de depressie schaal gevonden eveneens niet direct, maar 3 maanden na het beëindigen van 
de behandeling. Er wordt geconcludeerd, dat de resultaten van deze casusstudie aangeven, 
dat acupunctuur een positief effect zou kunnen hebben bij patiënten met schizofrenie 
wanneer het als een extra behandeling (naast de standaard Westerse) wordt ingezet. 
 
In eerder Westers onderzoek werden heterogene klinische resultaten binnen de schizofrenie 
groep en binnen de depressie groep gevonden. In Hoofdstuk 8 wordt onderzocht hoe deze 
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heterogeniteit vanuit een Traditioneel Oosters Geneeskundig perspectief verklaard zou 
kunnen worden. In deze studie worden de verschillende Traditioneel Oosterse Geneeskunde 
(diagnostische) patronen beschreven bij patiënten, die een Westerse diagnose schizofrenie, 
of een diagnose depressie, of een diagnose slaapstoornissen hebben en dit wordt zowel 
vanuit een  TOM literatuur- als vanuit een klinisch perspectief gedaan. Psychiatrische 
stoornissen kunnen zowel vanuit een Westers als vanuit een Oosters perspectief worden 
beschreven en behandeld, wat van belang is wanneer onderzoek naar acupunctuur in de 
psychiatrie wordt gedaan. Patiënten met schizofrenie en patiënten met depressie staan 
namelijk (hoogst)waarschijnlijk onder Westerse behandeling wanneer zij naar een 
acupuncturist(e) voor een (extra) behandeling worden door verwezen en zodoende is kennis 
van beide behandelmethoden noodzakelijk om tot een succesvolle integratie te kunnen 
komen. In deze studie wordt de data van 30 patiënten met depressie en 30 patiënten met 
schizofrenie gepresenteerd. Er werd gevonden, dat als een psychiatrische groep, ingedeeld 
in overeenstemming met de Westerse diagnostische criteria, wordt gediagnosticeerd op 
basis van de Traditioneel Oosterse (diagnostische) patronen, diezelfde psychiatrische groep 
kan worden gecategoriseerd in verschillende groepen van patiënten met psychiatrische 
stoornissen. Deze bevinding heeft verregaande consequenties voor het wetenschappelijk 
onderzoek naar acupunctuur. Ten slotte wordt slaapkwaliteit als een behandeldoel 
besproken, dat een cruciale, mediërende rol zou kunnen spelen bij de acupunctuur 
geïnduceerde behandeleffecten die bij schizofrenie en depressie patiënten worden 
gevonden. 
 
In Hoofdstuk 9, worden het klinisch bewijs voor het gebruik van acupunctuur als extra 
behandeling bij patiënten met depressie en schizofrenie en het bewijs voor de 
onderliggende werkmechanismen nader onderzocht. Hiervoor werden vier databases 
(Medline, Scopus, ERIC, en de Cochrane Library) tot 31 maart, 2014 doorzocht. In deze studie 
werden alle systematische review studies en meta-analyses op het gebied van 
acupunctuurbehandeling bij depressie en schizofrenie geïncludeerd. Gerandomiseerde, 
gecontroleerde studies en casus studies op het gebied van acupunctuur en schizofrenie 
werden ook geïncludeerd, omdat het aantal studies naar acupunctuur in de behandeling van 
patiënten met schizofrenie nogal klein is. Het hoofddoel van deze studie was het evalueren 
van de behandeleffecten van acupunctuur bij depressie en schizofrenie door middel van 
systematische review. Het tweede doel was het evalueren van mogelijke, onderliggende 
werkmechanismen achter acupunctuur, eveneens door middel van systematische review. De 
algehele resultaten voor het gebruik van acupunctuur bij depressie zijn veel belovend, 
echter slechts beperkt bewijs werd gevonden voor de effectiviteit van acupunctuur bij 
schizofrenie. Acupunctuur verbetert de levenskwaliteit van psychiatrische patiënten en dan 
vooral de slaapkwaliteit. Hersenonderzoek heeft aangetoond dat acupunctuur een 
modulerend en normaliserend effect heeft op het “limbisch-paralimbisch-neocorticale 
netwerk”, inclusief het “default-mode netwerk”. Omdat het limbisch-paralimbisch-
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neocorticale netwerk zowel gerelateerd is aan slaap als emoties kan dit netwerk de 
verbetering in levenskwaliteit en slaap na acupunctuur verklaren. 
 
Afsluitend kan worden geconcludeerd dat er sterkere indicaties werden gevonden voor een 
effectiviteit van acupunctuur in de behandeling van patiënten met depressie dan voor 
patiënten met schizofrenie, waarin slechts voorzichtige effecten op slaap werden gevonden. 
In patiënten met depressie, lijkt acupunctuur de stemming te verbeteren en dit zou kunnen 
werken via een positief effect op slaap. Toekomstig onderzoek naar de werkmechanismen 
van acupunctuur in patiënten met depressie is bruikbaar om te zien via welke processen 
acupunctuur werkt en om de vraag te beantwoorden waarom patiënten met schizofrenie 
schijnbaar minder sensitief voor deze therapie zijn. Mogelijk is het zo, dat acupunctuur meer 
effect heeft in patiënten met schizofrenie, die meer ernstige psychopathologie laten zien 
dan de patiënten in de huidige thesis. Vooral acupunctuur onderzoek dat eerste episode 
patiënten met schizofrenie vergelijkt met chronische patiënten vergelijkt is geindiceerd. 
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Prof. Dr. Sabina Lim and to our colleagues Prof. Dr. Seung-Hun Cho, and of course Prof. Dr. 
Sujung Yeo. It is a great honour for me/us to work together with you and may our 
collaboration continue endlessly! 
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Dan bedank ik graag de voorzitter van de manuscriptcommissie: Jan Derksen, die niet alleen 
voorzitter was, maar die daarnaast mijn Masterthesis- en mijn stagebegeleider was. Jan, de 
cirkel is rond, je had een aandeel in ieder diploma dat ik binnen de psychologie behaald heb 
en dat vind ik heel bijzonder! Je hebt me destijds in je praatje met een voormalig 
wedstrijdspringpaard van je vergeleken, dat altijd de mist in ging en pas als niemand er meer 
in geloofde, dan lukte het ineens toch. Daar had je destijds gelijk in en eerlijk gezegd zou je 
voor dit project hetzelfde kunnen zeggen. Bedankt voor alles! 
Verder bedank ik Bart Ellenbroek, die ook al aan het begin van dit project kort geïnvolveerd 
was, maar in verband met een beroepsmatige verandering niet verder betrokken kon zijn. 
Bart, je aanmoediging en je geloof in mijn project heeft me destijds al geïnspireerd en ik vind 
het super tof dat je ook aan het eind betrokken was en al helemaal dat je er extra voor bent 
overgevlogen. Kei bedankt voor alles! 
Ich danke Indira Tendolkar. Indira, wir kennen uns noch nicht so lange, aber ich hoffe wir 
werden noch weiter in der Radboud Universität oder in der LVR-Klinik zusammenarbeiten. 
Danke, dass du bereit warst in meiner Kommission ein zu treten. 
 
Verder bedank ik graag de andere opponenten, allereerst Jos Egger, waarmee ik talloze 
projecten met en zonder studenten heb doorgevoerd. Jos, je geloof in een succesvol einde 
van deze reis heeft me op veel momenten gesteund en ik vind het fantastisch dat je als 
opponent fungeert. Ik hoop van harte dat we nog lang zullen samenwerken! Op het moment 
dat ik Jos bedank, wil ik ook graag de CWOP bedanken, een groep toegewijde onderzoekers 
aan het Vincent van Gogh Instituut te Venray, die me als een van hen opnamen en me lieten 
zien hoe het kan zijn om onderzoek binnen een kliniek centraal te beoordelen en aan te 
sturen. De uiterst professionele werkwijze is een fantastisch voorbeeld dat hopelijk binnen 
de LVR-Klinik een navolging kan vinden. In het bijzonder bedank ik Elis Magnee, die me op 
genereuze wijze twee actiwatches heeft uitgeleend, die we momenteel in gebruik hebben 
voor ons volgende project. Hartelijk dank daarvoor! 
 
Ich möchte Brigitte Ausfeld-Hafter danken für ihre Unterstützung und für die vielen 
interessanten Gespräche in und über alle Welt, die immer wieder für Vertiefung von so 
ungefähr alles sorgen. Maurits und ich kommen dich immer sehr gerne in Zürich-See 
besuchen. Brigitte, du bist voller Überraschungen, deine heimliche und selbstlose 
Unterstützung anderer Menschen ist mir ein Vorbild, und auch dein Kampf für alternative 
Medizin soll weiter geführt werden. Deine Legacy muss behalten bleiben, danke dass ich 
daran teil haben durfte! 
 
Tineke van Rijn, altijd als ik op de afdeling kwam, keek je me enthousiast aan en vroeg hoe 
het was. Je interesse, vertrouwen in een goede afloop en je sprankelende aanwezigheid was 
me een steun. Dank dat je ook bereid bent als opponent te fungeren! 
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Winni Hofman, we kennen elkaar (nog) niet, maar ik wil je hartelijk danken dat je bereid 
bent als opponent te fungeren! 
 
Aan de Radboud Universiteit zou ik Gerard van Oijen willen bedanken. Gerard, je was er 
altijd als ik een technische ondersteuning nodig had en tegelijkertijd gaf je niet alleen 
technische support, maar ook een optimisme en een rotsvast vertrouwen in een goede 
afloop. Je steun heeft meer betekend dan je kunt weten, super bedankt dus voor alles! Ik 
bedank ook Saskia van Uum voor haar eindeloze support en alle moeite die ze voor me 
gedaan heeft. Saskia, je bent de stevige basis van waar uit het prettig werken is, je lost alle 
universiteit-gerelateerde problemen op en doet nog veel meer dan dat! Verder dank ik mijn 
voormalige kamergenoten voor de gezelligheid: Aglaia Zedlitz, Zita Boumann en Dirk 
Bertens. Ook dank ik Loes van Aken en Katinka von Borries voor de leuke samenwerking, hun 
interesse en het meeleven. Ook Annika Lüttjohann en Mehrnoush Zobeiri bedank ik voor de 
gezellige samenwerking! Marianne Nijland en Roald Maes, als mede-Klevenaren, dank voor 
alles! 
 
Magnus Hofmann möchte ich danken für die gesellige Zusammenarbeit mit den Gutachten. 
Du verbesserst mein Deutsch und obwohl ich noch immer Vieles nicht verstehe, habe ich 
den Eindruck ich lerne etwas… und wenn auch nicht, durch dich liefere ich deutsche 
Gutachten ab… Danke für deine Geduld! 
 
Tusen takk til Prof. Dr. Hugo Jørgensen, Prof. Dr. Else-Marie Loberg, Prof. Dr. Erik Johnsen, 
Henriette Murie, og Marianne Langeland. Sandviken sykkehus var den begynnelse av 
prosjekten min, og jeg takker allesammen for den inspirerende samtaler og for a respekteren 
Forskningen min og for alt support! Jeg takker også Prof. Dr. Kenneth Hugdahl, som også 
inspirerte meg å gjøre forskning på min veg og Prof. Dr. Karsten Specht og Dr. Merethe 
Nygard for en kjempe god tid i Norge og for alt support. 
 
Ik bedank Arthur en Miriam Paes voor hun bijdrage in de vorm van het bieden van een 
gelegenheid voor de broodnodige ontspanning. We hebben bij hen in Esneux enorm 
opgeladen, heerlijk gewandeld langs de Ourthe, toekomstplannen gesmeden en het was in 1 
woord top! 
 
Tante Annie en Ome Balt, ik heb het niet altijd beseft, maar de adviezen (en de uitvoering 
van de behandeling die er uit volgde) van tante Annie in het begin van mijn leven, hebben de 
rest ervan enorm beïnvloed. Bedankt daarvoor en ik ben trots dat we gedeeltelijk een zelfde 
weg zijn gegaan. Ik hoop dat ik ooit op een zelfde manier een dergelijke positieve invloed op 
iemands leven zal mogen hebben. Onze bezoeken aan jullie in Spanje en de fijne gesprekken 
aldaar betekenen heel veel voor ons. Bedankt! 
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Corry Habets, heel erg bedankt voor de yoga- en levenslessen, ze vormden een perfecte 
basis voor de rest van mijn leven, ik kon er altijd op terug grijpen als ik het nodig had en ik 
zou vermoedelijk geen PhD behalen in de psychologie en acupunctuur als ik niet deze start in 
mijn leven had gehad. Bedankt Corry, onze tijd samen heeft meer betekend dan ik kan 
uitdrukken. 
 
Ich danke Frau Hannah Szytar dafür, dass Sie mein Leben im Wesentlichen beeinflusst hat. 
Frau Szytar, nicht nur haben Sie mich zum Yoga geschickt, sondern Sie haben meine 
Gesundheit mehrfach gerettet, als niemand mehr weiter wusste. Ich bin Ihnen ewig dankbar. 
 
Dr. Stan Switalla and Dr. Liping Han, I thank you for the inspiring lectures on acupuncture 
and life. I would never have started this PhD project, if it weren’t for you guys. I hope you 
may continue to inspire many more patients and students! Thank you for writing in our book 
and thank you for everything! 
 
From the Shenzhou Open University of Amsterdam: Dr. Weixiang Wang, thank you for being 
my teacher in acupuncture and for taking me on as a teacher at the school afterwards. I find 
it an honour to work with and for you! Mea and Beate, your enthusiasm and your cosy way 
of reminding me of deadlines and all, is really perfect. I enjoy working with you greatly, so 
thanks a lot! Last but not least dhr. Dong, U heeft de perfecte acupunctuurschool opgericht 
voor iedereen in Nederland, die acupunctuur op de Chinese manier zou willen leren. Ik zal 
dat wat ik bij U geleerd heb voor de rest van mijn leven meenemen. Bedankt voor het 
oprichten van de Shenzhou-familie en voor de eer om aan Uw school les te mogen geven. Ik 
dank alle collega’s daar! 
 
Peter de Rover, bedankt voor je enthousiaste vragen en de gezellige samenwerking op het 
gebied van de Chinese ziektebeelden binnen de Westerse diagnosen. Het 
fruitmandprobleem is naar mijn mening een belangrijk punt en zonder jouw idee om de boel 
te vergelijken was het nooit tot het eerste artikel hierover gekomen. Op naar een vervolg! 
 
Jan van Proosdij dank ik voor het uitlenen van een aantal actiwatches. Een publicatie is nog 
in voorbereiding, maar zal zeker nog komen. Jan, je vertrouwen en aanmoediging heeft me 
enorm geholpen, dank daarvoor! 
 
International lectures: Yvonne en Roger, hartelijk dank voor jullie inspiratie en de gezellige 
samenwerking! Ik hoop dat we nog veel samen mogen ondernemen! Jullie professionele 
houding en fantastische missie is me een voorbeeld! 
 
In a cold scientific environment that is sometimes even acupuncture hostile, encounters with 
colleagues that share an interest in acupuncture research can really feel like a warm shower 
after a day on a cold and freezing mountain without protective clothing. There are several 
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colleagues that I would like to thank for their continuing interest, support, their friendship 
and for those moments that I have just described: Prof. Dr. Adrian White, Simon and Young-
Ju Becker-Shin, Prof. Dr. Hugh Macpherson, Prof. Dr. Vinjar Fønnebø, Gerd Ohmstede, 
Dr. Mark Bovey, Prof. Dr. Bruce Rosen, Dr. Patricia Ronan, Prof. Dr. Zhang-Jin-Zhang, Prof. Dr. 
Vadim Rotenberg and Dr. Natasha Rotenberg, Dr. Yifan Yang, Dr. Leila Kozak, Michael Helme 
and Xiao-Tong Gong, Prof. Dr. Nicola Robinson, Prof. Dr. Claudia Witt, Christian Yehoash, 
Linda & Stephen Janz, Judy James, Philip Vanderzeil, Ellen van der Hall, Prof. Dr. Anders 
Baerheim, Prof. Dr. Emil Iliev, Birgit Ziegler, Dr. Dr. Dominique Hertzer, Dr. Stefan Kloiber, 
Marian Nielsen Joos, Dr. Rogier Hoenders, Dr. Ralph Raben, Dr. Lothar Roth, Prof. Dr. 
Gerhard Litscher, Prof. Dr. Harald Walach, Prof. Dr. George Lewith and Dr. Miltiades Karavis. 
In this light, I would also like to thank the authors of our book that I have not thanked yet: 
Neil Quinton, Dominic Harbinson, Dick Brouwer, Ineke van der Lans, Annita Bosveld, Dzelal 
Dani, Dr. Lorin Boyton, Dr. Arushi Sinha, Jacob Bentley, Dr. Seung Youn, Dr. Chihyoung Son, 
Prof. Dr. Qinzhang Ding, Junying Yan, Yixiong Ma. 
 
I would like to thank Prof. Dr. Vitaly Napadow and Prof. Dr. Florian Pfab for the interesting 
discussions, for their time and for the great visit at Harvard Medical School. I hope we can 
continue our collaboration soon. 
 
Ich möchte mich beim ganzen Hogrefe Team bedanken, dass sie unser Buch (Schizophrenia, 
Sleep, & Acupuncture) 2008 herausgegeben haben, es war und ist mir/uns eine Ehre! Vor 
allem Herr und Frau Hogrefe, und natürlich Robert Dimbleby, aber auch Lisa, Christina und 
Gitta, ich danke euch allen! 
 
Marc Beerens bedank ik van harte de fantastische begeleiding rond het drukken van mijn 
thesis! 
 
Ein großer Dank geht an Frau Blumberg, Sie haben mir enorm geholfen mit den Aufträgen. 
Tausend Mal dank für alles! 
 
For our interesting scientific collaboration and the best and most delicious dinners ever, I 
thank the following colleagues at the Vrije Universiteit Brussel: Dr. Katrien Mondt, Prof. Dr. 
Piet van de Craen, Prof. Dr. Esli Struys, Dr. Els Consuegra, and Dr. Jill Surmont. 
 
Ich bedanke mich beim Hospiz Team in Kleve, und freue mich sehr auf die Zusammenarbeit! 
 
Ich danke meinen Mitstreitern für die Heilpraktikerprüfung: Susann Dittrich, Birgit Knoll, 
Angela Reinhardt und unserer Lehrerin beim ALH: Heike Erkelenz. 
 
I thank Angela, Martin, Jessica and Ben for their support and the memorable time. 
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I thank Prof. Dr. Edward Button, my American-English corrector for most articles, Ed, you are 
fast, you are an inspiration and you really increase the fun off it all. Thanks a lot and I hope 
our collaboration continues. 
 
Ich bedanke mich bei allen meinen Praktikanten für die Unterstützung: Nicole 
Küppenbender, Ines Kirchberg, Lara Werkstetter, Isabell Gladen, Lena Goemans, Mira 
Moerkerk, Astrid Schulz-Elze, Julia Schenkwald, Julia Lennertz, Mara Cofalla, Adam Cichon, 
Magnus Hofmann, Elisabeth Burgers, Theresa Wiesner, Lea Linke, Saskia Huld, Helen Leuner, 
Katharina Bachmann, Miriam Ueffing, Ariane Offori, Simon Tkotz, Sandra Westermann, Jana 
Derks, Julia Kleinfeld. 
 
Rosalinde, Ad en Vera, jullie kwamen naar Noorwegen toen we echt steun nodig hadden en 
dat zullen we nooit vergeten. Jullie vriendschap is goud waard! 
 
Silvia, we zijn beste vriendinnen sinds we 9 waren, al zien we elkaar niet zo vaak, de band is 
er altijd. Thank you for being my friend! Ced, onze vriendschap duurt iets minder lang, maar 
de waardering is er niet minder om, bedankt! 
Lenie, al sinds ik 9 ben kom ik bij jullie thuis, we hebben veel meegemaakt samen, nu met 
Benny erbij ben ik blij te kunnen zeggen dat het nog steeds zo voelt: Bedankt voor het 
thuisgevoel! 
 
Bram, jarenlang samen dansen was en is me goud waard. De herinneringen betekenen heel 
veel voor me. Al zien we elkaar tegenwoordig niet zo veel, de band blijft. Ik hoop dat we de 
intensiteit weer iets kunnen opvoeren en ik wil jou en Ton bedanken voor de vriendschap! 
Tonja, dank voor de danslessen, we hebben ervan genoten! 
 
Ik bedank Brigitte, Grietje en Martijn van de OGH Heldring Stichting voor het in mij gestelde 
vertrouwen en de vele gezellige uren vol met psychologische testen en toestanden. Ik 
verheug me op het vervolg! 
 
Dr. Willy Kandera, Dr. Sibylle Würgler , Dr. Gudrun Völker, Alex Bosca, Frau Dr. Hochstrasser 
und allen anderen, die damals in der Privat Klinik Meiringen gearbeitet haben, danke ich für 
meinen Start in die Psychologie. Die Zeit in Meiringen bleibt ewig in meiner Erinnerung als 
die schönste Psychiatriezeit die ich erleben durfte. 
 
Johan en Jenny Muller, Wim en Lisy Pols bedank ik voor hun interesse en gezelligheid! 
 
Dan zijn er nog enkele familieleden die ik speciaal wil bedanken: Allereerst Oma, die 
gedurende acht jaar bijna iedere week gevraagd heeft hoe het ging en die er altijd in geloofd 
heeft dat het me zou lukken om dit project succesvol af te ronden. Oma, de trotse reactie 
toen ik eindelijk echt klaar was, zal ik nooit vergeten! Bedankt voor het meeleven, bedankt 
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voor de afleiding op momenten dat ik er doorheen zat, bedankt voor het vertrouwen, 
kortom bedankt voor alles! 
 
Ik bedank ook graag mijn neefjes en nichtjes: Björn en Aaron, Pim en Nikkie, Sylvano en Una. 
Jullie zijn super! Ik hou heel veel van jullie en als ik ooit iets voor jullie terug kan doen, hoop 
ik dat jullie me weten te vinden! 
 
Mijn Peetoom Piet en Tante Erna wil ik bedanken voor de regelmatige kookavonturen en de 
gezellige tijd! Ik heb het gevoel dat we alles kunnen bespreken en ik ben jullie heel erg 
dankbaar voor het tweede thuis dat jullie me/ons geven! Ome Piet, super super bedankt 
voor het correctuur lezen van deze thesis! Het was geweldig om aan het eind nog iemand te 
hebben die alles door keek en met kritische vragen kwam, heel erg bedankt daarvoor! 
 
Mijn Peettante Carla en Ome Rien wil ik bedanken voor hun gezelligheid en interesse. 
 
Monique en Patrick, bedankt voor jullie steun, jullie waren er toen Maurits en ik echt iemand 
nodig hadden en dat zullen we nooit vergeten! Jullie zijn voor ons heel belangrijk en voor 
Maurits natuurlijk in het bijzonder! Ook Ome Franz en Tante Corrie ben ik erg dankbaar voor 
hun steun in moeilijke tijden en voor het gezellige samen zijn, evenals Simon en Cecilia! Ook 
de Bomma willen we natuurlijk hartelijk danken! Wij komen altijd bijzonder graag in 
Goldscheuer, waar we altijd op een warme ontvangst kunnen rekenen en wij hopen dat we 
die traditie nog lang voort kunnen zetten! 
 
Pap en Mam, ik geloof niet dat ik woorden heb voor wat ik eigenlijk wil zeggen. Jullie hebben 
altijd in me geloofd, me altijd het gevoel gegeven dat er niets in de wereld zou zijn dat ik niet 
aan zou kunnen (zelfs statistiek en mijn Heilpraktikerexamen veranderde daar niets aan) en 
jullie vertrouwen heeft me gevoelsmatig vleugels gegeven. Pap en Mam, bedank veur alles! 
 
Maurits, wij zijn beyond words, zonder jou was ik niet geworden wie ik nu ben. Samen staan 
we sterk is ons motto en dat werkt als een trein! Ik ben zo trots op jou en op het feit dat ik 
jou mijn partner mag noemen, dank je voor alles en ik hou van jou! 
 
Dank jullie allemaal, Thank you all, Tusen takk til alle, Herzlichen Dank an Allen, 
 
Peggy 
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